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CHAPTER 1
general introduction and
outline of thesis
General introduction
Oxygen delivery to the cells is one of the key goals of the circulation. Without 
oxygen, there can be no life. The main determinant of oxygen delivery is cardiac 
output which defines the amount of blood the heart pumps to the body in liters 
per minute. Blood pressure is necessary to push the oxygen enriched blood 
through the tissues. The relation between cardiac output and blood pressure is 
described as:
MAP = (CO x SVR) + CVP
where CO = cardiac output, MAP = mean arterial pressure, SVR = systemic 
vascular resistance and CVP = central venous pressure.  In patients where the 
oxygen delivery is compromised or at risk, one can attempt to optimize oxygen 
delivery by optimizing cardiac output. These patients are often admitted to an 
ICU but can also present in the emergency room, the ward or during surgery. 
Optimizing the circulation is often performed using fluid challenges but can also 
be achieved by the administration of vasoactive or inotropic medication or the 
withdrawal of fluids (1). Getting this right is a crucial step in the treatment of 
the hemodynamically compromised patient.  To optimize the circulation, first 
one needs to measure it. Blood pressure and cardiac output are two of the most 
frequently measured hemodynamic variables and they are mandatory to treat a 
patient with a (potentially) compromised circulation. Depending on the device 
being used, accuracy, risk of complications and discomfort for the patient may 
change. Since the first blood pressure measurement by Stephan Hales in 1733, 
many techniques of measuring blood pressure and cardiac output have been 
developed. Currently, blood pressure in anesthetized and critically ill patients is 
measured predominantly by one of two techniques: the oscillometric technique 
and the intra-arterial catheter.  Cardiac output can be measured by one of the 
multitude of cardiac output monitors currently available for clinical use. They 
all have unique properties and perform differently on qualities such as accuracy, 
ease of operation, risk of complications and operator independency. However, 
not one technique is  perfect and clinicians must base their choice on the specific 
clinical situation at hand (2). Is there a need for a highly accurate technique or is 
a quick and easy technique needed? Nexfin (Edwards Lifesciences/BMEYE B.V., 
Amsterdam, The Netherlands) provides both blood pressure and cardiac output 
measurement continuously and completely non-invasively using a finger cuff and 
has become commercially available several years ago. This technique of finger 
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blood pressure measurement has first been described by Penaz and has been 
implemented by Wesseling et.al. in two previous monitors, the Finapres device 
and the portable Portapres(3, 4).  Finger arterial pressure (FAP) measures blood 
pressure and calculates cardiac output. A finger cuff (Figure 1) is mounted in the 
middle phalanx of the 2nd, 3rd or 4th finger and contains a LED emitter-detector 
and an inflatable bladder. The LED emitter-detector measures blood flow in 
the two arteries at the lateral and medial side of the finger. Under physiological 
circumstances, finger artery diameter varies over the cardiac cycle. With FAP, 
changes in volume due to pulsation are estimated by measuring the change in 
absorbance of light across the finger via photoplethysmography. The inflatable 
bladder generates quickly adjustable pressures so it can keep the diameter of the 
finger arteries constant throughout a cardiac cycle. Because the cuff pressure is 
kept equal to arterial pressure, transmural pressure is kept at zero mmHg and the 
arterial blood supply distal to the finger cuff is not compromised (5). The amount 
of pressure needed to keep this diameter constant, the cuff pressure, is measured 
and this generates the arterial pressure waveform(6). A cross section of a finger 
with a finger cuff is shown in Figure 2.
As finger blood pressure physiologically differs from brachial artery blood 
pressure, the finger artery pressure signal is converted to brachial artery pressure 
by a software algorithm(7). This algorithm corrects for both the different shape of 
the pressure waveform, causing a different pulse pressure, as for the slightly lower 
blood pressure at the site of the fingers. Cardiac output is calculated by a pulse 
contour method, the CO-Trek algorithm. This uses the measured systolic pressure 
time integral from the reconstructed brachial artery waveform. Afterload of the 
heart is calculated from the three-element Windkessel model with characteristic 
impedance and arterial compliance derived from the aortic pressure diameter 
13
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Figure 2Figure 1
relationship using age, gender, height and weight as input parameters .
Beat-to-beat stroke volume (SV) is calculated by dividing the pressure-time 
integral by the calculated impedance (6, 8). The FAP technique thus provides 
a continuous, completely non-invasive blood pressure and cardiac output 
measurement using only a finger cuff. The measurements provides no discomfort 
to the patient and can therefore be used in awake patients and for longer periods 
of time. Its ability to measure blood pressure has been extensively investigated 
in previous studies in healthy volunteers, in outpatients, in anesthetized patients 
and in the critically ill (5, 9-11). 
Outline of this thesis
In the first part of this thesis we investigate the feasibility accuracy of FAP blood 
pressure measurement in small children. In Chapter 2 we measure FAP blood 
pressure measurement and we compare this to the intra-arterially measured 
blood pressure (IAP) and oscillometry (NIBP) in small children admitted to 
the pediatric intensive care unit. Hereafter we use a software algorithm to 
reconstruct brachial artery pressure offline and also compare this to IAP and 
NIBP. In Chapter 3 we investigate the accuracy of FAP to track blood pressure 
changes. We included small anesthetized children during cardiothoracic surgery 
and compared FAP to IAP during rapid blood pressure changes. Hereafter, we 
also compared the reconstructed brachial artery pressure to IAP offline. 
In Chapter 4 we determine the accuracy of FAP in measuring cardiac output 
and tracking cardiac output changes in adult patients. We included post-cardiac 
surgery patients admitted to the ICU requiring fluid therapy and compared FAP 
before and after a fluid challenge to transpulmonary thermodilution. To evaluate 
whether inaccuracies in measuring cardiac output using FAP were caused by 
the non-invasive finger measurement or by the CO-Trek algorithm itself, we 
also compared  cardiac output measured using the CO-Trek algorithm  on the 
intra-arterially derived pressure waveform and compared this to transpulmonary 
thermodilution. 
Chapter 5 describes the accuracy of FAP to determine fluid responsiveness 
in post-cardiac surgery patients. Fluid responsiveness was determined by the 
passive leg raising test using FAP and by pulse pressure, systolic pressure and 
stroke volume variation before a fluid loading.
14
We compared these variables to the change in stroke volume after the fluid 
challenge determined by transpulmonary thermodilution. 
In Chapter 6 we observed the effect of spinal anesthesia on hemodynamics. We 
included patients receiving two different dosages of local anesthetic intrathecally 
and measured FAP throughout the surgical procedure to evaluate whether 
hypotension after onset of spinal anesthesia is caused by a decrease in stroke 
volume, a decrease in vascular resistance or both. 
15
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Abstract 
Introduction
Continuous noninvasive arterial blood pressure can be measured in finger 
arteries using an inflatable finger cuff (FAP) with a special device and has proven 
to be feasible and reliable in adults. We studied prototype pediatric finger cuffs 
and pediatric software to compare this blood pressure measurement with intra-
arterially measured blood pressure (IAP) in critically ill children. 
Methods
We included sedated and mechanically ventilated children admitted to our 
pediatric intensive care unit. We performed simultaneous arterial blood pressure 
measurements during a relatively stable hemodynamic period and compared 
FAP, IAP, and the noninvasive blood pressure oscillometric technique. We also 
compared IAP to a reconstruction of brachial pressure from finger pressure. 
 
Results
Thirty-five children between 2 and 22 kg body weight were included. In total, 
152 attempts to record a FAP pressure were performed of which 4.6% were 
unsuccessful. When comparing FAP to IAP, bias was -16.2, -7.7, and -10.2 mm Hg 
for systolic arterial blood pressure, diastolic arterial blood pressure, and mean 
arterial blood pressure. Limits of agreement (LOA) were respectively 26.1%, 
30.1%, and 22.6%. When reconstruction of brachial pressure from finger pressure 
was compared to IAP, these results were -11.8, 0.6, and -0.9 mm Hg for bias and 
21.7%, 8.9%, and 8.9% for LOA. When noninvasive blood pressure oscillometric 
technique was compared to IAP, the results were: -6.8, -0.9, and -3.8 mm Hg for 
bias and 18.2%, 38.6%, and 22.1% for LOA. 
 
Conclusion
Beta type continuous noninvasive arterial blood pressure monitoring using 
a finger cuff with brachial arterial waveform reconstruction seems reliable in 
hemodynamically stable critically ill children. 
22
Introduction 
Continuous arterial blood pressure monitoring is of great importance in many 
clinical situations, including emergency and critical care medicine but also 
during anesthesia. In this respect, intra-arterial blood pressure measurement 
(IAP) is considered the clinical “gold standard.” In clinical practice, however, 
blood pressure is frequently measured using the noninvasive blood pressure 
oscillometric technique (NIBP) with a cuff around the upper arm. Unfortunately, 
this provides only intermittent measurements, and several studies have suggested 
that NIBP and IAP may differ significantly (1,2). In small children, an intra-
arterial catheter may be difficult to insert and requires specific medical skills. As 
in adults, NIBP measurements in children only provide intermittent data and 
may also be less reliable (3). Therefore, a beat-to-beat, noninvasive and reliable 
technique for tracking arterial blood pressure in small children is highly desirable. 
Continuous noninvasive blood pressure can be measured in finger arteries (FAP). 
It requires a small finger cuff and a special device (Nexfin, BMEYE, Amsterdam, 
The Netherlands). FAP thus provides a noninvasive finger arterial pressure curve 
and has proven to be feasible and reliable in adults (4-6). 
Recently, prototype small finger cuffs especially designed for the pediatric 
population were developed by BMEYE, and a pilot study has shown promising 
results (7). In the current study, we used these prototype pediatric finger cuffs 
(four different sizes) and pediatric software to compare this new noninvasive 
continuous blood pressure measurement with intra-arterially measured 
blood pressure in critically ill children. In a subgroup, we also compared IAP 
measurements with the standard NIBP technique. 
Methods
The local ethics committee responsible for medical research in humans approved 
the study and waived the need for informed consent. Inclusion criteria were 
body weight <60 kg, need for sedation, mechanical ventilation and continuous 
monitoring of intra-arterial blood pressure. Exclusion criteria were fast changes 
in blood pressure or heart rate, clinically detectable ischemia of the fingers and 
kinking or partial obstruction of the intra-arterial catheter. All measurements 
were performed by one of the authors (CH).
Patients were routinely sedated at the discretion of the treating physician 
using several sedatives in combination with morphine and acetaminophen. 
All children’s lungs were mechanically ventilated using a Servo 300 ventilator 
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(Maquet,Getinge, Sweden) with a positive end-expiratory pressure level set 
as judged clinically necessary. Besides IAP, children were monitored with 
electrocardiogram, transcutaneous arterial oxygen saturation, end tidal CO2 and, 
occasionally, central venous pressure. Hemodynamic and respiratory monitoring 
was performed using a HP Merlin type central nervous system monitoring 
system (original a product of HP, Irvine; at present: Philips, Eindhoven, The 
Netherlands). Hemodynamic support included the administration of additional 
fluids or vasoactive drugs when judged necessary. Furthermore, central and 
peripheral hand temperature, urine production, lactate level, capillary refill time, 
and base excess were collected. The severity of illness was calculated using the 
Pediatric Index of Mortality and Pediatric Risk of Mortality Version II score (8,9).
The sites of insertion of the intra-arterial catheter were the femoral, radial 
or brachial artery. The arterial catheters (either 20, 22 or 24-gauge) were 
connected to standard low compliant tubing and a pressure transducer (Edwards 
Lifesciences, Irvine, USA). The pressure transducer was zeroed to ambient air 
pressure and positioned at the level of the midaxillary position. Air bubbles 
were flushed from the system before data collection. The pressure transducer 
was connected to a type 78353B monitor (HP, Irvine, USA). This monitor device 
has an analog output channel, which was connected to the prototype pediatric 
noninvasive finger pressure device (BMEYE, Amsterdam, The Netherlands). 
This device recorded these blood pressure signals with 200 Hz sampling rate 
digitally. The prototype pediatric finger pressure device used in this study uses 
the basic FAP principles as originally developed for the Finapres, with several 
specific new pediatric components, including pediatric finger cuffs, modified servo 
hardware and software and a special pediatric version of the Physiocal expert 
system (5,10). The FAP technique is based on the volume clamp principle of Peñáz 
and was further developed by Wesseling et al (10,11). The method uses an inflatable 
finger cuff that contains an infrared photoplethysmograph on the inside. Figure 1 
shows a picture of a prototype finger cuff in a child. The plethysmograph and the 
air pressure in the cuff are linked by a fast reacting servo system. When pressure 
in the finger artery increases, more blood enters the finger and subsequently 
more light is absorbed. As a consequence, the output of the plethysmograph 
decreases. This output is compared with a set point, which reflects the diameter 
of the artery at near-zero transmural pressure. Consequently, more air is passed 
into the cuff to increase cuff pressure and oppose the initial increase in artery 
blood volume. Vice versa the cuff deflates with decreasing finger blood pressures. 
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Finger arterial pressure is measured indirectly by recording cuff pressure. The 
fast reacting servo system is driven by an expert system (Physiocal, BMEYE, 
Amsterdam) designed to determine and track the correct unloaded diameter at 
which the finger artery is clamped (12). The Physiocal algorithm will keep cuff 
pressure constant at regular intervals. As a consequence, the measurement of 
blood pressure is temporarily (for 2–3 beats) interrupted. Figure 2 depicts an 
example of a simultaneous registration of IAP and FAP. 
FAP measurements were, without preference, performed at the left or right 
hand depending on the possibility to measure on a particular side. For instance, 
bandages or splints to fixate a radial artery prevented measurements on this 
hand. The inflatable finger cuff was applied to the middle phalanx of the finger 
that gave the best signal, preferably the middle or index finger. The NIBP, based 
upon the oscillometric technique with an inflatable cuff around the upper arm, 
was measured using the Merlin type central nervous system monitor (HP, Irvine, 
USA). Because of the arousal reaction with subsequent changes in blood pressure 
as a consequence of NIBP cuff inflation, measurements were only performed when 
clinically feasible and in more deeply sedated children. We selected an upper 
arm cuff of the correct size according to the instructions of the manufacturer. 
Measurements were performed on the same arm as the FAP was measured. 
Because FAP is not measurable during the NIBP measurement at the ispilateral 
hand, we took the FAP value a few seconds prior start of the NIBP measurement.
The finger arterial pressure is physiologically somewhat lower compared to the 
blood pressure measured at the brachial level. A software algorithm can be used 
that converts FAP to a reconstructed brachial artery pressure waveform (reBAP) 
(13). The reconstruction of brachial pressure from finger pressure corrects both 
waveform (affecting pulse pressure) and offset (shifting the curve up or down). 
The cause of the different mean pressure is the resistance to flow, causing 
peripheral mean pressures to be lower than central mean pressures. This shift 
(and other effects) is corrected according to Bos et al (14). The waveform is 
affected by viscoelastic properties and reflections of the arterial tree. In adults, 
the pulse pressure is (on average) greater in the finger than in the brachial artery 
or the aorta. In mathematical terms, this can be described as an amplification of 
the high frequencies if one goes from central to periphery. To correct this, the 
inverse operation (filtering of high frequencies) is applied. In this study, we used 
the version of the algorithm as implemented in the Beatscope 1.1 software (TNO 
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Biomedical Instrumentation, Amsterdam, The Netherlands). In this way, the 
FAP signal was afterwards processed into the reBAP signal using this algorithm, 
although this is designed for adults (14). A version for a pediatric population 
is currently not available. In this study, the IAP data from the three different 
measurement sites (radial, brachial, femoral) were pooled and all blood pressure 
data were analyzed off-line. For each recording, a comparison was made by 
taking an average over a 20–30 s control period taken immediately after onset 
of a recording session as soon as a proper finger blood pressure was obtained. 
Whenever possible, the registrations were repeated over days with a maximum 
of 10 registrations per patient. The FAP signal was recorded simultaneously with 
the IAP signal. 
Data from FAP, reBAP, and IAP were analyzed using Beatscope 1.1 software. 
We compared systolic (SAP), diastolic (DAP), and mean arterial blood pressure 
(MAP) values of IAP, FAP, reBAP, and NIBP for determination of bias and 
limits of agreement in assessing absolute blood pressure levels using the Bland 
Altman analysis (15).  Bias was calculated by subtracting IAP from FAP, IAP from 
reBAP and IAP from NIBP. Limits of agreement were calculated by multiplying 
the standard deviation of the bias with 1.96. In the Bland Altman plot, the bias 
was plotted against the mean value (16). Correlation was calculated using the 
Pearson product moment correlation coefficient in case of a normal frequency 
distribution of data. Otherwise, the Spearman correlation coefficient was used. 
Possible differences between two variables concerning blood pressure values or 
bias were analyzed using the t-test for paired measurements after confirming 
normal frequency distribution of data. Possible differences between more than 
two variables concerning blood pressure values or bias were analyzed using 
analysis of variance. If the analysis of variance test was positive (P < 0.05), 
then a Student-Newman-Keuls test for pairwise comparison of subgroups was 
performed. Possible differences between standard deviations were calculated 
using the F-test. Calculations and data management were performed using Excel 
for windows (Office 2007, Microsoft, Seattle, USA). Statistical calculations were 
performed with MedCalc 9 (MedCalc Software, Mariakerke, Belgium). 
Results
Thirty-five sedated and mechanically ventilated children between 2 and 22 kg 
body weight were included in the study. Further patient details are depicted in 
Table 1. Table 2 shows concomitant variables recorded during the time of blood 
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pressure measurements. During blood pressure recording, some children received 
therapy with (a combination of) vasoactive drugs. There were 13 episodes with 
milrinone, 50 episodes with dobutamine, 15 episodes with epinephrine, and 25 
episodes with norepinephrine. In total, we performed 152 attempts in these 
35 children to record a FAP pressure. In 4.6%, these attempts were unsuccessful. 
On average, 2.5 attempts (range, 1–22) were required to obtain a signal of 
acceptable quality, in which each attempt takes about 1–2 min. The number of 
attempts to achieve a proper FAP recording, by reapplying the finger cuff, was 
higher when cuff-1 (the smallest cuff) was used (P < 0.05). A mean number of 3.7 
attempts was needed for cuff-1, 2.1 for cuff-2, 2.0 for cuff-3, and 1.4 for cuff-xs. 
Table 3 shows the blood pressure averages obtained during the first recording for 
IAP, FAP, and reBAP. Figure 3 shows the Bland Altman plot for SAP, DAP, and 
MAP comparing FAP–IAP and reBAP– IAP. The correlation coefficient between 
FAP and IAP was 0.89, 0.90, and 0.94 for SAP, DAP, and MAP, respectively. 
These values were 0.89, 0.91, and 0.95 for the correlation coefficient of SAP, 
DAP, and MAP between reBAP and IAP. The bias between reBAP–IAP was 
significantly smaller for SAP, DAP and MAP compared to the bias between FAP–
IAP (P < 0.0001). Also the limits of agreement (LOA) between reBAP–IAP were 
significantly smaller than those of FAP–IAP for DAP and MAP (P = 0.01 and 
P = 0.045, respectively) but not for SAP (P = 0.28). There were no significant 
differences in bias between FAP-IAP and reBAP-IAP for SAP, DAP, and MAP 
when IAP was measured using femoral, radial or brachial catheters. Table 4 
shows a comparison between patient subgroups for bias and LOA of FAP–IAP for 
SAP, DAP, and MAP. The correlation coefficient between the central (rectal) and 
peripheral (hand) temperature difference and the bias between FAP–IAP for the 
MAP was -0.17 (P = 0.05). The cuff type used had no effect on the bias between 
FAP and IAP for SAP and MAP. Only for DAP was a significant difference in bias 
between cuff-2 and cuff-1 was present (P = 0.04). 
In a subgroup of 13 children, we compared the bias between reBAP–IAP and 
NIBP–IAP. Fifty-two measurement pairs were collected. All NIBP measurements 
were successful. The subgroup with NIBP measurements was comparable to the 
total group for temperature, lactate level, base excess, urine production, and the 
use of vasoactive drugs. However, body weight was lower (P = 0.009), capillary 
refill time of the finger lesser (p = 0.003) and number of attempts increased (P 
= 0.002). Because of these differences, we did not compare blood pressure data 
from the NIBP group with the whole group. Figure 4 shows the Bland Altman 
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plots of this subgroup for the two methods (reBAP and NIBP) when compared to 
IAP. For DAP, the bias between reBAP–IAP and NIBP–IAP was not significantly 
different (P = 0.33). However, there was a significant difference for the bias in 
SAP (P = 0.0001) and MAP (P = 0.012). The LOA were comparable for SAP
(P = 0.59) but significantly smaller for MAP and DAP (both P < 0.001) when we 
compared NIBP to IAP. 
To exclude the possibility that the repeated measurements in a few patients 
influenced the total result, the bias between FAP–IAP for only the first 
measurement in each patient (n = 35) was compared to the other (repeated) 
measurements (n = 110). There were no differences in bias or LOA for SAP, DAP, 
and MAP. 
In order to analyze sensitivity and specificity of FAP in detecting hypotension, 
we calculated the 5th and 50th percentile of the normal MAP value based upon 
recent literature.16 Because no patient had an IAP value below the 5th percentile, 
we took the 50th percentile as reference. In doing so, the sensitivity for detecting 
a MAP level below or above this value was 98%, 86%, and 86%, respectively, for 
FAP, reBAP, and NIBP. The specificity was 52%, 79%, and 81%, respectively.
Discussion
This study shows that a continuous noninvasive finger arterial pressure 
measurement can be accurate for continuously measuring MAP in stable critically 
ill children. 
In 4.6% of attempts, a FAP signal was not obtainable. Also more than one attempt 
was often necessary to obtain a reliable FAP signal. This was significantly more 
frequent when using the smallest finger cuff, thus in smaller children. Improvement 
in cuff design (cuff-1) and or start-up process of the software in order to shorten 
the interval time for obtaining a proper FAP value seems warranted.
The overall results show a considerable bias between FAP and IAP. The largest 
difference being -21.1% (SAP). The bias for MAP and DAP was lower (-18.6% 
and -18.8%, respectively) and in concordance with results in adults (17,18). 
Interestingly, Andriessen et al. using similar prototype equipment, observed a 
smaller bias in newborns  (7). They observed that the (not reconstructed) mean 
finger pressure was on average about 5 mm Hg lower than the invasive mean 
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pressure. In the current study, the bias of the mean finger pressure is about -10 
mm Hg. Both studies confirm the expected lower peripheral mean pressure. 
Both studies also indicate that the pulse pressure attenuation when reconstructing 
central pressures is not applicable in children. In the current study, the MAP 
and DAP are properly corrected by the reconstruction of the blood pressure, but 
the SAP is 10 mm Hg too low. Also in the latter study, the pulse pressure of the 
FAP is smaller than the pulse pressure of the invasive pressure. It might be more 
appropriate to amplify pulse pressure in the process of reconstructing central 
blood pressures from peripheral pressures in children.
Application of a commercially available device (Finapres) has been described 
earlier in neonates. In this study, the cuffs were put around the baby’s wrist. Results 
showed a small bias and LOA (19). However, when measuring on the finger, venous 
congestive blood pooling is limited to the finger tip, whereas measurements on 
the wrist cause blood pooling in the whole hand, which is painful and not the 
intended use of the method and device. Brachial waveform reconstruction (reBAP) 
in adults leads to a more central blood pressure measurement with narrower LOA 
(14,20,21). In the present study, the performance improved significantly when 
this adult reBAP algorithm was used: for MAP, the bias decreased from -10 to 
-1 mm Hg but also the LOA improved from ±22.6% to ±14%. Considering that 
this algorithm was designed for adults and that arm arterial properties and pulse 
wave propagation in children are different, further improvement seems possible. 
Although, in our study, reBAP was computed afterwards, this is also possible in 
a real-time mode.
Several studies have compared NIBP with IAP and results were comparable to 
our findings in the present study (2,22). However, when NIBP was compared 
to reBAP, the latter had a significantly lower bias for SAP and MAP and also 
significantly lower LOA for MAP and DAP. This demonstrates that measurement 
of MAP in these pediatric patients could be more reliable with reBAP than with 
NIBP.
The study is limited by several factors. First, we used different arterial catheter 
sites. This makes a comparison more difficult, although we could not demonstrate 
a difference between measurements using different arterial catheter sites. 
Second, the cuffs and software used are still f type and must be adjusted for 
commercial use. Third, different interventions and medications can influence 
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the arterial pressure curve on various locations (23,24). Finger artery pressure 
measurement is another way of measuring blood pressure at a site that was 
not used before in children. It therefore has the same limitations as pressures 
measured at the radial, femoral or brachial level in that it does not always reflect 
the aortic pressure. Fourth, although we could not find an effect of a compromised 
peripheral perfusion on the measured pressure difference, this may be explained 
by the relatively stable hemodynamic situation. Therefore, these results should 
not be extrapolated easily to children with severe shock or a rapidly changing 
blood pressure. Fifth, this study was designed to analyze absolute blood pressure 
values. It remains to be studied how accurate this technique is in reflecting (rapid) 
changes in blood pressure. Sixth, we tested the FAP method for a relatively short 
period. It remains to be studied if it can be used in our patients for a longer time.
The finger cuffs can be unpleasant for children. Therefore, clinical use in 
awake children might be limited. If the start-up time of the FAP technique is 
improved, it could provide a fast and continuous signal that might be useful in 
emergency cases but also during procedures when an arterial catheter is difficult 
or impossible to insert. The possibility to estimate and track cardiac output using 
the same technology makes it even more interesting (25). Further studies are 
warranted to prove its clinical value. 
In summary, beta type continuous noninvasive arterial blood pressure monitoring 
using a finger cuff and brachial arterial waveform reconstruction seem reliable in 
critically ill children. The accuracy for measuring DAP and MAP seems at least 
equal to the noninvasive standard, upper arm cuff oscillometric technique. 
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Table 1
Patient characteristics (n = 35)
PICU = pediatric intensive care unit; PIM = pediatric index of mortality;
PRISMII = pediatric risk of mortality version II.
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Diagnosis
      Mean (range)
 
Weight (kg)      7.4 (2 - 22) 
Length (cm)      68.8 (40 - 130) 
Age (months)      20.2 (0.1 – 125.5) 
Length of PICU stay (days)     14 (0.7 - 101.8) 
Survival       93% 
Mean probability of death using PIM    12% (1 – 65%) 
Mean probability of death using PRISM II   28% (3 - 90%) 
 
      22 x congenital cardiac surgery
      3 x trauma
      4 x respiratory insufficiency  
      3 x status epilepticus 
      2 x abdominal surgery
      1 x cardiac failure 
Table 2
Patient variables during blood pressure measurements (n = 145)
PEEP = positive end expiratory pressure; FAP = finger arterial pressure.
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      Mean (range) 
PEEP (cmH2O)      6.2 (3 – 24) 
Body  temperature  (°C)     37.1 (35.0 – 40.7) 
Hand temperature (°C)     32.5 (26.3 – 36.7) 
delta temp % (central – hand temp.)    12.2 (-2.8 – 31.7) 
Lactate level (mmol/l)     1.9 (0.8 – 5.2) 
Urine production in last 2 hours (ml/kg/hour)   3.9 (0.0 – 11.0) 
 
Base excess      -0.7 (-8.9 – 9.4) 
Capillary refill time finger (sec)    2.1 (1 – 12) 
Capillary refill time central (sec)    1.9 (1 – 5) 
Cuff size FAP      57 x cuff-1 
      37 x cuff-2 
      20 x cuff-3 
      31 x cuff-xs 
Arterial catheter position     26 x brachial artery
      51 x radial artery
      68 x femoral artery 
Attempts to achieve FINAP pressure    2.5 (1 – 12) 
Table 3 
Mean blood pressure values with (range)
SAP = systolic arterial pressure; DAP = diastolic arterial pressure;
MAP = mean arterial pressure; IAP = intra arterial pressure;
FAP = finger arterial pressure; reBAP = Reconstructed brachial arterial pressure a 
= Different from FAP b = Different from reBAP c = Different from IAP
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   IAP            FAP                   reBAP 
SAP (mmHg)  89.2 (55.8 – 160.0)a,b          73.1 (44.4 – 154.3)c         77.8 (51.4 – 144.4)c 
DAP (mmHg)  49.9 (31.2 – 90.0)a                42.3 – (18.9 – 91.7)b,c        50.5 (32.6 – 92.6)a 
MAP (mmHg)    63.8 (42.1 – 115.0)a                53.7 (28.7 – 113.6)b,c          62.9 (42.4 – 115.4)a 
ANOVA (p < 0.05)
Table 4
SAP = systolic arterial pressure; DAP = diastolic arterial pressure; MAP = mean arterial pressure; 
SD = standard deviation * = dobutamine or epinephrine or nor-epinephrine or milrinone or 
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SAP (mmHg)   p value       DAP (mmHg)    p value          MAP         p value
bias (LOA)         bias (LOA)   bias (LOA)          bias (LOA)     (mmHg)     bias (LOA)
Body weight 
< 5 kg (n = 68)                    17.0 (17.1)           0.31 (0.03)           7.3 (10.3)            0.59 (0.26)       9.9 (10.6)     0.6 (0.94)   
>= 5 kg (n = 77)                  15.3 (22.2)                                         7.9 (11.8)                                       10.4 (10.7)  
Lactate level 
> 2 mmol/l (n = 65)           14.2 (20.7)          0.40 (0.61)          7.2 (10.2)            0.85 (0.39)        9.7 (9.7)      0.78 (0.19) 
<=2 mmol/l (n = 37)         16.1 (21.2)                                          7.7 (11.5)                                        9.3 (11.7) 
Urine production
< 2 ml/kg/hour                  15.7 (19.1)            0.80 (0.85)         7.0 (13.9)               0.6 (0.1)          9.8 (13.4)    0.78 (0.83) 
                                              16.2 (19.8)                                         7.8 (10.5)                                         10.2 (9.9) 
Capillary refill 
> 2 sec (n = 35)                 17.2 (22.6)            0.47 (0.22)        5 .4 (10.4)             0.54 (0.35)         8.7 (9.3)      0.07 (0.5) 
<= 2 sec (n = 110)             15.8 (19.1)       4.4 (12.1)                                        10.6 (10.9) 
Base Excess 
                                             15.7 (19.7)             0.69 (0.85)         8.1 (11.7)             0.38 (0.45)       10.5 (11.2)     0.46 (0.43)   
                                             16.4 (20.2)                                         7.3 (10.70                                        9.9 (10.3) 
  
Delta temperature 
> 5 ºC (n = 49)                 15.7 (22.7)             0.78 (0.06)         6.7 (12.4)             0.23 (0.27)        9.3 (10.7)    0.25 (0.79)   
<= 5 °C (n = 86)               16.2 (18.1)                                           8.1 (10.8)                                       10.4 (11.0) 
All vasoactive drugs  
With (n = 56)                    20.1 (19.2)                                           7.8 (12.3)            0.72 (0.54)       10.9 (12.2)  0.22 (0.036) 
Without (n = 89)              13.7 (18.9)    7.5 (10.4)                  9.7 (9.5) 
Nor-epinephrine 
With (n = 25)                     13.6 (15.6)            0.17 (0.1)             8.1 (12.5)             0.62 (0.34)       9.2 (12.4)    0.35 (0.18)  
Without (n = 120)     16.7 (20.7)                     7.5 (10.9)              10.3 (10.2) 
last 2 hours
time finger
(n = 32)
*
>=2 ml/kg/hour
(n = 109)
< -2 mmol/l (n = 60)
< -2 mmol/l (n = 85)
0.0002 (0.88)
in bias and limits of agreement (LOA) for SAP, DAP, and MAP among several subgroups
Comparison Between Finger Arterial Pressure (FAP) and intra-arterial pressure (IAP), differences
enoximone or a combination of these drugs
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Figure 1
Example of a beta type blood pressure cuff in use.
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Figure 2
Example of a simultaneous recording of intra-arterial and finger arterial blood 
pressure (without waveform reconstruction). 
Registration in a boy of 6 kg with status epilepticus. The intra-arterial catheter 
was inserted in the right radial artery. Finger blood pressure was obtained from 
the middle finger of the left hand. The intra-arterial blood pressure (IAP) curve is 
lagging behind because of a build-in delay of about 0.25 s of the monitor system. 
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Figure 3
Bland Altman plot for systolic, diastolic and mean arterial blood pressure.
Comparison between IAP, FAP, and reBAP. The printed numbers reflect percen-
tage values for bias and limits of agreement. IAP = intra-arterial pressure; FAP = 
finger arterial pressure; reBAP = reconstructed brachial arterial pressure; SAP = 
systolic arterial pressure; DAP = diastolic arterial pressure; MAP = mean arterial 
pressure.
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Figure 4
Bland Altman plots for arterial pressure, comparison between IAP, 
reBAP and NIBP. 
The printed numbers reflect percentage values for bias and limits of agreement. 
IAP = intra-arterial pressure; FAP = finger arterial pressure; 
reBAP = reconstructed brachial arterial pressure; SAP = systolic arterial pressure; 
DAP = diastolic arterial pressure; MAP = mean arterial pressure.
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In the March 2009 issue of Anesthesia & Analgesia, in the article by Lemson et al., “The Reliability of
Continuous Noninvasive Finger Blood Pressure Measurement in Critically Ill Children” (Anesth Analg
2009;108:814–21), Figure 4 on page 820 was identical to Figure 3 on page 818. The correct Figure 4 is
reproduced below. The authors regret the error.
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Abstract
Background
Continuous non-invasive measurement of finger arterial pressure (FAP) is a 
reliable technology in adults. FAP is measured with an inflatable cuff around the 
finger and simultaneously converted to a reconstructed brachial artery pressure 
waveform (reBAP) by the NexfinTM device. We assessed the adequacy of a 
prototype device (Nexfin-paediatric), designed for a paediatric population, for 
detecting rapid blood pressure changes in children during cardiac surgery.
Methods
Thirteen anaesthetised children with a median age of 11 months (2 months – 7 
years) undergoing congenital cardiac surgery were included in the study. reBAP 
and IAP were recorded simultaneously during the surgical procedure. To assess 
the accuracy of reBAP in tracking blood pressure changes the 4 largest IAP 
variations within a 5-minute time interval were identified from each procedure. 
These variations were compared offline with reBAP during a 10s control period 
before and a 10s period after a blood pressure change had occurred.
Results
In 10 out of 13 children a non-invasive blood pressure recording could be 
obtained. Therefore recordings from these 10 children were eligible for further 
analysis resulting in 40 data points. The correlation coefficient between reBAP 
and IAP in tracking blood pressure changes was 0.98. reBAP followed changes 
in IAP with a mean bias for systolic, diastolic and mean arterial pressure of 0.0 
mmHg (SD 5.8), 0.1 (SD 2.8) and 0.19 (SD 2.7) respectively. 
Conclusion
The prototype device closely follows arterial blood pressure changes children. 
However, in a considerable number of attempts obtaining a signal was time-
consuming or unsuccessful. This technique seems promising but requires further 
technical development.
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Introduction
In children undergoing major surgery, significant changes in arterial blood pressure 
may result in decreased organ perfusion and tissue damage (1). Routinely, non-
invasive blood pressure measurement (NIBP) using the automatic oscillometric 
technique with an upper arm inflatable cuff is used during anaesthesia. Non-
invasive blood pressure measurement is an easy, relatively fast, non-invasive but 
intermittent technique. Therefore NIBP is less suitable for monitoring patients 
with (possible) rapid changes in blood pressure. Also NIBP measurements may 
be less reliable compared to intra-arterial blood pressure (IAP) measurement (2-
5). Intra-arterial blood pressure measurement using an intra-arterial catheter is 
commonly used during major surgery and in critically ill patients. IAP provides 
a reliable and continuous blood pressure measurement and also allows for 
blood sampling. However arterial catheter placement in children is undesirable 
before induction of anaesthesia, can be time-consuming and requires extensive 
experience. In addition, the method is associated with a small risk of bleeding, 
infection and distal limb ischemia (6). For these reasons NIBP is still frequently 
used in small children. 
Blood pressure can be continuously monitored using an inflatable cuff around the 
finger using the NexfinTM device (BMEYE, Amsterdam, The Netherlands). The 
NexfinTM device is the successor of the former FinapresTM device (Ohmeda, USA) 
and is based upon similar technology. This non-invasive finger blood pressure 
measurement method It has been widely studied and has proven to be feasible 
and reliable in adult subjects (7,8). Accuracy and precision of NexfinTM in adult 
patients are compatible with the standards of the Association for the Advancement 
of Medical Instrumentation (AAMI) that allow a maximum bias of 5 mmHg and 
a maximal standard deviation of 8 mmHg (9,10). The former Finapres device has 
previously been studied in children using cuffs originally designed for adults. In 
these studies there was a significant measurement bias compared to IAP, but the 
Finapres accurately tracked short-term blood pressure changes (11-13). Recently 
a research prototype with special adaptations for use in the paediatric population 
(Nexfin-paediatric) was developed by the company that developed the NexfinTM 
device and, in the past, also developed the Finapres device (BMEYE, Amsterdam, 
The Netherlands). In two recent studies, the accuracy of the new prototype for 
measuring arterial pressure in critically ill children under hemodynamic stable 
conditions was shown to be acceptable compared to IAP (14,15).
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The goal of the present study was to assess the accuracy of Nexfin-pediatric in 
detecting rapid blood pressure changes in young children undergoing congenital 
cardiac surgery. 
Methods
Subjects
We included thirteen children scheduled for congenital cardiac surgery. In all 
children IAP monitoring was part of their routine anaesthetic management. 
Non-invasive finger blood pressure measurements were only used for research 
purposes and not for clinical decision making. Because of the non-invasive and 
observational design of adding finger arterial pressure measurements the local 
ethics committee approved the study protocol and waived the need for informed 
consent. We choose this patient group because of the availability of IAP in all 
children and the magnitude of the expected blood pressure changes.
 
Anesthesia 
Premedication consisted of the rectal administration of midazolam 0.3 to 0.5 
mg kg-1. Induction of anaesthesia was performed using inhaled sevoflurane 
(3 – 8%). General anaesthesia was instituted using continuous inhaled 
administration of sevoflurane (approximately 3%) and midazolam (range 0.2 
– 0.3 mg kg-1) in combination with fentanyl boluses (range 1 – 5 microgram/
kg) or continuous infusion (0.1 microgram/kg/min) at the discretion of the 
attending anaesthesiologist. Muscle relaxation was achieved using pancuronium 
0.2 mg/kg. The trachea was intubated using a 3.5 to 6 mm cuffed endotracheal 
tube (Mallinckrod, Hazelwood, USA) and the lungs were mechanically ventilated 
in a volume-controlled mode using tidal volumes of approximately 6-10 ml/kg 
(Aestiva, Datex-Ohmeda, Madison, USA). Normocapnia, guided by capnography, 
was achieved by adjusting the respiratory frequency or tidal volume to maintain 
an end tidal CO2 tension between 4 – 5 kPa. At the end of the surgical procedure, 
all children were admitted to the paediatric intensive care unit. Children were 
routinely monitored using EKG, IAP, transcutaneous arterial oxygen saturation, 
capnography, core temperature, skin temperature and central venous pressure.
 
46
Non-invasive blood pressure measurement
The Nexfin-pediatric is a research prototype that provides continuous, non-
invasive finger blood pressure in children. Both the former Finapres device 
and the new prototype are based upon the volume clamp principle of Peňaz in 
combination with the Physiocal criteria of Wesseling (16-18). The device uses an 
inflatable finger cuff with a built-in photoplethysmograph (figure 1). The pressure 
in the finger cuff is controlled by a fast reacting servo system. The setpoint of 
the servo is determined by the Physiocal criteria and is dependent on the visco-
elastic properties of the wall of the finger arteries. The Physiocal criteria drive 
the calibrating procedure of the device. This calibrating procedure is performed 
automatically and is activated frequently at the start of the measurement, its 
frequency declines when a more stable signal is detected. With this method the 
finger cuff never occludes the finger arteries, which means that the blood flow to 
the finger is maintained under all circumstances. The pressure in the inflatable 
cuff closely resembles the finger arterial pressure (FAP). FAP is physiologically 
lower than blood pressure measured at the brachial level which is the most 
common site of blood pressure readings. Also the waveform characteristics are 
different (19,20). To solve this discrepancy, a software algorithm can be used that 
converts the finger arterial pressure to a reconstructed brachial artery pressure 
waveform (reBAP) (8,21,22). In adults, reBAP is used and displayed real time 
in the NexfinTM device. The Nexfin-pediatric also has this capability. However, 
during this study, the reconstruction of reBAP from the FAP was performed off-
line solely for research purposes. Nexfin-pediatric differs from Nexfin as follows. 
Specially designed research prototype small paediatric finger cuffs in four 
different sizes were used to acquire FAP. The measurement device was adjusted 
for this study and equipped with special paediatric software for servo control and 
physiological setpoint (Physiocal) determination. The device allowed for storing 
FAP and IAP signals simultaneously with a 200 Hz sample rate. Subsequently 
the stored data were processed offline with a special software package (Beatscope 
1.1, TNO biomedical instrumentation, Amsterdam, the Netherlands). Beatscope 
incorporates a software algorithm to convert FAP waveforms to reBAP waveforms. 
After application of the software algorithm for reconstructing the brachial 
arterial signal the resulting reBAP values were stored and compared with IAP 
values. Thus we collected the “raw” finger arterial pressure signal (FAP) digitally. 
Subsequently, we used a software algorithm offline to produce the reconstructed 
signal (reBAP). reBAP is considered the standard and most accurate blood 
pressure signal from this device. 
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Invasive arterial blood pressure measurement
After induction of anaesthesia a 22- or 24-gauge catheter was inserted and 
connected, using standard low compliant tubing, to a disposable pressure 
transducer (Edwards Lifesciences, Irvine, CA, USA). The attending paediatric 
cardiac anaesthetist chose the site of insertion based upon clinical judgment. 
The radial and femoral arteries were the preferred sites. The brachial artery was 
only used when other routes were unsuccessful. The pressure transducer was 
zeroed to ambient air pressure and positioned at the level of the mid axillary 
line. Air bubbles were flushed from the system before data collection. The intra-
arterial pressure measurement was checked for quality by visually inspecting 
the waveform and performing a square wave test. With this test underdamped 
(extra oscillations) or overdamped (slowed upstroke and loss of oscillations) 
pressure systems can be identified. Routine monitoring was instituted using the 
HP Merlin CMS monitoring system (originally a product of HP, Irvine, USA; 
Nowadays: Philips, Eindhoven, the Netherlands). The monitor output signal was 
connected to the Nexfin-pediatric pressure measurement device, which enabled 
the registration of the arterial curve with 200 Hz sampling rate.  
Recording of IAP and FAP
After IAP was obtained, an appropriate size finger cuff was placed on the middle 
phalanx of the second or third finger preferably according to the guidelines 
provided by the manufacturer. In the child with a brachial arterial catheter the 
cuff was placed on the contralateral hand. In five children with a radial artery 
catheter the cuff was also placed on the contralateral side in all but one. When 
a femoral arterial catheter was used either hand could be taken for finger cuff 
placement. The same observer (CMH) applied the finger cuff in all experiments. 
An attempt to acquire FAP was defined as a procedure to apply or reapply the 
finger cuff and start the device until an acceptable finger arterial curve appeared 
on the screen and the Physiocal calibrating procedures were infrequent. The 
quality of the FAP curve was the primary consideration and resemblance with 
the IAP curve was not checked since reconstruction of the FAP signal to reBAP 
was not performed at this stage. The hand was fixed at the midaxillary level to 
prevent any hydrostatic level errors. FAP and IAP were simultaneously and 
continuously recorded using the prototype device during the whole course of 
the surgical procedure, with exception of the period on cardiopulmonary bypass 
(CPB). Although measurement of FAP is possible during CPB this was not the 
goal of this study. Core temperature and temperature of the palm of the hand 
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to which the finger cuff was attached were constantly monitored. The hand and 
fingers were checked regularly for signs of tissue hypoxia or other side effects.
Data comparison
As noted above data were analysed off line. We compared IAP and reBAP 
measurements of absolute blood pressure levels during a 10 second control period 
after onset of a recording session. To determine the ability of reBAP to track blood 
pressure changes, we identified the 4 largest changes in IAP during each surgical 
procedure. This was done by analysing the complete IAP recording afterwards 
for the whole procedure. For each patient we searched for large changes in mean 
arterial pressure (MAP) regardless whether these changes were an increase or a 
decrease in blood pressure. In order to select only rapid changes we also searched 
only for changes that occurred within a five-minute time frame. Eventually the 
four largest changes in (MAP) that occurred within a five-minute time interval 
were eligible for further analysis. At last we compared the blood pressure values 
acquired with IAP with the values of reBAP during a 10 second period just before 
and after a blood pressure change occurred.
Statistical analysis
To assess the adequacy of reBAP in determining absolute blood pressure levels 
we compared reBAP and IAP and calculated bias (reBAP  – IAP) and limits 
of agreement (1,96 x SD) using the Bland Altman method (23,24). Only one 
measurement per patient was used for comparing absolute values. To determine 
the accuracy of tracking blood pressure changes we compared the IAP changes 
to the changes in reBAP using the Pearson correlation coefficient and the Bland-
Altman analysis for repeated measurements (25). Data were checked for normal 
distribution using the Kolmogorov-Smirnov test. The influence of vasoactive 
drugs on the mean bias was checked using the student’s t-test. 
The primary goal of this study was to compare changes in blood pressure as 
measured by reBAP and IAP. Therefore we considered a correlation coefficient 
between changes in reBAP and IAP of 0.9 or greater significant. At the same time 
a value of 0.7 (or less) would be unacceptable. When using a significance level of 
0.05 and power of 0.9 this would require a sample size of 31.7. Since we planned 
to analyse e the four greatest changes in blood pressure per patient this would 
result in 8 children. Because of uncertainties with respect to technical aspects 
we included 5 more children (total 13). Calculations and data management 
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were performed using Excel for windows (Office 2007, Microsoft, Seattle, USA). 
Statistical calculations were performed with MedCalc 11 (MedCalc Software, 
Mariakerke, Belgium).
Results
Thirteen children (ASA class 2-4) with a median age of 11 months scheduled 
for congenital cardiac surgery were included in the study. All patients had an 
adequate IAP signal. In three children no finger arterial blood pressure curve 
could be obtained even after multiple attempts with different sized cuffs on 
different fingers. These children were not different from the other 10 concerning 
type of surgery, baseline blood pressure, heart rate or hand temperature. The 
overall success rate was therefore 76%. Patient characteristics are described in 
table 1. 
On average, we needed 5 attempts for each patient (range 1 – 22) to obtain an 
acceptable FAP signal. A total of 1100 minutes of simultaneous blood pressure 
registration was recorded with a mean of 106 minutes (range 50-180 minutes) 
per patient. Eventually data from 10 patients were eligible for further analysis 
including the 4 largest blood pressure changes per patient this resulted in 40 data 
points for analysis.
During anaesthesia, the mean MAP value measured intra-arterially was 59.5 
mmHg (range 28.4 mmHg to 106.6 mmHg). An example of an individual tracing 
of reBAP and IAP is shown in figure 2. Compared to IAP, reBAP underestimated 
SAP by 8.9 mmHg with limits of agreement (LOA) +/- 20, overestimated DAP 
with bias of 1.8 mmHg (LOA +/- 11) and overestimated MAP with a bias of 0.3 
mmHg (LOA +/- 9.3). The bias between the two measurement methods was not 
significantly correlated to body weight, hand temperature or core temperature 
with a correlation of -0.53 (95% CI -0.86 – 0.14), 0.08 (95% CI -0.74 – 0.66 and 
-0.24 (95% CI -0.84 – 0.62) respectively. There was no difference in bias between 
IAP measured at the radial and reBAP or IAP measured at the the femoral artery 
and reBAP.
Changes in blood pressure measured with reBAP and IAP were highly correlated 
with r2 of 0.96 for SAP, 0.97 for DAP and 0.98 for MAP. The changes in MAP are 
shown in Figure 3. reBAP tracked changes in IAP with a mean bias for systolic, 
diastolic and mean arterial pressure of 0.0 mmHg (SD 5.8), 0.1 (SD 2.8) and 0.2 
(SD 2.7) respectively (Figure 4). 
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Discussion
Our study demonstrates that reBAP measured with the prototype Nexfin-pediatric 
is capable of tracking blood pressure changes in children undergoing congenital 
cardiac surgery. Although several previous studies have been performed in 
children using the former Finapres device, this is the first study to use finger cuffs 
and physiological software especially designed for small children during major 
surgery. The accuracy of reBAP in determining absolute blood pressure was 
comparable to a previous study performed in critically ill children (14).
Unfortunately in almost 25% of patients a FAP signal was not obtainable after 
induction of anaesthesia. This is different from previous studies performed in 
small children admitted to an ICU and from studies in adult patients where reBAP 
shows a success rate of 97% (8,12-15,26). Besides a lower success rate the absolute 
difference between reBAP and IAP was comparable with the previous study (14). 
The lower success rate may be explained by the use of volatile anaesthetics, the 
occurrence of core hypothermia and a decreased environmental temperature in 
the operating theatre. Volatile anaesthetics may reduce peripheral blood flow 
(27). However, after induction, intra-arterial diastolic pressure dropped to an 
average of 46 mmHg, which was only slightly lower than the pressures measured 
in previous studies. Core hypothermia, which commonly occurs during surgery, 
causes vasoconstriction in digital arteries, which reduces blood flow. The use of 
sevoflurane impairs this thermoregulatory response, lowering the threshold for 
peripheral vasoconstriction to 35.1° C (28). However, hand temperature was not 
significantly lower in those patients where a non-invasive signal was unobtainable. 
When assessing the accuracy of a new measuring device, one has to ensure 
an appropriate “gold standard” for comparison. When a gold standard does 
not exist, a new method has to be compared to the next best method. In this 
particular study we used the intra-arterially measured blood pressure. However, 
the adequacy of the IAP, systolic pressure in particular, is affected by the quality 
of the pressure waveform (29). Therefore, measurement discrepancies between 
reBAP and IAP may also result from measurement errors in IAP, although an 
adequate IAP signal was obtainable in every patient.
A limitation of this study is the use of different catheter insertion sites for the 
measurement of IAP, although we were unable to detect significant differences 
in bias between various arterial catheter insertion sites. Also, there was 
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no relationship between bias on the one hand and core temperature, hand 
temperature, and use of vasoactive drugs on the other. Despite a recording period 
of several hours we didn’t encounter any side effects. This is in agreement with 
previous studies in children (12-15).
The research prototype type and the paediatric finger cuffs need further 
development for clinical use in a next version of this device. Also, this version of the 
software algorithm for reconstructing the brachial arterial signal is designed for 
adults. Although it performed acceptably in an earlier paediatric study, a further 
improved version for a paediatric population is currently under construction 
(14). This further improvement is based upon the different elastic properties 
of arteries in children compared to adults (19). Thereafter, more research is 
needed to evaluate the accuracy of this new technique in children. With regard 
to the commercially less interesting paediatric market this development poses a 
challenge to every manufacturer.
In adults the Nexfin technology is capable of measuring cardiac output using a 
reconstructed brachial arterial pressure curve this may be a valuable adjunct to 
Nexfin-pediatric (30,31). Also the reBAP signal could be used for determining 
fluid status using arterial pressure variations (32). In certain cases where a fast 
continuous technique is vital, such as emergency medicine, anaesthesia and 
critical care medicine, a non-invasive finger sensor device could prove to be 
effective. Also, given the non-invasive nature of the measurement, this continuous 
technique could be valuable for research purposes. 
Conclusion
Continuous non-invasive reconstructed brachial artery pressure from finger blood 
pressure adequately reflects intra-arterial blood pressure changes in children 
during cardiac surgery. However the measurement in the operating theatre using 
this prototype can, at the present state of development, still be time-consuming 
and has a significant failure rate. With further development, this technology 
could be useful for monitoring blood pressure in children in the clinical setting.
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Table 1
Patient characteristics
Data expressed as mean values (range)
k= ketanserin, d = dobutamine, m = milrinon, f = fenylephrine, n = nor-epinephrine, 
e = epinephrine, VSD = ventricle septal defect, ASD = atrial septal defect, Fallot = 
tetralogy of fallot, Ross = Ross procedure for aortic stenosis, Glenn = bidirectional 
glenn procedure in case of hypoplastic left heart syndrome, PA = pulmonary artery, 
rad = radial artery, fem = femoral artery, brach = brachial artery.
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Patient  Age   Weight    Vaso-       Procedure            FAP            Temperature   IAP mean       IAP
                                             active            measurement     of the               (range)
                                             drugs                                      successful         hand                                               catheter
                (age)    (kg)                                                                                       (C)                (mmHg)                   site                                                       
                                                                                           
1           47      15  k        PA               yes                35,6           42.5 (48.5- 110.2) rad
                                    reconstruction               
2          33      12  -   Fallot              yes                33,9           46.9 (33.2-63.5) fem
  
3           3       5  d     VSD              yes                37               67.2 (41.7 - 89.7) fem
 
4          90      31   -            Ross procedure          yes                36,4           63.7 (36.2 - 88.0) rad
5          44      13   -     ASD              yes                32,9           64.6 (36.5-77.5) rad
  
6            3        4         m,n,d     VSD              no                 33                54.2 (43.2-68.2) fem
 
7            4        4    -     VSD              no                 35               54.8 (38.0-70.7) fem
8          23       15 m,f   Fontan              yes                35,5           43.8 (35.0-54.0) fem
9            3        4 m     VSD              no                 33                49.2 (30.8-64.2) fem
10         37       12 m,f   Fontan              yes                34,7            53.3 (33.0-68.8) brach
11           2        4 m,n,d     VSD              yes                31,1            41.0 (19.7-87.2) rad
12          8        7 e   Glenn              yes                34,4           54.9 (35.0-67.0) fem
13          11       10 m   Fallot              yes                30,6           55.5 (36.7 - 67.0) rad
Figure 1
Example of a prototype finger cuff applied in a child of 2.5 year (11 kg) with 
finger circumferential of 3.5 cm.
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Figure 2
Example of a 20 second simultaneous pressure recording of reBAP and IAP
In the reBAP signal tracing at 10 seconds, a calibration (physiocal) period can be 
identified
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Figure 3
Changes in IAP versus changes in reBAP for mean arterial pressure
The dotted line reflects the line of equality.  
The solid line reflects the linear correlation
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Figure 4
Bland Altman plot for delta SAP, DAP and MAP
Delta reBAP (the magnitude of the blood pressure change) is compared with delta 
IAP for systolic, diastolic and mean arterial pressure. Mean difference (bias) is 
indicated by the solid line, limits of agreement (1.96 x SD) by the
dashed lines.
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Abstract
Background
Nexfin (Edwards Lifesciences, Irvine, CA) allows for noninvasive continuous 
monitoring of blood pressure (ABPNI) and cardiac output (CONI) by measuring 
finger arterial pressure (FAP). To evaluate the accuracy of FAP in measuring 
ABPNI and CONI as well as the adequacy of detecting changes in ABP and CO, 
we compared FAP to intra-arterially measured blood pressure (ABPIA) and 
transpulmonary thermodilution (COTD) in postcardiac surgery patients during a 
fluid challenge (FC).
Methods
Twenty sedated patients post cardiac surgery were included, and 28 FCs were 
performed. Measurements of ABP and CO were simultaneously collected before 
and after an FC, and we compared CO and blood pressure.
Results
Finger arterial pressure was obtainable in all patients. When comparing ABPNI 
with ABPIA, biaswas2.7mm Hg (limits of agreement [LOA], ±22.2), 4.9 mm Hg 
(LOA, ±13.6), and 4.2 mm Hg (LOA, ±13.7) for systolic, diastolic, and mean 
arterial pressure, respectively. Concordance between changes in ABPNI and 
ABPIA was 100%. Mean bias between CONI and COTD was −0.26 (LOA, ±2.2), 
with a percentage error of 38.9%. Concordance between changes in CONI vs COTD 
and was 100%.
Conclusion
Finger arterial pressure reliably measures ABP and adequately tracks changes in 
ABP. Although CONI is not interchangeable with COTD, it follows changes in CO 
closely.
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Introduction
Maintaining adequate tissue perfusion and oxygenation is of paramount 
importance during anesthesia and in the critical care environment. Establishing 
an adequate cardiac output (CO) is an essential determinant of this therapeutic 
goal. Therefore, over the last decade, there has been an increasing interest in the 
continuous measurement of CO under various clinical conditions. Thermodilution 
is the clinical criterion standard for CO measurement (1), but this technique 
requires the placement of a specific intra-arterial or pulmonary artery catheter 
that might lead to various complications. Therefore, there is a growing need for 
minimally invasive and continuous CO monitoring. This new technique should 
meet the desired requirements of accuracy, operator independence, safety, ease 
of application, and continuous use (2). Furthermore, a fast continuous method 
could be beneficial in tracking CO changes as a result of diagnostic maneuvers 
and interventions. Although a number of methods are available to measure 
CO noninvasively, none of these techniques answers to all requirements, and 
therefore, the method of choice will depend on the physician’s experience, the 
patient, and the clinical situation. 
The Nexfin device (Edwards Lifesciences, Irvine, CA) measures blood pressure 
and CO continuously and noninvasively by measuring finger arterial pressure 
(FAP). The device uses a finger cuff to construct an arterial blood pressure 
waveform using a technique that is based on the volume clamp method developed 
by Peňaz and the physiocal criteria of Wesseling et al (3,4). Nexfin CO-TREK is 
a mathematical model incorporated in the software that calculates beat-to-beat 
stroke volume using the arterial blood pressure waveform (5). This combination 
enables the continuous measurement of blood pressure and CO in a noninvasive 
manner. With the application of the CO-TREK algorithm, it is also possible to 
determine the CO off-line using the invasive blood pressure signal measured 
with an intra-arterial catheter. A small number of studies has been undertaken 
to assess the accuracy of FAP CO in determining absolute CO levels with varying 
results (6-8). However, an important part of hemodynamic optimization is the 
effect of a given treatment such as fluid expansion. Therefore, we assessed the 
accuracy of FAP in tracking CO changes after a fluid challenge (FC).
In this study, we compared CO-TREK CO derived from the noninvasive 
finger blood pressure signal (CONI) and CO-TREK CO derived from the intra-
arterial blood pressure signal (COIA) with CO derived from transpulmonary 
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thermodilution (COTD) using PiCCO (Pulsion Medical Systems, Munich, 
Germany) as the reference method. We also compared FAP blood pressure 
(ABPNI) to intraarterially measured blood pressure (ABPIA).
Methods
Subjects
With the approval of the institutional review board and after obtaining participants’ 
written informed consent, 20 patients admitted to the intensive care unit (ICU) 
following elective conventional cardiac surgery were studied. Exclusion criteria 
were cardiac arrhythmias, preoperative inotropic or intra-aortic balloon pump 
support, and patients requiring emergency or redo cardiac surgery.
Hemodynamic monitoring
Anaesthesia was according to the institutional protocol at the discretion of the 
attending anaesthesiologist. A 20 GA right radial intra-arterial catheter (Becton 
Dickinson and Co, Franklin Lakes, NJ) was introduced before anesthesia induction 
and connected via standard low compliant tubing to a disposable pressure 
transducer (Edwards Lifesciences). After induction, a 2-lumen central venous 
catheter was inserted in the right internal jugular vein for the measurement of 
central venous pressure. Cardiac output was monitored using the PiCCO monitor 
and a 5F thermistor-tipped arterial PiCCO catheter inserted in the femoral artery 
(Pulsion Medical Systems). All pressure monitors were zeroed at the midaxillary 
line. Signals were recorded simultaneously using a sample rate of 200 Hz and 
stored on a hard disk.
Finger arterial pressure CO monitoring
Finger arterial pressure is a device for noninvasive and continuous measurement 
of blood pressure using a finger cuff. A phoplethysmograph mounted inside the 
finger cuff detects changes in finger arterial diameter. Using a fast pneumatic 
system, the diameter of the finger artery can be held at a constant level by rapidly 
varying the pressure in the finger cuff air bladder. This is called the volume clamp 
method. If the artery is clamped at the correct diameter, the pressure in the air 
bladder is identical to the pressure inside the artery, and finger arterial pressure is 
measured. The correct arterial diameter is determined at regular intervals during 
a blood pressure measurement, by a physiological calibration called physiocal (9). 
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Nexfin applies a waveform and level correction methodology to reconstruct finger 
arterial pressure to the arterial pressure waveform at brachial artery level (10). 
Finger arterial pressure calculates beat-to-beat stroke volume by dividing the 
area under the systolic portion of the arterial pressure curve by the aortic input 
impedance (11). The value of this aortic input impedance is determined from a 
3-element Windkessel model described by Westerhof et al (12). In this model, 
the nonlinear effect of mean pressure as well as the influence of the patient’s 
age, height, weight, and sex on aortic mechanical properties is incorporated. 
The algorithm that converts finger arterial waveform to CO is called CO-TREK. 
The noninvasive arterial signal (ABPNI) and CO (CONI) were obtained using an 
appropriate size finger cuff applied to the midphalanx of the left middle or index 
finger according to guidelines provided by the manufacturer. The finger with the 
cuff was positioned at the midaxillary line, and the finger was checked regularly 
for signs of tissue hypoxia. To determine whether inaccuracies in the predictive 
value of the noninvasive finger signal were caused by the noninvasive character 
of the measurement or were caused by inaccuracies in the CO-TREK algorithm 
itself, we also calculated CO using the stored intra-arterial blood pressure signal 
(COIA). The COIA was calculated off-line using the CO-TREK algorithm, and we 
compared this with COTD.
Study design
After surgery, patients were admitted to the intensive care unit (ICU) and sedated 
with midazolam. Finger arterial pressure recording started immediately after 
arrival at the ICU. FAP measurement was considered adequate if physiocal occurred 
at intervals longer than 30 seconds. The intra-arterial pressure measurement 
was checked for quality by visually inspecting the waveform and performing fast 
slush test. If, at the discretion of the attending intensive care physician, an FC 
was indicated, a transpulmonary thermodilution measurement was performed 
by 3 injections of 15 mL of ice-cold saline through the central venous catheter 
before the FC (T1) and 5 minutes after completion of FC (T2). If a difference of 
more than 20% occurred between the 3 thermodilution measurements, injection 
was repeated. Criterion for an FC was presence of a mean arterial pressure below 
70 mm Hg. To evaluate the clinical effect of the FC, another thermodilution 
measurement was performed 30 minutes after completion of the FC if the clinical 
situation permitted, for example, patient still fully sedated, no change in inotropic 
medication, and others (T3). The FC was performed by infusing 6 mL per kg 
ideal body weight of a 130/0.4 6% hydroxyethyl starch solution (Fresenius Kabi, 
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Bad Homburg, the Netherlands) over a period of 15 minutes. Simultaneous data 
of COTD, CONI, ABPNI, and ABPIA were collected throughout the postoperative 
period in the ICU until the patient was extubated according to local standard 
operating procedures.
Statistical analysis
To compare CONI and COIA to COTD, we averaged a 20-second time interval of the 
noninvasive finger measurement and intra-arterial measurement and compared 
it with the simultaneously performed COTD. This interval was chosen to evade 
periods of physiocal, which occurs at regular intervals during a FAP measurement. 
The same time intervals were used to compare ABPNI to ABPIA. Hemodynamic 
parameters were reported as mean ± SD. The Kolmogorov-Smirnov test was 
used to test the normality of the distribution. To assess agreement (bias and 
limits of agreement [LOA]) between the invasive and noninvasive derived 
parameters Bland-Altman analysis was used, which was corrected for repeated 
measurements in 1 subject (13,14). The mean percentage error was assessed using 
the Critchley and Critchley method (15). In addition, we defined an agreement 
tolerability interval ratio using a tolerability interval of 4 L/min (4-8 L/min) (16). 
To assess the hemodynamic change that occurred, we compared a time point 
to the hemodynamic measurement taken earlier, that is, T1 to T2 and T2 to T3. 
For assessing the trending ability of COTD,we determined concordance using a 
4-quadrant plot. Changes in blood pressure and CO smaller than 5% were not 
considered clinically relevant and therefore excluded. Hereafter, we constructed 
a polar plot of CO changes among consecutive time points described by Critchley 
et al (17,18). Influence of temperature and use of vasoactive drugs on bias were 
checked using the Student t test. Statistical analyses were carried out using 
GraphPad Prism version 5.01 (GraphPad software, Inc, La Jolla, CA). Assuming 
an SD of 1.33 L/min (7), we needed a minimum of 69 simultaneous measurements 
to achieve a confidence interval of 0.25 L/min. Assuming we would perform 4 
measurements in each subject, we included 20 patients.
Results
Twenty patients were included in the study. In all patients, a sufficient quality 
FAP waveform was obtained. There were no signs of tissue hypoxia distal to the 
finger cuff, and no adverse events were noted. Twenty-eight FCs were performed 
in 19 patients. One patient did not receive an FC. Because of technical difficulties 
intra-arterial blood pressure, recording failed in 4 patients, which led to 66 pairs 
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of CONI and COTD and 54 pairs of ABP and CONI, COIA and COTD data. Patient 
baseline characteristics and hemodynamic data are shown in Tables 1 and 2, 
respectively.
ABPNI vs ABPIA
Mean bias (SD) and LOA between ABPNI and ABPIA was 2.7 mm Hg (LOA,±22.2), 
4.9mmHg (LOA,±13.6), and 4.2mmHg (LOA,±13.7) for systolic, diastolic, and 
mean arterial pressure, respectively. Comparison between ABPNI and ABPIA for 
mean arterial pressure by a Bland-Altman analysis is depicted in Fig. 1. The ABPNI 
tracked changes of ABPIA with a mean bias of 0 (LOA, ±13.7), −1 (LOA, ± 10.0), 
and −1 (LOA, ±9.6) mm Hg for systolic, diastolic, and mean arterial pressure, 
respectively. Concordance between ABPNI and ABPIA was 100% using the 5% 
exclusion zone. Fig. 2 shows a polar plot depicting the changes in mean arterial 
pressure for the 2 methods. Mean polar angle was 10.4° with an SD of 10.3°. All 
data points lie between the 30° radial limits.
CONI and COIA vs COTD
No significant difference was found between mean absolute values of CONI and 
COTD. The relation between CONI and COTD is depicted in Fig. 3. Mean bias 
between CONI vs COTD and COIA vs COTD was −0.26 (LOA, ±2.2) L/min and −0.78 
(LOA, ±1.9) L/min, respectively. The percentage error between CONI and COTD 
was 38.9%; the percentage error between COIA and COTD was 35.1%. Agreement 
interval was 4.4 L/min, which did not meet the criterion of an agreement 
tolerability interval ratio of 4 L/min, representing marginal agreement. Bias was 
not influenced by temperature of the hand or the use of vasoactive medication.
Changes in CONI vs COTD
The mean change in CO after an FC measured with thermodilution was 0.59 
(range, −1.0 to 2.4) L/min. Concordance rate between CONI and COTD and 
concordance rate between COIA and COTD were 100% and 91.7%, respectively, 
using the 5% exclusion zone. The CONI and COIA tracked changes in COTD with a 
mean bias of −0.31 L/min (LOA, ±1.0) and −0.25 L/min (LOA, ±1.2), respectively. 
Fig. 4 shows a polar plot depicting the changes in CO for 2 methods. Mean polar 
angle was 17.8° with an SD of 13.0°. Of all data points, 82% lie within the 30° 
radial limits. 
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Discussion
The main conclusions from our study are that in a population of patients after 
cardiac surgery, blood pressure was accurately measured by FAP and also FAP was 
capable of tracking blood pressure changes. However, both CONI and COIA were 
not interchangeable with transpulmonary thermodilution for CO measurement, 
although FAP shows strong tracking capabilities for CO changes after an FC.
Bias and precision of diastolic and mean arterial pressure are within the limits 
set by the Association for the Advancement of Medical Instrumentation that 
allow for a maximum bias of 5 mm Hg and a maximal precision of 8 mm Hg 
(19). These results are in concordance with previous studies (7,20,21) where FAP 
was plotted against intra-arterially measured blood pressure. Studies comparing 
ABPNI against a noninvasive blood pressure measurement technique, such 
as oscillometry, show more diverse results, possibly reflecting the underlying 
variability of the noninvasive blood pressure measurement technique (22,23). 
In this study, FAP was not interchangeable with transpulmonary thermodilution 
CO. Although bias was low, percentage error did not meet the criterion of a 
maximum percentage error of 30% proposed by Critchley et al (17). Accuracy of 
FAP was, however, similar to the accuracy of COIA, suggesting that inaccuracy 
of the CO-TREK algorithm is not caused by a less reliable noninvasive arterial 
signal. However, the technique of intra-arterially measured blood pressure relies 
on pressure differences where finger pressure measurement relies on arterial 
diameter changes. This fundamental difference may account for the difference 
between CONI and COIA. In addition, because of the nature of the measurement, 
FAP cannot be influenced by several factors that influence the accuracy of 
intra-arterially measured blood pressure such as kinking, presence of bubbles, 
and blood clots or underdamping. Several other clinical studies evaluating the 
accuracy of FAP show diverse results with percentage errors ranging from 25% 
to 50% (6-8,21,24,25). However, methodological differences such as reference 
techniques, use of vasoactive medication, patient characteristics, and clinical 
situations ranging from critical care to outpatient evaluation preclude direct 
comparison and may account for this wide range in observed accuracy. 
In this study, 82% of all data points fall between the 30° radial LOA reflecting 
marginal trending. This finding is caused by the angular bias of 17.8°. Although 
this angular bias is quite large, the spread around this angle was quite small with 
an SD of 13.0°. This possibly reflects a significant offset in calibration where COTD 
measured greater changes in CO than did CONI.
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In this study, we obtained a good quality noninvasive signal in all patients 
despite the presence of vasoactive medication, hypothermia, or the fact that most 
subjects had a history of hypertension and vascular disease. Although finger 
blood pressure and CO measurement are dependent of finger arterial flow, we 
found no correlation between bias and core temperature or the use of vasoactive 
medication (26). However, norepinephrine dosage did not exceed 0.1 μg/kg per 
minute, and patients were not exposed to core temperatures below 35.4. 
Compared with a single CO measurement, tracking of CO changes to evaluate 
the clinical course or the effect of an instituted treatment may be a more valuable 
tool in patients with hemodynamic abnormalities. In this study, we found a high 
concordance between changes to evaluate the clinical course or the effect of an 
instituted treatment may be a more valuable tool in patients with hemodynamic 
abnormalities. In this study, we found a high concordance between changes in 
CONI and COTD, which corresponds with previous studies investigating the ability 
of FAP in tracking CO changes (6,25). However, this is the first study evaluating 
the accuracy of FAP in tracking CO changes after fluid expansion, in clinical 
practice commonly the first intervention to improve CO. 
Several limitations of our study should be noted. First, we investigated a group 
of postoperative cardiac surgery patients under stable hemodynamic conditions. 
Although 45% of patients required inotropic or vasoactive medication, dosage was 
low. Our data are, therefore, not automatically transferable to other subgroups 
such as critically ill patients or trauma care. Second, although, to our knowledge, 
this is the first study evaluating the accuracy of CONI in tracking CO changes after 
fluid expansion, CO changes after an FC were modest with a maximum of 2.03 L/
min. Further research in tracking CO changes in hemodynamic unstable patients 
is necessary. Third, this study is not designed to determine the accuracy of FAP in 
determining fluid responsiveness. In addition to CO measurement, the prediction 
of fluid responsiveness is an important tool to guide fluid resuscitation during 
hemodynamic optimization. Considering its desirable characteristics, FAP could 
provide a valuable monitor to determine fluid responsiveness. However, further 
research is mandatory to evaluate the accuracy and feasibility of FAP in the 
guidance of fluid optimization.
In this study, we compared CONI to transpulmonary thermodilution. Although 
thermodilution is considered the criterion standard for CO measurement, 
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in previous studies, transpulmonary thermodilution using PiCCO has been 
shown to be less accurate during thoracic surgery or hemodynamic instability 
(27). This may, in part, explain the wide percentage error found in the present 
study. Recently, Peyton and Chong (27) published a meta-analysis comparing 4 
different minimally invasive CO monitors showing that none of the 4 methods 
tested achieved to meet the 30% LOA with thermodilution. They propose that 
a percentage error of 45% in agreement with thermodilution is a more realistic 
precision in clinical practice. The CONI does not meet the criterion of a maximum 
agreement tolerability interval ratio of 1 L/min in the present study (16). The 
concept set by Columb (16) is interesting because it assesses the potential for 
misclassification of a measurement technique that could result in opposing 
interventions. It defines a priori what will constitute an acceptable agreement 
given a certain clinical situation. For example, misclassifying a patient with a low 
output state as a hyperdynamic patient can have severe clinical consequences and 
is therefore unacceptable. However, the concept does not define an acceptable 
agreement for a given measured hemodynamic value within a certain treatment 
population. For example, where an SD of 0.5 L/min in a patient with a CO 
of 8 L/min would be very satisfactory, the same SD in a patient with a mean 
CO of 3 L/min could have severe consequences in clinical decision making. A 
concept that assesses agreement by considering clinical implications given a 
certain measurement value would be very interesting. In an editorial, Feldman 
(28) underlines that in evaluating the efficacy of a new CO monitor, one should 
consider a more dynamic approach incorporating not only bias and precision but 
also clinical utility and safety as well as impact on decision making. In addition, 
next to accuracy several desirable characteristics of a monitoring technique are 
defined, such as safety, operator independence, ease of use, and continuous use 
(2). Considering these characteristics, FAP could be a valuable monitor in the 
perioperative and critical care setting.
Conclusion
Finger arterial pressure is a promising technique for the determination of blood 
pressure and CO. The technique is safe, fast, and easy to use and provides 
a continuous noninvasive blood pressure and CO signal. It is reliable in the 
measurement of blood pressure and the tracking of blood pressure changes. 
Our data suggest that FAP CO is not interchangeable with transpulmonary 
thermodilution with a percentage error of 38.9%, although trending analysis 
showed a high concordance with thermodilution after an FC.
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Table 1
Patient characteristics
CABG = coronary artery bypass grafting, AVR = aortic valve replacement,
FC = fluid challenge, IBW = ideal body weight
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Patient Characteristics
Age (years)
BMI (kg/m2)
Male/Female (n)
Type of surgery (n)
CABG
AVR
CABG + AVR
APACHE II
History (m)
Ischaemic heart disease
Hypertension
Diabetes Mellitus
Obesity
Core temperature (°) at time of FC
Respiratory parameters
Tidal volume (ml kg-1 IBW)
Respiratory rate (1 min-1)
Positive end-expiratory pressure (cmH2O)
Plateau pressure (cmH2O)
Hemodynamic support
Patients receiving norepinephrine (n)
Mean dose (mcg/kg/min)
Patients receiving inotropic support
(Dobutamine/ Milrinone) (n)
Mean dose (mcg/kg/min)
Mean (range)
67 (50-81)
28.3 (21.4-37.1)
17/2
15 
2
2
12.5 (5-20)
18 (90%)
14 (35%)
  7 (35%)
  6 (30%)
37.7 (35.4-38)
Mean (SD)
7.0 (±0.8)
12.6 (±1.2)
6.2 (±1.8)
19.0 (±4.4) 
No (%)
8 (40%)
0.03 (0.01 – 0.08)
4 (20%)
3.8 mcg/kg/min (2.6 – 5) 
Table 2
Hemodynamic changes before and after a fluid challenge.
Data are expresses as mean and standard deviation, n = 28, 5 pairs missing COIA 
and MAPIA due to technical difficulties. * significantly different from reference 
techniques (p < 0,05). SAP = systolic arterial pressure, DAP = diastolic arterial 
pressure, MAP = mean arterial pressure, CO = cardiac output
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Before fluid
challenge,
T1 (n = 28)
5 min after
completion of 
fluid challenge, 
T2 (n = 28)
30 min after 
completion of 
fluid challenge,
T3 (n = 10)
SAPNI (mmHg)        102.2 (12.6)       113.3 (16.7)                 125.4 (19.2)
SAPIA (mmHg)          101.5 (11.5)  116.7 (17.1)         123.2 (19.4)
DAPNI (mmHg)         59.2 (8.9)*  63.0 (9.7)*         71.0 (14.5)*
DAPIA (mmHg)          53.5 (7.4)  58.2 (5.9)         62.0 (7.6)
MAPNI (mmHg)         71.6 (5.1)  81.8 (12.0)*         87.6 (17.2)
MAPIA (mmHg)         68.7 (7.7)  77.4 (8.3)         81.0 (10.9)
COTD (L/min)           5.31 (1.26)  6.29 (0.94)         5.81 (1.36)
CONI (L/min)           5.32 (1.23)  6.12 (1.03)         5.43 (1.38)
COIA (L/min)             4.91 (0.88)*  5.50 (1.03) *         5.66 (0.99)
Figure 1 
Agreement between ABPIA and ABPNI depicted in a Bland-Altman
plot for mean arterial pressure
ABP = Arterial blood pressure
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Figure 2
Polar plot comparing the changes between ABPNI vs ABPIA for mean arterial 
pressure before and after an FC using a 5% exclusion zone. 
The horizontal and vertical axes represent the mean change in blood pressure; 
agreement is represented by the angle with the horizontal axis. Solid line, mean 
polar angle; dotted lines, 95% confidence interval.
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Figure 3
Agreement between COTD and CONI depicted in a Bland-Altman analysis.
CO = cardiac output
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Figure 4
Polar plot comparing the changes between CONI vs COTD before and after an FC 
using a 5% exclusion zone.
The horizontal and vertical axes represent the mean change in CO; agreement is 
represented by the angle with the horizontal axis. Solid line, mean polar angle; 
dotted lines, 95% confidence interval.
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Abstract 
Background
Finger arterial pressure (FAP) calculates stroke volume index (SVI) continuously 
and non-invasively using a finger cuff. This study determines if fluid responsiveness 
can be predicted using the FAP-derived changes in SVI during the passive leg 
raising test (PLR-test), the secondary aim was determining the predictive value 
of the FAP-derived pulse pressure, systolic pressure and stroke volume variation 
(PPV, SPV and SVV, respectively). 
Methods 
Nineteen ventilated post-cardiac surgery patients were studied before and 
after a fluid challenge. SVI was monitored invasively with transpulmonary 
thermodilution using the PiCCO system. FAP (NexfinTM, Edwards Lifesciences, 
Irvine, CA) SVI response to a PLR-test and FAP-derived PPV, SPV and SVV were 
compared to the change in PiCCO SVI after a fluid challenge. 
Results
27 fluid challenges were recorded, 14 cases were classified as responders. The 
area under the receiver operating characteristic curve (AUROC) of the PLR-test 
induced change in FAP SVI was 0.64 (95% CI 0.42-0.82). AUROC of PPV, SPV 
and SVV were 0.78, 0.55 and 0.83 respectively. 
Conclusion 
PLR-test induced changes in SVI measured with FAP cannot reliably predict fluid 
responsiveness in ventilated post-cardiac surgery patients. Fluid responsiveness 
can be predicted adequately using FAP derived PPV and SVV. 
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Introduction
Fluid resuscitation is considered the first choice of therapy to improve 
haemodynamics in most hemodynamically unstable patients. In previous 
studies, optimizing cardiac output has been shown to reduce morbidity and 
mortality following high risk surgery, although controversy regarding the efficacy 
of goal directed therapy remains (1-3). However, approximately only half of 
the administered fluid challenges with the intention to increase cardiac output 
actually result in a significant increase in cardiac output.(4) As also excessive fluid 
resuscitation is associated with increased morbidity and mortality (5), accurate 
prediction of fluid responsiveness, i.e. a n increase in stroke volume index (SVI) 
of > 10-15%,  is of paramount importance in daily clinical practice (6). In previous 
studies, the “traditional” static indices, like central venous pressure, (CVP), have 
proven to be inaccurate and have been replaced by the more reliable so called 
dynamic indices (7). Dynamic indices, including pulse pressure variation and 
systolic pressure variation, can be derived from the arterial waveform. However, 
this requires the placement of an intra-arterial catheter, with its inherent risks. 
Also, it is only reliable in patients on controlled mechanical ventilation, using tidal 
volumes ≥ 8ml/kg and in the absence of various arrhythmias and are therefore 
of limited use in routine practice (8). An increase in stroke volume index (SVI) 
of > 10 during a passive leg-raising test (PLR-test) is an accurate alternative 
clinical test to predict fluid responsiveness with high sensitivity and specificity in 
both ventilated and spontaneous breathing patients (9).  However, the PLR-test 
requires invasive cardiac output monitoring to measure SVI response or operator 
dependant techniques such as oesophageal Doppler or echocardiography. 
Nexfin™ monitor (Edwards Lifesciences, Irvine, CA, USA) provides a non-
invasive continuous arterial pressure and cardiac output measurement using 
finger arterial pressure (FAP)(10, 11). It is a fast and simple technique by means 
of a finger cuff. Several studies have been undertaken to assess the accuracy of 
FAP in determining absolute cardiac output (CO) values and track CO changes 
levels and the found accuracy varied  (12-17). However, in clinical practice, 
predicting the effect of a fluid challenge may be of greater value than determining 
the absolute CO.
In this study, we determined the adequacy of FAP to predict fluid responsiveness 
in post-cardiac surgery patients non-invasively using two different tests. The 
primary objective was to determine the adequacy of a change in SVI measured 
with FAP for use with the PLR test for predicting fluid responsiveness. The 
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secondary objective was to determine fluid responsiveness using the respiratory 
dynamic indices from both FAP and the intra arterial blood pressure measurement 
(ABPIA). We also compared their predictive value to the invasively derived stroke 
volume index response to the PLR-test and respiratory dynamic indices.  
Methods
Patients. 
Ethical approval for this study (Ethical Committee N° 20091171) was provided 
by the Regional Ethics Committee in Nijmegen, the Netherlands. The study 
was registered as part of a larger study protocol in an International directory, 
www.ClinicalTrials.gov (Identifier: NCT01113073). After obtaining participants’ 
written informed consent, 20 patients were studied following cardiac surgery. 
Exclusion criteria were recent myocardial infarction, preoperative inotropic or 
intra-aortic balloon pump support and postoperative cardiac rhythm disturbances 
and spontaneous breathing activity. Patients that did not receive a fluid challenge 
during their ICU admission were excluded from analysis afterwards.
Haemodynamic monitoring. 
A central venous catheter was inserted in the right internal jugular vein for the 
measurement of the central venous pressure (CVP). Arterial blood pressure 
(ABP) was monitored using a 20G radial artery catheter connected via standard 
low compliant tubing to a disposable pressure transducer (Edwards Lifesciences, 
Irvine, CA, USA). The non-invasive arterial signal (ABPNI) was obtained using a 
finger cuff adjusted to the size of the index finger according to the guidelines of 
the manufacturer and connected to the Nexfin™ monitor (Edwards Lifesciences, 
Irvine, CA, USA). The cuff was placed on the contralateral side of the radial 
artery catheter. This non-invasive device is based on the principle of Peňaz (18) 
and measures the diameter of the digital artery using an inflatable finger cuff 
and a built-in photo-electric plethysmograph. From this signal, blood pressure 
in the brachial artery is reconstructed.(19) NexfinTM also calculates beat-to-
beat cardiac output (CONI) and stroke volume index (SVINI) using a dedicated 
algorithm (CO-TREK). The area under the systolic portion of the arterial pressure 
curve is divided by the aortic input impedance (20) and the value of this aortic 
input impedance is determined by a three-element Windkessel mode, using 
the influence of the patient’s age, height, weight and sex on aortic mechanical 
properties.(21)  Reference stroke volume index was intermittently measured 
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by transpulmonary thermodilution using the PiCCO monitor (SVITD) and a 
5-F thermistor-tipped arterial PiCCO catheter inserted in the femoral artery 
(Pulsion Medical Systems, Munich, Germany). A transpulmonary thermodilution 
measurement was performed by three injections of 15 ml of ice-cold saline through 
the central venous catheter. If a difference of more than 20% occurred between the 
three thermodilution measurements, injection was repeated. We did not use the 
continuous PiCCO SVI derived from the femoral artery waveform. All signals were 
recorded simultaneously using a sample rate of 200 Hz and stored on a hard disk. 
We studied the non-invasive prediction of fluid responsiveness in several ways. 
First, we studied the accuracy of the finger pressure derived change in SVINI in 
predicting fluid responsiveness using the PLR test. Secondly, we determined the 
clinical value of predicting fluid responsiveness using non-invasively determined 
respiratory dynamic indices (Table 1). Therefore, we calculated pulse pressure 
variation, systolic pressure variation and stroke volume variation offline from 
the non-invasive finger signal (PPVNI, SPVNI and SVVNI respectively).  We also 
evaluated whether inaccuracies of the FAP in predicting fluid responsiveness were 
caused by the non-invasive character of the measurement or by the algorithm 
itself. Therefore, we performed two more tests. The third test calculated the SVI 
from the intra-arterial pressure wave (SVIIA) offline using the same CO-TREK 
algorithm software provided by the manufacturer, and compared this to SVINI. 
And lastly we compared the non-invasively derived respiratory dynamic indices 
to the predictive value of the invasive derived respiratory dynamic indices using 
the intra-arterial catheter (PPVIA, SPVIA, and SVVIA). For the calculation, the 
average values of the 4 maximum and the 4 minimum pulse pressures (PP), 
systolic pressures (SP) and stroke volumes (SV) during 30 seconds were used: 
PPV = (PPmax – PPmin)/PPmean , SPV = (SPmax – SPmin)/SPmean, and SVV 
= (SVmax – SVmin)/SVmean. Calculation was performed using Matlab (Matlab 
R2009b, MathWorks Inc., MA, USA), and were visually inspected for errors 
afterwards.
Design. 
Recording of physiological data started directly after arrival on the ICU. Fluid 
challenges were administered by the attending physician based upon signs of 
inadequate tissue perfusion, per protocol: mean arterial pressure (MAP) below 65 
mmHg, urine production below 0.5 ml/kg/hr, cold extremities, elevated lactate 
level or low central venous oxygen saturation. Prior to every fluid challenge (6ml 
per kg ideal body weight of a 130/0.4 6% HES solution, Fresenius Kabi, the 
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Netherlands in 5 minutes) SVITD and SVINI were determined and subsequently, 
a PLR test was performed.(22) The PLR test was performed by transferring the 
patient from a semirecumbent posture to a supine position with leg elevation of 
45°. To determine the predictive value of the PLR-test induced change in SVINI the 
fluid challenge was given, irrespective of the hemodynamic result of the PLR test 
measured using FAP. Immediately after completing the fluid challenge, a second 
thermodilution measurement was done to determine the hemodynamic effect of 
the fluid challenge. Patients were identified as a responder if SVI according to 
the PiCCO (SVITD) increased by more than 12% (6). A flowchart of the study is 
depicted in figure 1. 
Statistical analysis. 
To determine the accuracy of non-invasively derived prediction of fluid 
responsiveness using the PLR-test we compared the change in SVINI during 
the PLR-test with the change in SVITD after a fluid challenge and constructed a 
Receiver Operator Characteristic (ROC) curve. To determine the predictive value 
of the invasively measured SVIIA response to a PLR-test we performed the same 
analysis and compared this ROC curve to the predictive value of SVINI using the 
method of Delong et. al.(23) We also used the Bland Altman analysis to compare 
change in SVINI to SVIIA during a PLR. Responders were defined as patients where 
SVITD increased ≥ 12% after a fluid challenge. To compare measured hemodynamic 
parameters at several time-points, 30-second time intervals of ABPNI, SVINI and 
ABPIA were used for further analysis off-line. Normally distributed haemodynamic 
parameters were reported as mean ± standard deviation (SD), data not-normally 
distributed as median and interquartile range (IQR). Differences in baseline 
parameters between responders and non-responders were analysed using t-test 
or the Wilcoxon Signed-Rank test and changes in haemodynamic parameters 
due to the volume expansion were assessed using paired t-test or Mann-Whitney 
U test (based on distribution). For assessing the trending capability of SVINI, 
we determined concordance using a four-quadrant plot. ROC curves were 
constructed for the respiratory dynamic indices to evaluate the predictive value 
of fluid responsiveness and also compared using the method of Delong et. al.(23) 
P-values less than 0.05 were considered statistically significant and statistical 
analysis was done using SPSS Statistics 19.0 for MAC (SPSS Inc., Chicago, Ill.) 
and MedCalc® (MedCalc Software bvba, Belgium).
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Results
We included 20 patients, one patient did not receive a fluid challenge and was 
excluded from further analysis. Characteristics of the remaining 19 patients are 
presented in Table 2. In total, these 19 patients received 27 fluid challenges of 
which 14 resulted in a change in SVI>12% (52%). Three fluid challenges were 
not preceded by a PLR-test due to clinical reasons such as severe hemodynamic 
instability. Therefore, results regarding the PLR involve 24 fluid challenges from 
16 patients. Due to technical difficulties, we were not able to record the intra-
arterial pressure signal in 4 patients. Results regarding the respiratory dynamic 
indices and SVIIA therefore involve 20 fluid challenges from 15 patients. Baseline 
static haemodynamic parameters were not different between responders or non-
responders including MAP, heart rate (HR), global end-diastolic volume (GEDV) 
and central venous pressure (CVP) (p=0.6, 0.6, 0.5 and 0.1, respectively). 
However, SVINI was significantly lower in responders (p=0.01, Table 3).
Non-invasively derived variables
Passive leg-raising test
PLR-induced changes in hemodynamic parameters are depicted in Table 2. 
Regarding the direction of change, concordance between changes in SVINI after 
a PLR and changes in SVITD after a fluid challenge was 89% using a 5% exclusion 
zone (Figure 2). The predictive value (area under the curve) of the change in 
SVINI during a PLR-test for fluid responsiveness was 0.64 (95% confidence 
interval 0.42 – 0.82, sensitivity 79% and specificity 60%) (Figure 3). 
Respiratory dynamic indices
At baseline, PPVNI and SVVNI were significantly higher in the fluid responders 
(see Table 3). The predictive values for fluid responsiveness (area under the 
curve) of the respiratory dynamic indices were 0.78 (95% CI 0.54 – 0.93), 0.55 
(0.31 – 0.77) and 0.83 (0.60 – 0.96) for PPVNI, SPVNI and SVVNI 
Invasively derived variables
Area under the curve of change in SVIIA during a PLR was 0.68 (confidence in-
terval 0.39-0.97, sensitivity 91% and specificity 57%). There was no significant 
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difference between the area under the curves of the change in SVI during a PLR 
between the invasively SVIIA and non-invasively derived values SVINI (p = 0.66). 
Median bias between change in SVIIA and SVINI during a fluid challenge was -1.19 
ml/m2 [IQR -3.2 - 0.9]. The predictive values for fluid responsiveness of the re-
spiratory dynamic indices were 0.83 (95% CI 0.60 – 0.96), 0.64 (95% CI 0.40 
– 0.84) and 0.78 (95% CI 0.54 – 0.93) for PPVIA, SPVIA and SVVIA, respectively 
(see Figure 4 and Table 4 for more details). There was no significant difference 
between predictive value of the invasively derived respiratory dynamic indices 
and the respiratory dynamic indices derived using the finger cuff, p = 0.42, p = 
0.12 and p = 0.6 for PPV, SPV and SVV, respectively. 
Discussion
This study shows that the accuracy of the prediction of fluid responsiveness using 
a PLR test with the non-invasively FAP system is too limited to be used in clinical 
practice. Although concordance of the direction of SVI change between SVINI  and 
SVITD after a fluid challenge was high (in agreement with earlier studies), (24) 
area under the curve showed limited discriminative value for predicting changes 
in SVINI after fluid loading. However, the non-invasively derived respiratory 
dynamic indices (PPV and SVV) perform evenly accurate compared to their 
invasive derived counterparts. 
To our knowledge, this is the first study determining the capability of FAP of 
predicting fluid responsiveness using a PLR and subsequent fluid loading. There 
was no significant difference between the predictive values of the SVINI and the 
invasively derived variables. This indicates that inaccuracies of SVI measurement 
are not caused by the non-invasive nature of the finger measurement, but by 
the CO-TREK algorithm itself. In previous studies regarding the validation 
of PLR using various cardiac output measurement techniques to identify fluid 
responsiveness, baseline cardiac output and mean increase in SV in reaction to 
PLR or fluid challenges were larger between responders and non-responders (22, 
25-27). Considering the above, the apparent inability of the CO-TREK algorithm 
to predict fluid responsiveness using PLR may be caused by the fact that the 
precision of thermodilution together with the precision of CO-TREK, which is 
currently unknown, is too wide to achieve a high AUC with a cut-off point of 
12%, especially when relatively small changes in SV occur such as in this study. 
Fifty-two percent of the patients were classified as fluid responders which is in 
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concordance with previous literature (4). We used a cut-off point of 12% as it was 
determined that this is the smallest relevant change that can be reliably measured 
using three thermodilution bolus injections (28). Clinical studies are necessary to 
further determine CO-TREK precision.  
The non-invasive blood pressure signal was obtainable in all patients without 
adverse events. In other studies however, ABPNI (and consequently SVINI) was 
not obtainable in a considerable amount of patients, possibly related to reduced 
finger arterial flow due to shock and the use of norepinephrine.(12, 29, 30) 
Although in our study also 42% of all patients received norepinephrine, mean 
dosage was low compared to a previous studies performed in critically ill patients.
(12, 30, 31)
An acceptable agreement was found between the respiratory dynamic indices 
derived both non-invasively and invasively, which confirm our results from a 
previous study.(32) Furthermore, the present study also shows that non-invasive 
derived respiratory dynamic indices predict fluid responsiveness as good as the 
invasively derived ones. These results are in agreement with other studies that 
compared the prediction of non-invasively derived PPV (using Finapres® monitor 
or Infinity® CNAPTM SmartPod®) (33, 34) and SVV (by oesophageal Doppler) 
21 during surgery and in critically ill patients using FAP (29) However, probably 
because the average tidal volume did not met the frequently used criterium of 
8ml/kg,(8) the predictive value of the respiratory respiratory dynamic indices 
was somewhat lower compared to other studies.(4, 35) We found a remarkable 
difference between the predictive value of SPV compared to PPV and SVV. In 
previous studies determining the accuracy of finger arterial blood pressure, 
systolic blood pressure measurement was less accurate than diastolic and mean 
arterial pressure measurement.(10, 36) This finding may be caused by the change 
in the arterial waveform from central arteries to the periphery. This causes a 
pressure gradient along the arterial tree resulting in pulse wave amplification.28 
This phenomenon may explain the moderate predictive value of SPVNI measured 
at the site of the digital arteries. 
Several limitations of our study should be noted. First, we used PiCCO® as 
our reference method to determine the cardiac output response following the 
fluid challenge. Although PiCCO® has been shown to be interchangeable with 
Swan-Ganz thermodilution cardiac output monitoring, it has several limitations, 
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especially during cardiac surgery or episodes of haemodynamic instability.
(37, 38) This inaccuracy, caused by the fact that this technique is sensitive to 
differences in injection technique, and blood temperature,(39) may result in a 
precision error of 12%. This makes the thermodilution technique possibly less 
reliable compared to a reference technique under circumstances where small 
changes in cardiac output occur, as during the PLR. Second, we investigated only 
a small group of patients following cardiac surgery. A recent study investigating 
the adequacy of FAP for tracking the effects of a fluid challenge in 45 septic 
patients also showed a low reliability. These unfavourable results were possibly 
caused by finger hypoperfusion due to sepsis and high dosage of norepinephrine.
(30) Whether the results of our study are also applicable to other clinical settings 
such as trauma care or perioperative care remains to be investigated. Potentially, 
improved sensitivity of FAP could be observed in patients with larger cardiac 
output changes after fluid loading such as in patients with severe hypovolemia or 
septic shock. Future studies should evaluate the accuracy of FAP in these patient 
categories.  
This study was conducted in sedated and mechanically ventilated patients. An 
important patient category where fluid optimisation currently remains a challenge 
is the awake patient with spontaneous breathing activity. Due to its fast and non-
invasive nature, if proven accurate in this clinical setting, FAP could provide a 
valuable tool in haemodynamic optimisation in this patient category where 
invasive monitoring is less desirable. However, this remains to be confirmed in 
future studies. 
Conclusion
In conclusion, the predicitive accuracy of FAP is too limited to reliably predict 
fluid responsiveness using the PLR-test. However, responders can easily and 
accurately be identified using respiratory dynamic indices derived from finger 
blood pressure wave. The ability of FAP to predict fluid responsiveness using 
PLR-testing or respiratory dynamic indices did not differ from the predictive 
value of invasively derived variables using the same software algorithm.  
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Table 1
Derived variables from each measurement device
PPV = pulse pressure variation, SPV = systolic pressure variation, 
SVV = stroke volume variation, SVI = stroke volume index, 
GEDV = global end-diastolic volume
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Measurement device     Derived variables
FAP       SVINI
       PPVNI
       SVVNI
       SPVNI
Intra arterial catheter (+ CO-TREK)   SVIIA
       PPVIA
       SVVIA
       SPVIA
       MAP
PiCCO        SVITD
       GEDVTD
Table 2
Patients’ characteristics and baseline haemodynamic variables. 
Data are expressed as mean and rage or standard deviation. SD = standard devia-
tion, CABG = coronary artery bypass graft, AVR = aortic valve repair, IBW = ideal 
body weight
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Patient characteristics         Mean (range)
Age (years)         67 (50-81)
Body mass index (kg/m2)        28.5 (21-37)
Male/Female (#)         16/3
Type of surgery (#)
   CABG           15 
   AVR           2
   CABG + AVR          2
Core temperature         36.5 (35.8 – 37.8)  
Respiratory parameters         Mean (SD)
   Tidal volume (ml kg-1 IBW)        7.1 (0.8)
   Respiratory rate (1 min-1)        12.5 (1.2)
   Positive end-expiratory pressure (cmH2O)       6.1 (1.8)
   Plateau pressure (cmH2O)        18.9 (4.3)
Patients receiving norepinephrine       %, mean dosage               Sign diff
        (p-value) 
   Responders                      56%, 0.04 (0.01–0.07)      No (0.29)
          mcg/kg/min
 
  Non-responders                      30%, 0.04 (0.01–0.05) 
          mcg/kg/min
Table 3
Haemodynamic changes during study protocol. 
Data are expressed as mean and standard deviation (SD). Significance mark 
(*=p<0.05, **=p<0.01) in the second column indicates significant difference between 
non-responders and responders, the mark in third, fourth and fifth column indicates 
significant difference compared to baseline. FC = fluid challenge , HR = heart rate, CVP 
= central venous pressure, MAP = mean arterial pressure, SVI = stroke volume index, 
GEDV = global end-diastolic volume, PPV = pulse pressure variation, SPV = systolic 
pressure variation, SVV = stroke volume variation
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Baseline 
(95% CI)
N = 24
73 (33-114)
67 (45-89
9.8 (3.5-16.2)
12.1(6.8-17.4)
69.9 (55.5-84.3)
67.9 (52.2-83.5)
33.6 (23.7-43.4)
39.7 (30.2-49.2)**
33.4 (16.6-50.1)
43.2 (31.7-54.6)**
642 (458-826)
698 (556-836)
12.4 (-0.1-24.9)
7.7 (1.8-13.6)*
6.5 (1.0-12.0)
5.7 (2.8-8.6)
10.7 (-6.7-28.1)
6.4 (1.5-11.3)*
PLR
(95% CI)
N = 24
73 (34-112)
68 (47-89)
12.3 (5.1-19.2)
12.3 (5.0-19.6)
85.2 (57.3-115.6) **
79.8 (62.6-97.0) **
36.1 (24.6-47.7)
42.2 (37.7-49.6)
5 min after 
FC (95% CI)
N = 24
73 (35-111)
68 (50-87)
11.0 (4.1-19.7)
12.2 (3.7-20.8)
76.4 (58.4-94.5) *
74.3 (58.2-90.3)
36.9 (27.2-46.7)
41.4 (31.6-51.3)
41.9 (24.9-58.9)
44.9 (32.7-57.0)
725 (532-916)
733 (598-868)
8.6 (-1.0-18.2)
6.0 (0.7-11.2)
4.6 (0.7-8.6)*
4.8 (1.7-7.9)
9.7 (-6.7-26.1)
5.3 (1.8-8.8)
30 min after FC
(95% CI)
N = 10
75 (30-120)
75 (50 -102)
10.1 (0.2-19.9)
14.1 (8.2-20.0)
87.5 (65.5-109.5) *
75.9 (59.8-92.0)
35.1 (19.3-50.9)
35.5 (24.8-48.3)
38.2 (24.4-52.1)
41.9 (36.4-47.5)
676 (609-739)
775 (517-948)
10.8 (-0.4-22.0)
6.5 (3.2-9.8)
5.4 (0.7-10.1)
5.3 (1.8-8.8 )
9.5 (1.7-17.3)
6.4 (5.0-7.8)
Resp
Non-resp
Resp
Non-resp
Resp
Non-resp
Resp
Non-resp
Resp
Non-resp
Resp
Non-resp
Resp
Non-resp
Resp
Non-resp
Resp
Non-resp
HR
(b/min)
 
CVP
(mmHg)
MAPIA 
(mmHg)
SVINI 
(ML/m2)
SVITD 
(ML/m2)
GEDVITD 
(ml/m2)
PPVNI 
(%)
SPVNI 
(%)
SVVNI 
(%)
Table 4
Results of the ROC for the prediction of fluid responsiveness curve analysis. 
Data are expressed as mean and 95% confidence interval. PPV = pulse pressure 
variation, SPV = systolic pressure variation, SVV = stroke volume variation, SVI = 
stroke volume index, 95% CI = 95% confidence interval 
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        Variable            AUC (95% CI)     Sens (%) Spec (%)    Threshold (%)      Sign (p)
Dynamic
indices
PLR
PPVNI
SPVNI
SVVNI
PPVIA
SPVIA
SVVIA
SVINI
0.78 (0.57-0.99)
0.55 (0.30-0.81)
0.83 (0.63-1.00)
0.80 (0.56-0.94)
0.58 (0.34-0.79)
0.74 (0.50-0.91)
0.64(0.42 - 0.82)
73
55
91
63
45
91
79
89
67
78
100
89
56
60
9.4
6.5
8
9.4
6.5
7
4.5
0.01
0.7
<0.01
<0.01
0.6
0.04
0.26
Figure 1
Study flowchart. 
SVI = Stroke volume index
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Sign of tissue hypoperfusion
Passive leg raising
Start fluid challenge
Figure 2
4-Quadrant concordance analysis using percentage change in SVINI after PLR 
plotted against percentage change in SVITD after FC.
SVI = stroke volume index, PLR = passive leg raising, FC = fluid challenge
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Figure 3
ROC curve analysis for predicting fluid responsiveness using PLR-test induced 
change in SVINI. 
PLR = passive leg raising, SVI = stroke volume index
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Figure 4
ROC curve analysis for predicting fluid responsiveness using PPVNI. 
PPV = pulse pressure variation
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Abstract
Background
Hypotension is common during spinal anesthesia (SA) and is caused by a 
decrease in systemic vascular resistance (SVR) and/or cardiac output (CO). The 
effect of the dose of bupivacaine administered intrathecally on the changes in CO 
in elderly patients is largely unknown. This study investigated the hemodynamic 
effect of SA in elderly patients by studying the effect of two different dosages of 
intrathecal bupivacaine.
Methods
This prospective cohort study included 64 patients aged >65 years scheduled for 
procedures under SA; the patients received either 15 mg bupivacaine (the medium 
dose [MD] group) or 10 mg bupivacaine and 5 μg sufentanil (the low dose [LD] 
group). Blood pressure and CO were monitored throughout the procedure using 
Nexfin™, a noninvasive continuous monitoring device using a finger cuff.
Results
Thirty-three patients received MD and 31 received LD and there was no mean 
difference in baseline hemodynamics between the groups. On an average, the CO 
decreased 11.6% in the MD group and 10.0 % in the LD group. There was no 
significant change in SVR. Incidence of a clinically relevant decrease in stroke 
volume (SV) (>15% from baseline) was 67% in the MD and 45% in the LD groups 
(P<0.05).
Conclusion
CO and blood pressure decreased significantly after the onset of SA in elderly 
patients. This is mainly caused by a decrease in SV and not by a decrease in SVR. 
There was no difference in CO and blood pressure change between dosages of 10 
or 15 mg bupivacaine.
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Introduction
Hypotension is a common side effect of spinal anesthesia (SA) and it occurs 
in 16–33% of cases.(1) This response is exaggerated in the elderly where a 
negative influence on a relatively higher resting sympathetic tone and decreased 
baroreceptor activity may explain the higher incidence of hypotension in response 
to SA.(2,3) Hypotension after the onset of SA is thought to be caused by either a 
decrease in systemic vascular resistance (SVR) or cardiac output (CO) or both.
Until recently, CO measurement required invasive monitoring, which is 
unsuitable in awake patients having SA for short procedures. Therefore, 
studies regarding factors that might influence the hemodynamic effect of SA 
on CO, eg, doses of intrathecal local anesthetics, are limited.(4,5) Moreover, 
most CO monitors produce only intermittent measurements thereby providing 
only limited understanding of fast hemodynamic changes. Nexfin™ (Edwards 
Lifesciences, Irvine, CA, USA) provides a continuous, noninvasive blood 
pressure and CO measurement using a finger cuff. This device does not bring 
inconvenience to patients making it clinically suitable for monitoring awake 
patients having regional anesthesia. Several recent studies have shown the device 
to be sufficiently accurate in the measurement of absolute CO and blood pressure 
values as well as in tracking CO and blood pressure changes.(6–8) In this study 
we have investigated the hemodynamic effects of SA during uncomplicated 
surgical procedures. Since we hypothesize that the hemodynamic effects would 
be dose-dependent, we evaluated two different dosages of local anesthetics to 
provide a better understanding of the underlying cause of hypotension after the 
onset of SA.
Methods
Patients
We performed a prospective double cohort study. The Regional Ethics 
Committee in Nijmegen, the Netherlands, responsible for medical research in 
humans (Ethical Committee No. 20091171) approved the study and the need 
for informed consent was waived because of the purely observational nature of 
the study. The research was performed in accordance with the Declaration of 
Helsinki. Participants recruited were individuals admitted for elective surgery 
to a 500-bed teaching hospital in Nijmegen, the Netherlands. The study period 
was from December 2009 to January 2011. Seventy-one consecutive patients, 
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American Society of Anaesthesiologists class I–III, aged ≥65 years scheduled for 
elective orthopedic, general, or vascular surgery using SA were included. Patients 
with cardiac arrhythmia, digital ischemia, allergic reactions to opiates or local 
anesthetics, perioperative blood loss that exceeded 1 L, and New York Heart 
Association class III–IV congestive heart failure were excluded from the study.
Spinal Anesthesia
Since the main focus of this study was to evaluate the hemodynamic effect of 
SA, we performed an observational study in patients receiving local anesthetics 
intrathecally. To provide a better understanding of their effect on hemodynamics, 
we observed two different intrathecal dosage groups. For the medium dose (MD), 
we included patients receiving 15 mg bupivacaine intrathecally. For the low dose 
(LD), we chose to study the lowest intrathecal dose of bupivacaine that would 
with great probability still provide effective anesthesia for certain long procedures 
such as hip surgery or vascular surgery. Five microgram Sufenta™ was regularly 
added to the LD to ensure adequate intensity and duration of analgesia and to 
administer an identical volume intrathecally.(9) We compared  patients receiving 
10 mg bupivacaine with 5 μg Sufenta™ to patients receiving ‘medium’ intrathecal 
dose of 15 mgbupivacaine. Extension of anesthesia to the higher thoracic 
dermatomes may lead to bradycardia due to blockage of the cardiac sympathetic 
accelerator fibers arising from the first four thoracic segments. To avoid this, as 
a high spinal block would surely have an effect on CO, SA was performed at L2-3 
or L3-4 and never at a higher interspace.(10) For clarity, we named the 10 mg 
bupivacaine regime as LD and the 15 mg bupivacaine regime as MD. The dose 
of bupivacaine, LD or MD, was based upon the clinical decision of the attending 
anesthesiologist based on patient characteristics and personal preference, 
and there was no randomization. The research team was blinded for the dose 
administered intrathecally. 
Study protocol
One hour before surgery, patients received 1,000 mg acetaminophen and anxious 
patients received either 7.5 mg midazolam or 10 mg oxazepam orally. The 
patients were fasted overnight and oral fluid intake was allowed for up to 2 hours 
before the procedure. Neither IV fluid was infused before entering the study, 
nor were any prophylactic vasoactive drugs administered (like, ephedrine or 
atropine). After arrival in the operating room intravenous access was established. 
Perioperative hemodynamic monitoring included the noninvasive measurement 
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of heart rate (HR) using electrocardiographic recording electrodes, noninvasive 
blood pressure using oscillometry, and a pulse oximeter. The noninvasive arterial 
blood pressure (ABPNI) and CO measurement (CONI) were obtained using a 
finger cuff adjusted to the size of the index finger of the patient according to the 
guidelines of the manufacturer and connected to the Nexfin™ monitor. This 
noninvasive device is based on the principle of Peňaz and measures the diameter 
of the finger’s artery using an inflatable finger cuff and a built-in photoelectric 
plethysmograph.(11) From this signal, blood pressure in the brachial artery is 
reconstructed. Nexfin™ calculates beat-to-beat CO by dividing the area under the 
systolic portion of the arterial pressure curve by the aortic input impedance, which 
is determined from a three-element Windkessel model described by Westerhof et 
al (12) using the influence of the patient’s age, height, weight, and sex on aortic 
mechanical properties. SA was performed with the patient in sitting position, a 
27-gauge pencil-point needle was inserted in the subarachnoid space at the L2-3 
or L3-4 interspace. After obtaining free flow of clear cerebrospinal fluid either 
3 mL bupivacaine, 5 mg/mL (MD) or an admixture of 2 mL bupivacaine 0.5% 
and 1 mL sufentanil, 5 μg/mL (LD) was injected with the spinal needle bevel 
facing cephalad. Immediately after injection, patients were placed in the supine 
position. Hypotension was defined as a decrease in mean arterial pressure (MAP) 
>25% from baseline value or systolic arterial pressure (SAP <100 mmHg, and 
was treated with 5 mg IV bolus ephedrine and repeated every 3 minutes until the 
hypotension resolved. Bradycardia was defined as a HR <40 beats per minute and 
was treated with atropine 0.5 mg IV. During surgery, isotonic saline 0.9% solution 
was infused at a rate of 1.5 mL/kg/hour. If blood loss exceeded 300 mL this was 
compensated using hydroxyethyl starch solution (130/0.46% hydroxyethyl starch 
solution; Fresenius Kabi, Bad Homburg vor der Hohe, Germany).
Measurements
A baseline ABPNI and CONI measurements were performed during 3 minutes in 
supine position before commencing the SA procedure. Hemodynamic data were 
recorded and stored electronically using the Nexfin™ and analyzed offline. After 
performance of SA, the patient was repositioned in supine position and ABPNI 
and CONI were measured continuously until the end of surgery as measurements 
beyond this point, during transport to the recovery room, etc, would introduce 
movement artifacts and bias due to replacement of the finger cuff. The sensory 
block level was tested at 5-minute intervals using a cold discrimination. Time to 
discharge from the recovery room to the ward, according to the Post Anesthesia 
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Care Unit protocol after regression of sensory level to Th12, Aldrete score ≥9 and 
NRS <4, was recorded.(13) 
Statistical analysis
A decrease in stroke volume (SV) is one of the most important possible sources of 
hypotension after SA. However, to our knowledge, there are no studies regarding 
the effect of the dosage of intrathecal local anesthetics on SV, and therefore, we 
used a composite outcome parameter, CO, as the primary effect parameter 30 
minutes after the onset of anesthesia. Based on a previous study we expected 
the difference in CO between the two study groups to be 0.75 L/min.5 We 
calculated that a total sample size of 60 patients would allow us to detect this 
CO difference based on a SD of 20% and a 5% type 1 error risk.(14) To allow for 
potential dropouts from treatment, we included 71 patients. A decrease of >25% 
in MAP or SAP or a decrease in SV >15% was considered clinically significant. 
A MedCalcR software package (MedCalc Software, Ostend, Belgium) was used 
for statistical analysis. Patient characteristics are expressed as mean and range, 
and hemodynamic data as mean and SD. Assumption of normality was checked 
using a Kolmogorov–Smirnov test. To compare demographic and hemodynamic 
data from baseline Student’s t-test, chi-squared test, and one-way ANOVA were 
used. P<0.05 was considered statistically significant. Hemodynamic variables 
were stored on the Nexfin™ monitor and analyzed offline. We used 30-second 
time intervals to analyze hemodynamic effects of SA that were sampled at various 
intervals during the surgical procedure until 40 minutes after the onset of SA.
Results
Seventy-one patients were included in the study. In three patients a good quality 
noninvasive finger signal could not be obtained. Four patients were excluded 
from further analysis because perioperative blood loss exceeded 1 L, this resulted 
in 64 patients with a complete data set (Figure 1). Patient characteristics are 
depicted in Table 1. The majority of patients underwent hip surgery, either 
elective replacement or repair after a hip fracture. Data collection ended at 
the end of surgery with a mean duration of 40 minutes. Two patients required 
supplemental intravenous analgesia, one in each study group. Baseline patient 
characteristics and hemodynamic values did not differ statistically between the 
two groups (Table 2). 
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The course of changes in SV after initiation of SA is depicted in Figure 2. Mean 
hemodynamic changes that occurred during the course of measurements are 
depicted in Table 3. SV decreased 11% (P<0.001) in the MD group and decreased 
8% in the LD group (P=0.01). An SV decrease of >15% occurred in 67% and 45% 
of patients in the MD and the LD group, respectively (Table 4). 
Mean dosage of ephedrine was 7.8 mg in the MD group and 4.7 mg in the LD 
group (P=0.14). Three patients in the MD group required rescue medication 
(phenylephrine) to maintain blood pressure, no patients in the LD group had 
hypotension unresponsive to ephedrine. Baseline hemodynamic values did not 
differ between patients who did and did not require ephedrine (Table 5). Changes 
in blood pressure, HR, and CO were not influenced by blood loss or the height of 
sensory block. 
Discussion
Blood pressure decreases significantly after onset of SA. In this study, this 
was caused by a decrease in CO and not by a decrease in SVR. There was no 
difference in mean decrease in CO and MAP between the two dosage groups. 
Nexfin™proved to be suitable to demonstrate different hemodynamic effects of 
two spinal anesthetic regimes. 
Several mechanisms are proposed to be the cause of the hypotensive response 
after SA. First, sympathetic blockage from T1 to L2 with subsequent arteriolar 
vasodilation leads to a reduction in SVR, contributing to intraoperative 
hypotension. This decrease in SVR is often thought to be the main cause of 
hypotension after SA. Second, a decrease in venous vasomotor tone increases 
venous pooling and consequently reduces venous return, thereby decreasing CO. 
Finally, the physiological hemodynamic reserve capacity decreases with age, and 
limited cardiovascular compensation mechanisms contribute to a decline in CO 
and blood pressure in response to SA.(15) 
After the onset of SA, CO decreased in both groups as a result of a decrease in SV. 
The incidence of a clinically relevant decrease in SV and SAP was higher in the MD 
group compared to the LD group. Since blood pressure (afterload) decreased and 
a change in cardiac muscle contractility was unlikely, the only explanation for the 
decrease in SV was a reduction in venous return.(16,17) Indeed, a study in dogs 
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showed that SA causes a decline in mean systemic filling pressure (MSFP). This 
decrease in MSFP is caused by a redistribution of blood volume to the splanchnic 
vasculature and to the lower extremities as a result of sympathetic ‘denervation’ 
induced by local anesthetics used for SA.(3,18) This causes a reduction in venous 
return, and therefore, a decrease in SV.(19,20) This decrease in SV was not 
compensated by an increase in HR to maintain CO. 
Possible explanations are a blunted β-adrenoreceptor response that is observed 
in elderly patients,21 use of beta-adrenergic blocking medication, or blockade 
of the sympathetic cardio-accelerator fibers caused by SA,3 although very 
few patients had a peak sensory block height ≥ Th5. However, a sympathetic 
block can extend above 2–6 dermal segments with sensory loss.(22) Several 
previous studies have identified a decrease in SVR as the main determinant 
of hypotension. In these studies patients received fluid loading just before or 
after the onset of SA.(16,18,23) This fluid loading can significantly increase 
stressed volume and, therefore, venous return. In individuals to whom preload 
is administered as a ‘standard procedure’, SV and CO remain unchanged after 
the onset of SA. In our study, patients did not receive any fluid loading, possibly 
explaining why hypotension was mainly caused by a decrease in SV and not by a 
decrease in SVR. Also, fluid loading in itself may cause a decrease in SVR because 
of hemodilution with a decline in viscosity, which explains why an increase in 
CO may not necessarily lead to an increase in blood pressure.(24,25) The mean 
decrease in CO was 11%, 40 minutes after the onset of SA. Other studies reported 
similar results with CO decreases ranging from 8%–14% in similar research 
populations.(18,26,27) We did not observe a significant difference in changes 
in CO between the two dosage groups. This was also found in a previous study 
in an obstetric population. 4 A correlation between change in CO and dosage of 
subarachnoid bupivacaine-sufentanil has been suggested.5 However, in the latter 
study lower dosages of subarachnoid bupivacaine (7.5 and 12.5 mg) were used, 
study population was small and a different noninvasive CO monitor was used, 
impedance cardiography. The administration of vasopressor medication might 
blur statistical difference in CO between the two groups. Vasopressor medication 
exerts an important part of its action by increasing venous return by increasing 
MSFP and therefore CO.(28,29) 
In this study, hypotension was caused by a decrease in SV. Low SV can be treated 
with volume therapy; the administration of vasopressor medication likewise 
increases SV due to an increase in preload. However, a clinical implication 
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of this study can be that if a patient remains hypotensive despite vasopressor 
medication, administration of intravenous fluid is indicated to increase SV and 
consequently blood pressure. This hypothesis is supported by an earlier study 
in elderly patients undergoing hip surgery SA. Lithium dilution cardiac output 
(LiDCO, Lido Group, London, UK)-based fluid therapy was applied to optimize 
SV, patients required very little vasopressor medication as a consequence.(30) 
This is further supported by previous studies in obstetric patients, where co-
loading, infusing fluid immediately after the onset of SA with either crystalloid 
or colloid fluids, led to an increased hemodynamic stability.(31,32) We chose 
to administer no fluids to be able to evaluate the hemodynamic response to SA 
with minimal effect on preload. Moreover, the administration of overzealous and 
unnecessary fluid can lead to complications such as bladder retention, pulmonary 
edema, and increased length of stay.(33)
Several limitations to our study should be noted. First, because our main focus 
was to study the hemodynamic effect of SA using only a finger cuff, the decision 
whether to allocate patients to the MD or LD group was left at the discretion of 
the attending anesthesiologist based on the patient characteristics and type of 
surgery due to patient safety. This may introduce a selection bias. However, after 
evaluation, baseline patient characteristics, types of surgery, and hemodynamic 
variables did not differ between the two dosage groups. However, small 
differences between patients such as frailty are not represented in “crude” scores 
such as American Society of Anaesthesiologists class and age. Although the range 
of sensory block was quite large, this is comparable with previous literature.(9) A 
second limitation of this study is the lack of knowledge of the precision of Nexfin™. 
Although Nexfin™ has been shown to accurately provide CO measurement and 
show acceptable CO tracking capabilities,(6,34) its precision is uncertain due to 
difficulties in previous studies evaluating this device, such as unknown precision 
of the reference technique, small sample sizes, specific patient study groups, and 
the studies’ COs to determine accuracy range from very low to very high.(35,36) 
This makes Nexfin™ possibly unsuitable to demonstrate subtle CO differences. 
However, Nexfin™ is the only CO measuring device that is adequately validated 
in a clinical setting and measures continuously and noninvasively, making it 
applicable to monitor awake patients. 
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Conclusion
Blood pressure decreased significantly after the onset of SA without fluid 
preloading in elderly patients. The hypotension that occurred was caused 
by a decrease in SV but not by a decrease in SVR. There was no difference in 
CO and blood pressure change between dosages of 10 or 15 mg bupivacaine.
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Table 1
Patient characteristics 
Data are expressed as mean and range unless states otherwise. MD = medium 
dose, LD = low dose
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        MD (n=33)          LD (n=31)    P-value
Age (years), mean (range)
Sex (M/F), n/n
BMI(kg/m2), mean (range)
ASA (I/II/III), n/n/n
Type of Surgery, n   
   Orthopedic
   Vascular
   General
Sensory level, mean (range)
Blood loss (ml), mean (range)
Time in recovery room (min), 
mean (range)
Ephedrine (mg), mean (range)
Ephedrine, n (%) 
Rescue medication, n
74 (65 – 89)
(10 / 23)
26.6 (19.4 – 35.6)
(4 / 24 / 8)
27
3
3
Th9 (Th4 – Th12)
222 (30 – 600)
94 (30-180)
7.8 (0-40)
19 (57,6%)
3
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
74 (65 – 86)
(12 / 19)
26.1 (20.0 – 33.5)
(4 / 22 / 5)
26
1
4
Th9 (Th6 – L1)
218 (20 – 500)
81 (30-180)
4.7 (0-15)
13 (41,9%)
0
Table 2
Baseline hemodynamic variables.
Data are expressed as mean (SD). CO = cardiac output, SV = stroke volume , MAP 
= mean arterial pressure, SAP = systolic arterial pressure, DAP = diastolic arterial 
pressure, HR = heart rate, SVR = systemic vascular resistance, NS = not signifi-
cant, MD = medium dose, LD = low dose
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Baseline  MD   LD  P  Value
CO (L/min)  4.32 (SD 1.3)  4.49 (SD 0.89)       NS
SV (ml)   64 (SD 16)           67 (SD 17)       NS
MAP (mmHg)  99 (SD 17)          99 (SD 16)       NS
SAP (mmHg)             141 (SD 30)          140 (SD 25)       NS
DAP (mmHg)  74.5 (SD 11.5)          74.6 (SD 11.8)       NS
HR (b/min)         68 (SD 14)                    69 (SD 11)       NS
SVR (dyn·s/cm5)     1905 (SD 625)             1838 (503)       NS
Table 3
Maximum increases and decreases in hemodynamic variables and mean
decrease at 30 minutes after onset of spinal anesthesia.
Data are expressed as mean (SD). CO = cardiac output, SV = stroke volume , MAP 
= mean arterial pressure, SAP = systolic arterial pressure, DAP = diastolic arterial 
pressure, HR = heart rate, SVR = systemic vascular resistance, NS = not signifi-
cant, MD = medium dose, LD = low dose. * p ≤ 0.05 compared to baseline
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                                        MD            LD          P  
                                                                                                                      Value     
CO % change at 10 minutes        -5.9  (SD 12.1)*    -5.3 (SD 16.1)          NS
 % change at 20 minutes       -10.1 (SD 10.9)*    -12.4 (SD 16.6)*    NS
 % change at 30 minutes       -11.6  (SD 13.6)*    -12.9 (SD 15.2)*      NS
SV % change at 10 minutes       -3.3   (SD13.3)       -1.5 (SD 18.9)          NS
 % change at 20 minutes       -7.3   (SD 13.8)*    - 4.9 (SD 20.4)*      NS
 % change at 30 minutes       -10.7 (SD 16.2)*    -8,0 (SD 18,9)*       NS
MAP % change at 10 minutes       -4.6   (SD 14.3)      -2.3 (SD 11.8)          NS
 % change at 20 minutes       -6.5   (15.4)             -10.4(SD 15.3)*       NS
 % change at 30 minutes       -8.4   (SD 21.2)*     -9.9 (SD 15.1)*    NS
SAP % change at 10 minutes       -3.9   (SD 15.1)       -0.2(SD 15.6)          NS
 % change at 20 minutes       -7.6   (15.2)*           -7.8 (SD 17.2)*       NS
 % change at 30 minutes       -12.3 (SD 20.4)*    -9.9 (SD 17.8)*        NS
DAP % change at 10 minutes       -0.9   (SD 14.9)       0.8 (11.8)         NS
 % change at 20 minutes       -1.3    (SD 16.8)      -5.0 (13.6)       NS
 % change at 30 minutes       -4,9   (18.4)*           - 5.8 (13.7)*       NS
HR % change at 10 minutes       -2.2   (SD 9.1)        -3.9 (SD 8.8)      NS
 % change at 20 minutes       -1.5    (SD 12.2)      -6.8 (11.8)*         NS
 % change at 30 minutes         1.0   (SD 16.0)      -3.7 (SD 14.9)     NS
SVR % change at 10 minutes         7,4   (SD 27,3)       8,2 (SD 23,15))     NS
 % change at 20 minutes         7,5   (SD 20,7)       8,6 (SDD 32,4)       NS
 % change at 30 minutes         5,0   (SD 23,0)       5,6 (SD22,9)       NS
Table 4
Percentage of patients developing clinically significant hemodynamic changes in 
both study groups
SV = stroke volume, MAP = mean arterial pressure, SAP = systolic arterial 
pressure, MD = medium dose, LD = low dose
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                                                             MD                                  LD                          P value                
       
SV decrease     > 15%         23/33 (67%)               14/31 (45%)            0.047
MAP decrease > 25%        12/33 (37%)                6/31 (19%)                 NS
SAP decrease > 25%         16/33 (48%)                6/31 (19%)              0.014
Table 5
Baseline hemodynamic values of patients who required Ephedrine and patients 
who did not require Ephedrine. 
Data are expressed as mean (SD). CO = cardiac output, SV = stroke volume 
, MAP = mean arterial pressure, SAP = systolic arterial pressure, DAP 
= diastolic arterial pressure, HR = heart rate, SVR = systemic vascular 
resistance, NS = not significant
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                                              With Ephedrine           Without Ephedrine         P value      
CO (L/min)       
SV (ml)          
MAP (mmHg)         
SAP (mmHg)          
DAP (mmHg)        
HR (b/min)         
SVR (dyn·s/cm5)          
NS
NS
NS
NS
NS
NS
NS
4.23 (SD 1.0)     
63.1 (SD 14.7)          
99.3 (SD 18.1)         
140.4 (SD 29.2)         
75.2 (SD 12.7)       
68.0 (SD 13.2)         
1964.9 (SD 624.7)    
4.59 (SD 1.15)   
68.4 (SD 17.6)          
100.1 (SD 16.2)         
142.8 (SD 28.4)         
74.5 (SD 10.7)       
68.4 (SD 11.9)         
1819.3 (SD 512)          
Figure 1
Flow diagram of trial procedure
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because of
inadequate
nexfin signal
(n=3)
71 Patiens
assessed for
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Patients in MD
group (n=36)
Patients in LD
group (n=32)
1 L blood loss
(n=3)
1 L blood loss
(n=1)
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Analyzed in MD
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Figure 2
Change stroke volume in the medium dose and low dose groups at 10, 20 and 30 
after spinal anesthesia.
Baseline values are represented as 100%, white box represents medium dose, grey 
box represents low dose, the dots represent outliers 
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CHAPTER 7
Summary
Introduction
Blood pressure and cardiac output are the two main determinants of the 
hemodynamic system and both are essential parts of the transportation of oxygen 
and thus, life. The first technique to routinely measure cardiac output was the 
Swan-Ganz catheter, introduced in 1970. This device measures cardiac output 
using a catheter placed in the pulmonary artery. However, since its introduction 
concerns have been raised regarding its high complication rate and a possible 
increase in mortality. Although an increased mortality has been refuted in 
several studies, there has since been a trend in the development of newer, less 
invasive CO monitors. One of these new techniques to measure blood pressure 
and cardiac output is Nexfin (Edwards Lifesciences/BMEYE B.V., Amsterdam, 
The Netherlands). This technique measures RR and CO both continuously and 
completely non-invasively by using a finger cuff. The overall aim of this thesis 
was to assess the reliability and feasibility of this finger arterial pressure (FAP) 
technique in several patient categories under different clinical circumstances. We 
also used FAP to predict or evaluate the effects of a hemodynamic intervention. 
This chapter will summarize the outcome of our research, discussed following the 
aims laid out in Chapter 1. 
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Summary
Part I – Blood pressure in children
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In chapter 2 we investigated the reliability of FAP blood pressure 
measurement in critically ill children. We performed simultaneous FAP 
blood pressure measurement and compared this to the intra-arterial blood 
pressure (IAP) measurement using a catheter inserted in the brachial, 
radial or femoral artery. We also compared the IAP to the non-invasive 
oscillometric blood pressure measurement (NIBP) performed at the 
upper arm using an inflatable cuff. Because of the arousal reaction and 
subsequent changes in blood pressure invoked by a NIBP measurement, 
we only performed NIBP measurements in 13 deeply sedated children. All 
measurements were performed during a relatively stable hemodynamic 
period. Finger blood pressure is physiologically lower than upper arm 
blood pressure. Therefore, we also used a software filter to reconstruct 
brachial artery pressure from finger pressure (reBAP) and compared this 
to IAP end NIBP. We included 35 children admitted to the ICU with a body 
weight between 2 and 22 kg. All children were sedated and mechanically 
ventilated. In 103 measurement episodes, vasoactive and/or inotropic 
medication was used. Of the 152 attempts to perform FINAP, 4.2% were 
unsuccessful. Failure of FAP was more frequent in smaller children and the 
number of attempts needed to obtain FAP increased with decreasing body 
weight. When comparing FAP to IAP, bias was -16.2, -7.7, and -10.2mm Hg 
for systolic arterial blood pressure, diastolic arterial blood pressure, and 
mean arterial blood pressure. Limits of agreement (LOA) were respectively 
26.1%, 30.1%, and 22.6%. When the reconstructed finger pressure signal 
was used, bias and limits of agreement improved: -11.8, 0.6, and -0.9 mm 
Hg for bias and 21.7 mmHg, 8.9 mmHg, and 8.9 mmHg for LOA. Results for 
NIBP compared to IAP were -6.8, -0.9, and -3.8 mm Hg for bias and 18.2 
mmHg, 38.6 mmHg, and 22.1 mmHg for LOA. We conclude that FAP is 
reliable and feasible in measuring blood pressure continuously in critically 
ill children when reconstruction of brachial artery blood pressure from 
finger blood pressure is applied. Also, finger blood pressure measurement 
is at least as accurate as NIBP for measuring MAP and DAP. 
 Part II – Cardiac output
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After investigating the reliability of FAP in measuring absolute blood 
pressure levels, we set out to determine the validity of FAP in tracking blood 
pressure changes. In chapter 3 we included children undergoing cardiac 
surgery where significant blood pressure changes occur. We monitored FAP 
and IAP continuously during the whole procedure and the 4 largest blood 
pressure changes that occurred were used for further analysis where we 
compared IAP to reBAP offline. We included 13 children aged 2 – 90 months 
(weight 4 – 31 kg) undergoing cardiac surgery under general anesthesia. In 
three children, aged 3 and 4 months, a FAP signal was unobtainable which 
leads to a success rate of 76%. These 3 children did not differ from the other 
10 where a good quality blood pressure signal was obtainable, concerning 
type of surgery, baseline arterial pressure, heart rate, or hand temperature.
Also, starting up a FAP signal was time consuming, with a mean of 5 
attempts to obtain a good quality signal (range 1 – 22). Compared with IAP, 
bias of reBAP was 8.9 mm Hg (LOA +/-20) for SAP, 1.8 mm Hg (LOA +/-
11) for DAP, and 0.3 mm Hg (LOA +/-9.3) for MAP. Changes in arterial 
pressure measured with reBAP closely followed changes in IAP with R2 of 
0.96 for SAP, 0.97 for DAP, and 0.98 for MAP.  ReBAP also tracked changes 
in IAP closely with a mean bias for SAP, DAP, and MAP of 0.0 (SD 5.8), 0.1 
(SD 2.8), and 0.2 mm Hg (SD 2.7), respectively. 
We concluded from this study that FAP is very accurate in tracking blood 
pressure changes measured with an intra-arterial catheter in children 
undergoing cardiac surgery. However, obtaining a good quality FAP signal 
was either time-consuming or impossible in a significant part of the study 
population.
In chapter 4 we investigate the accuracy of FAP in measuring blood 
pressure and cardiac output and tracking blood pressure and cardiac output 
changes in adult patients admitted to the intensive care unit. To study CO 
changes we included post-cardiac surgery patients with a transpulmonary 
thermodilution catheter in situ requiring fluid therapy.  Twenty fully 
sedated and ventilated patients after cardiac surgery admitted to the ICU 
(mean age 67 years) were included in the study. 
Part III – Fluid responsiveness
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If a patient required fluid therapy (6 ml/kg), by discretion of the attending 
physician,  FAP (ABPNI) and intra-arterial (ABPIA) blood pressure  and 
FAP (CONI)and thermodilution (COTD) cardiac output were measured 
simultaneously before and after fluid loading. Also, to exclude the finger 
arterial pressure cuff as a possible source of bias, we analyzed the IAP 
signal using the FAP pulse contour algorithm to obtain COIA. Finger 
arterial pressure was obtained in all patients. Twenty-eight fluid challenges 
were performed in 19 patients. When comparing ABPNI with ABPIA, bias 
was 2.7mm Hg (LOA, ±22.2), 4.9 mm Hg (LOA, ±13.6), and 4.2 mm Hg 
(LOA ±13.7) for SAP, DAP and MAP, respectively. The ABPNI tracked 
changes of ABPIA with a mean bias of 0 (LOA ±13.7), −1 (LOA ± 10.0), and 
−1 (LOA ±9.6) mm Hg for SAP, DAP and MAP, respectively. The ABPNI 
tracked changes of ABPIA with a mean bias of 0 (LOA ±13.7), −1 (LOA ± 
10.0), and −1 (LOA ±9.6) mm Hg for SAP, DAP and MAP, respectively. 
Concordance between changes in ABPNI and ABPIA was 100%. Mean bias 
between CONI vs COTD and COIA vs COTD was −0.26 (LOA ±2.2) L/min 
and −0.78 (LOA ±1.9) L/min, respectively. In conclusion, FAP is reliable 
in the measurement of blood pressure and the tracking of blood pressure 
changes. In this study, FAP cardiac output is not interchangeable with 
transpulmonary thermodilution with a percentage error of 38.9%, although 
trending analysis showed a high concordance with thermodilution after an 
FC. Bias did not improve when the finger arterial blood pressure signal was 
replaced with an intra-arterially obtained blood pressure signal and further 
analyzed with pulse contour analysis. 
One of the most important purposes of CO measurement is to determine fluid 
responsiveness. Both  to prevent fluid overloading and to avoid withholding 
essential fluids to a hypovolemic patient. An easy and continuous CO 
measuring technique is mandatory to determine fluid responsiveness as 
rapid changes in CO must be detected. Two of the most commonly used 
methods to determine fluid responsiveness are the passive leg raising test 
(PLR) and the dynamic indices measured using a continuous blood pressure 
signal. In chapter 5 we determine whether fluid responsiveness can be 
predicted with FAP using either the PLR test or dynamic indices.  
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We included fully sedated and ventilated adult patients admitted 
to the ICU post cardiac surgery where fluid loading was indicated as 
determined by the attending physician. Before fluid loading, CO was 
measured using FAP and transpulmonary thermodilution. Next, we 
performed a PLR-test using FAP and after fluid loading (6 ml/kg) 
CO was again determined using both techniques. FAP stroke volume 
response to a passive leg-raising test before the fluid challenge was 
compared to the change in PiCCO stroke volume as a result of the fluid 
challenge. Dynamic indices were measured continuously using FAP and 
the intra-arterial catheter and their predictive value was determined by 
comparing the dynamic indices before fluid loading to the change in SV 
after fluid loading measured using PiCCO. Also, we determined whether 
the non-invasive character of SVINI itself introduces inaccuracies. 
To do so, we calculated the SVI from the intra-arterial pressure 
wave (SVIIA) offline using the same algorithm software provided 
by the manufacturer, and compared this to SVITD. In total, 27 fluid 
challenges were recorded in 19 patients, 14 cases were classified as 
responders defined as an increase of the stroke volume index >12%. 
Concordance between changes in FAP stroke volume during passive 
leg-raising and changes in PiCCO stroke volume index during a fluid 
challenge was 89%. Area under the receiver operating characteristic 
curve of the passive leg raising induced change in FAP stroke volume 
index was 0.64 (95% confidence interval 0.42-0.82). The predictive 
values for fluid responsiveness (area under the curve) of the dynamic 
indices were 0.78, 0.55 and 0.83 for PPVNI, SPVNI and SVVNI. There 
was no significant difference in the predictive value between the FAP 
derived and the invasively derived dynamic indices using an intra-
arterial catheter. Also, there was no significant difference between the 
area under the curves of the change in SVI during a PLR between the 
invasively SVIIA and non-invasively derived values SVINI (p = 0.66). In 
conclusion, FAP cannot predict fluid responsiveness using the PLR-
test. However, responders can easily and accurately be identified using 
dynamic indices derived from finger blood pressure waveform. FAPs 
ability to predict fluid responsiveness using PLR-testing or dynamic 
indices did not differ from the predictive value of invasively derived 
variables using the arterial catheter. 
Part IV – Physiology of spinal anesthesia 
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In chapter 6, we use FAP to study a phenomenon that commonly 
occurs during spinal anaesthesia, hypotension. It is often postulated 
that hypotension is caused by a decrease in vasomotor tone and not 
by a decrease in cardiac output caused by a lower venous return and 
consequently a decrease in stroke volume. However, given the locoregional 
aspect of spinal anesthesia, an invasive cardiac output monitoring device 
is not feasible. However, FAP provides a continuous and completely non-
invasive cardiac output measurement which makes it very suitable to study 
this phenomenon in awake patients. We included patients receiving two 
different spinal anesthesia regimes, 10 mg Bupivacaine + 5 mcg Sufenta 
(low dose, LD) or 15 mg Bupivacaine (medium dose, MD) and measured 
cardiac output and blood pressure throughout the procedure using FAP. 
Patients did not receive any fluid loading. Hypotension was treated with 
vasopressor medication, bradycardia was treated with atropine.  We 
included 33 patients in the MD group and 31 patients received LD. There 
was no difference in baseline hemodynamic parameters between the groups. 
In three patients a good quality finger blood pressure was unobtainable.
On average, SV decreased 11% (p < 0.05) in the MD group and decreased 
8% in the LD group (p < 0.05). Incidence of a clinically relevant decrease 
in stroke volume (> 15% from baseline) was 67% in the MD and 45% in the 
LD group (p < 0.05). There was no significant change in systemic vascular 
resistance. Mean dosage of ephedrine was 7.8 mg in the MD group and 4.7 
mg in the LD group (P=0.14). Three patients in the MD group required 
rescue medication (phenylephrine) to maintain blood pressure, no patients 
in the LD group had hypotension unresponsive to ephedrine. 
In conclusion, blood pressure decreased significantly after the onset of spinal 
anaesthesia without fluid preloading in elderly patients. This hypotension 
was caused by a decrease in stroke volume but not by a decrease in vascular 
resistance. There was no difference in CO and blood pressure change 
between a medium and a low dose bupivacaine.
Conclusions
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We conclude that FAP is reliable and feasible in measuring blood
pressure and tracking blood pressure changes continuously in critically  
ill children. However, obtaining a good quality FAP signal was time-
consuming or impossible in a significant part of the study population.  
FAP is  reliable in the measurement of blood pressure and the tracking
of blood pressure changes in adult patients.
FAP cardiac output is not interchangeable with transpulmonary  
thermodilution with a percentage error of 38.9%, although trending  
analysis showed a high concordance with thermodilution.
FAP cannot predict fluid responsiveness using the PLR-test.
Volume responders can easily and accurately be identified using dynamic 
indices derived from finger blood pressure wave 
FAPs ability to predict fluid responsiveness using PLR-testing or dyna-
mic indices did not differ from the predictive value of invasively derived 
variables. 
Hypotension that occurred after spinal anesthesia was caused by a decre-
ase in stroke volume but not by a decrease in vascular resistance. 
1.
2.
3.
4.
5.
6.
7.
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CHAPTER 8
Discussion and future perspectives
Discussion
Background
When introducing a new monitoring technique, it is mandatory to compare it to 
the gold standard to assess accuracy. Moreover, any new technique has to provide 
the user with one or more advantages previously unavailable to be of value. 
However, before discussing FAP`s reliability, advantages and disadvantages, we 
must first focus on the question of why we should measure cardiac output. 
One of the major functions of the cardiovascular system is to supply the body with 
a sufficient amount of oxygen to meet the metabolic demands of cells and cardiac 
output is the main determinant of the transport of oxygen from the heart to the rest 
of the body. Blood pressure is needed to perfuse the tissues with oxygen enriched 
blood. Because of its critical role in the oxygen delivery, it seems reasonable to 
measure cardiac output in clinical situations where  tissue oxygenation is (at risk 
of) deteriorating, i.e. shock. However, there are no absolute cardiac output values 
that are associated with a good outcome. Although a very low cardiac output 
resulting in low oxygen delivery and subsequent tissue ischaemia leads to a very 
high mortality rate (1, 2), a normal cardiac output is no guarantee for normal 
tissue oxygenation or good outcome (3-5). Therefore, knowing the absolute value 
of cardiac output is not useful. So why measure cardiac output at all?
An important reason to measure CO is to understand and treat any sign of tissue 
ischaemia, most commonly caused by low cardiac output. In this setting a cardiac 
output monitor can aid in the diagnosis and treatment of low cardiac output, such 
as the start and evaluation of fluid resuscitation in case of hypovolemic shock or 
septic shock. Fluid resuscitation is often seen as the cornerstone of hemodynamic 
stabilization (6). However, once the first phase of hemodynamic resuscitation has 
passed, only 50% of all fluid boluses results in a clinically relevant increase in 
stroke volume. Moreover, only a small percentage of the total amount of fluid that 
is administered remains in the intravascular compartment. Studies performed in 
healthy volunteers, septic patients or  experimental models have shown that as 
little as 5-15% of the initial bolus was present in the intravascular compartment 
even shortly after the end of the infusion and 50% of the total bolus volume 
ended up in the extracellular compartment  (7-10).  Even in “fluid responders”, 
148
i.e. a clinically relevant increase in stroke volume, the effect on hemodynamics 
such as an increase in mean arterial pressure or increased urine output, may 
be very modest or even absent (8, 11).  The fluid boluses administered without 
a subsequent increase in stroke volume are not only futile. It has been well 
established there is a strong association between an increasingly positive fluid 
balance and increased mortality (12-14). Hence, a cardiac output guided fluid 
resuscitation by predicting fluid responsiveness before administering fluids is an 
important tool to resuscitate a patient without doing further harm. The topic of 
fluid responsiveness will be discussed later in this chapter.
Another reason to measure cardiac output is to optimize hemodynamics in the 
perioperative setting, e.g. goal directed therapy (GDT). Goal directed therapy 
refers to optimizing oxygen delivery (DO2)  through targeting a predefined 
hemodynamic goal by titrating fluid therapy, vasopressors and /or inotropic 
therapy. While earlier studies, often using invasive CO measurement techniques 
such as the pulmonary artery catheter, showed promising results, more recent 
studies investigating the effect of GDT using less invasive techniques show 
inconsistent results (15-19). This inconsistency may be caused by heterogeneity 
of the study population and type of surgery, an increasingly  restrictive use of 
fluids in the control group in more recent studies, different GDT protocols and 
the fact that overall mortality tends to decrease by introduction of Early Recovery 
Pathways in both the control and the study groups (20) . Benefits of GDT have 
been shown to be the most outspoken in the high risk surgery groups (mortality 
> 10-20%) and when compared to liberal fluid strategies or no fluid protocol 
used in the control group (20, 21).  GDT can also be used in critically ill patients 
and, just like in the perioperative setting, the benefit of GDT in this patient 
category is undetermined (22-27).  The lack of established benefits of GDT in ICU 
patients is also likely multifactorial, one important reason being different patient 
populations. Different ICU syndromes have different hemodynamic profiles, e.g. 
distributive shock may present with a very high cardiac output and will likely 
not benefit from further elevation whereas administering fluids to further elevate 
stroke volume in hypovolemic shock may be very beneficial. Therefore, before 
initiating any GDT protocol to treat shock one must first consider the specific 
underlying hemodynamic profile.  Another reason for the failure of GDT to 
improve outcome in meta-analyses is the variation in timing of initiation of GDT. 
Early resuscitation, at the moment of the first “hit”, such as the start of sepsis or 
high risk surgery, can help prevent  organ failure whereas in established organ 
failure, GDT is probably too late (28, 29). Also, variation in GDT protocols, end 
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points and treatment of the control group may have further contributed to the 
inconsistency in the literature surrounding GDT.  
Considering the above, it is unlikely that any “one size fits all hemodynamic 
protocol”  will improve patient outcome in the treatment of shock. The literature 
concerning the efficacy of GDT in the critical care and preoperative setting puts 
further emphasis on the importance of individualized hemodynamic therapy. 
A thorough understanding of the underlying pathophysiology is mandatory to 
improve patient outcome and in this situation a cardiac output monitor suited for 
the specific clinical situation is of great use.
Feasibility
FAP measures blood pressure and cardiac output continuously and non-invasively. 
Earlier studies  performed in critical care and perioperative care show that FAP is 
a safe, reliable and easy to execute technique. Blood pressure and cardiac output 
recording is available within seconds to minutes. Since FAP does not impair 
arterial blood flow to the finger no complications, such as digital ischemia, have 
been described. Only one complication with FAP has been reported; blisters 
caused by direct pressure of the finger cuff, which occurred in a patient during 
anesthesia that lasted 17 hours (30). Currently, maximum advised duration of a 
continuous FAP measurement is eight hours, hereafter a different finger should 
be used and caution is advised in patients with severe impairment of blood flow 
to the finger, such as Reynaud’s disease. Clinical circumstances that influence 
blood flow to the finger, such as hypothermia, hypovolemia or vasopressor use, 
can decrease the percentage of patients from which a successful measurement 
can be obtained to 85-95%. Under these circumstances time to obtain a good 
quality recording increases to several minutes (31, 32). Also, excessive patient 
movement may cause inaccurate or failed recording, rendering the technique less 
suited for restless patients and small children. 
Blood pressure
Studies investigating the accuracy of FAP mostly show acceptable accuracy in 
measuring mean arterial pressure (MAP) and diastolic arterial pressure (DAP) 
when using intra-arterial pressure (IAP) as a reference technique in both critical 
illness and perioperative care. Systolic arterial pressure measurement is not 
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clinically interchangeable with intra-arterial pressure measurement. FAP can 
adequately identify episodes of clinically relevant hypotension and hypertension 
and track blood pressure changes (32-39). When discussing acceptability of 
the accuracy of a new blood pressure measurement device, the Association for 
the Advancement of Medical Instrumentation (AAMI) requirements are often 
cited and The AAMI provides a standard for the validation of an oscillometric 
blood pressure measuring device, requiring the bias and standard deviation of 
a new device to be below 5 and 8 mmHg respectively when compared to the 
gold standard (40). Although the AAMI requirements are not developed for the 
validation of continuous blood pressure measurement devices in the critical care 
setting, they are frequently cited when evaluating and interpreting the results of 
a validation study. Moreover, these statistical guidelines are often misinterpreted 
causing the bias as reported in method-comparison studies using Bland-Altman 
analysis to result in a greater mean error and SD than AAMI standards recommend 
for comparison of two blood pressure measurement devices (38). The AAMI 
standards propose to use the “zero-zone” which is calculated using the reference 
IAP values of a minimum of 30 s. These beat-to-beat IAP-values are averaged and 
their standard deviations (SDs) are calculated which results in the “zero-zones” 
(mean ± 1 SD). The investigated blood pressure device is compared to this zone, 
instead being compared to one reference value. Using the zero-zone approach, 
the AAMI benchmark of acceptable accuracy and precision of 5 ± 8 mmHg are 
wider than the way new blood pressure monitors are usually analyzed (41). Also, 
while a mean bias (SD) of 5 mmHg (8) may be acceptable for adult patients, this 
represents a very wide 95% confidence intervals when measuring blood pressure 
in small children with a MAP of 40 mmHg. This emphasizes the need for relative 
rather than absolute acceptability standards, such as proposed by Critchley et.al 
for cardiac output monitors (42). The trending capacities of a monitor may be 
of greater importance than the accuracy of the absolute measurement because 
this gives the clinician a better understanding of the clinical scenario and more 
insight in the effectiveness of a given treatment (43). Therefore, there is a need 
for specific standards for conducting, reporting and interpreting measurement 
comparison studies in which not only the absolute value of a given measurement 
but also the trending capacities are uniformly presented. 
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When evaluating a new monitoring technique, one must consider its place in 
the clinical setting. Do we need FAP to replace intra-arterial blood pressure 
measurement, intermittent oscillometric pressure measurement or fill the gap 
between the two techniques? Oscillometric blood pressure techniques are easy, 
robust and cheap but also provide only intermittent measurements, slight patient 
discomfort and are prone to inaccuracy due to inadequate cuff size selection. 
While  oscillometry provides adequate BP readings during stable hemodynamic 
conditions, it tends to overestimate BP during hypotension and underestimate BP 
during hypertension (39, 44). This, together with its intermittent nature,  renders 
the technique insufficient in clinical scenario`s where hemodynamics are unstable 
or critical, such as during high risk surgery or critical illness. It is unlikely FAP 
will replace intra-arterial blood pressure measurement in this patient category 
due to its inaccuracies, sensitivity to movement and, most importantly, the fact 
that it cannot be used to draw arterial blood samples. Likewise, in all probability, 
FAP will not replace oscillometry in low risk surgery or stable patients due to 
the fact that the latter technique is very easy, robust and cheap. In our opinion, 
FAP will most likely fill the gap between the two. Recent studies emerging from 
perioperative care show that both the duration and the  severity of intraoperative 
hypotension are associated with adverse patient outcome, such as stroke, acute 
kidney injury and increased mortality (45). Even a few minutes of hypotension 
(MAP < 55 mmHg) can adversely affect organ function (46) which emphasizes the 
need for continuous blood pressure measurement during clinical situations where 
hypotension is likely to occur. Recent studies show that continuous non-invasive 
BP measurement during anesthesia reduces both hypotensive and hypertensive 
episodes during various clinical settings such as beach chair position, orthopedic 
surgery and obstetric surgery (47-51) Whether better hemodynamic stability 
using FAP improves patient outcome perioperatively is yet to be investigated in 
adequately powered clinical trials. So where does this leave us? In our opinion, 
FAP has a place in the operating theatre during surgery where an arterial catheter 
is deemed too invasive or impossible but episodes of hemodynamic instability are 
likely to occur such as intermediate risk surgery, beach chair position, obstetric 
surgery and in patients with an established history of hypertension. When 
considering critical and emergency care, due to its continuous nature and the fact 
that FAP is no less accurate than oscillometric techniques (39), FAP has a place 
in relatively stable patients, during the time needed to insert an arterial catheter 
or to postpone/abolish an arterial catheter altogether. 
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Cardiac Output
When validating a new measuring device, one must also consider the inaccuracies 
of the reference technique. Otherwise, large discrepancies between the two devices 
may not only be caused by the low accuracy of the device being investigated, i.e. 
the technique doesn’t accurately reflect “true” cardiac output,  but also by the 
inaccuracy of the reference technique itself, causing low agreement between 
the two devices. Therefore, to discuss the accuracy of FAP in measuring cardiac 
output, we only discuss clinical studies using reference techniques with a high 
accuracy and a known precision, i.e. thermodilution techniques. Whether or not 
a given standard deviation of the bias of a new technique is acceptable depends 
on the mean of the variable that is being measured. Where a SD of 1 L/min would 
be acceptable if the cardiac output is 9 L/min in a septic patient, it would be 
highly unacceptable in a patient with severe heart failure and a cardiac output 
of 3 L/min. In the second example, this standard deviation would provide a 95% 
confidence interval of 1.05 - 4.95 L/min. In other words, if the new technique 
measures a cardiac output of 3 L/min, there is a 95% chance the actual cardiac 
output lies between 1.05 – 4.95 L/min, not a range most clinicians would be 
comfortable working with. Therefore, when evaluating the accuracy of a cardiac 
output monitor, Chritchley et.al. proposed to determine the percentage error 
(42). This can be calculated by taking two times the standard deviation of the bias 
normalized by the observed average cardiac output with the golden standard used. 
Because the percentage error is a product of the precision of both the investigated 
and the reference technique, one must consider the precision of the reference 
technique to decide whether or not a given percentage error in a certain study 
is acceptable or not. By most clinicians, a percentage error below 30% would be 
acceptable when comparing the new technique to a thermodilution measurement 
with a known precision of +/-20% (52). Several studies investigating the accuracy 
of FAP in measuring absolute cardiac output have been performed in various 
patient groups, such as perioperatively and in critical care during both stable 
and less stable conditions. Although bias in these studies is small, FAP shows 
a considerable standard deviation ranging from 0.5 to 2.33 L/min (32, 53-56). 
The percentage error found in these studies ranges from 28% perioperatively to 
57% in a mixed ICU population (53-57). Although variable, most authors report 
a percentage error that is clinically unacceptable. One previous study found FAP 
to be inaccurate in patients with low cardiac output, high vascular resistance 
index or hypothermia, but interchangeable in patients with high cardiac output, 
low vascular resistance and even high dose norepinephrine (58). This may, in 
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part, be explained by the fact that a higher cardiac output in a subject with a 
stable standard deviation, would yield a better percentage error simply due to 
mathematics. 
To assess the possible deterioration or improvement of a patient`s clinical 
condition or the effect of an initiated treatment, a cardiac output monitor must 
also follow cardiac output changes closely. In a previous report it has been 
suggested that a concordance rate of >92% with the reference technique indicates 
good trending. Small cardiac output changes are excluded from analysis as they 
don`t reflect trending ability, have little clinical consequence and are severely 
affected by the precision of the reference technique. In the previous literature, it 
is suggested that changes < 15% should be excluded when using thermodilution 
as a reference technique (43). However, not only the direction of the CO change 
influences clinical decision making, but also the magnitude of the change. 
Therefore, Critchley et al. suggested constructing a polar plot that incorporates 
both the direction and the magnitude of the change. When thermodilution is 
the reference method, the authors would recommend an angular bias below 5° 
and radial limits of agreement below 30° (59). In previous studies, FAP  shows 
acceptable trending with concordance rates of 84-100% and adequate radial 
limits of agreement (53, 56, 60) (61) although in two previous studies in post 
cardiac surgery patients and morbidly obese patients  polar angles were too wide 
to be deemed acceptable (54, 57). 
Fluid responsiveness is determined to decide whether a patient needs fluids to 
improve hemodynamics by optimizing stroke volume or whether fluid loading 
would only lead to volume overload. Several studies have investigated the ability 
of FAP to assess fluid responsiveness using  dynamic indices. These investigations 
show FAP to accurately determine fluid responsiveness in various patient groups 
and to be interchangeable with the invasively derived dynamic indices using an 
arterial catheter (33, 62-65). Fischer et.al found FAP to be unable to accurately 
identify fluid responders (66).  However, in this study the reference technique, 
the PiCCO intra-arterial catheter, also showed a lower than usual ability to predict 
fluid responsiveness, possibly contributing to the observed inaccuracy of FAP. In 
our study, FAP was unable to predict fluid responsiveness using the passive leg 
raising test, which can possibly be explained by the fact that the accuracy of FAP 
is too low to discriminate between small stroke volume changes. In our study, we 
also found FAP to adequately predict fluid responsiveness using dynamic indices 
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and to be interchangeable with the invasively derived parameters. In addition, 
we evaluated whether the (in)ability of FAP to predict fluid responsiveness was 
caused by the CO-Trek algorithm or the finger measurement itself. To do so, 
we also applied the CO-Trek algorithm to de blood pressure waveform derived 
from the intra-arterial catheter. This showed there was no difference between 
invasively derived and finger derived determination of fluid responsiveness using 
the PLR-test or dynamic indices. 
Several factors have been identified that negatively affect the accuracy of FAP. 
First of all, accuracy decreases when blood flow to the finger is low, such as in 
low cardiac output states, high vascular resistance and hypothermia (36). Studies 
regarding the effects of norepinephrine show inconsistent results (32, 39, 58, 
60, 67). In addition to the quality of the measurement  being influenced by a 
low blood flow, it is also affected by factors interfering with detection of flow in 
the finger, such as excessive patient movement, morbid obesity and peripheral 
edema (57, 67). Lastly, quality of the measurement is influenced by variability in 
hemodynamics and peripheral  vascular physiology such as heart rate and blood 
pressure variability (56). 
In conclusion, FAP is a completely non-invasive, safe, easy and fast technique 
that adequately measures diastolic and mean arterial blood pressure but 
underestimates systolic blood pressure. FAP is not interchangeable with invasive 
thermodilution techniques in measuring cardiac output but it can adequately 
follow cardiac output changes and predict fluid responsiveness using dynamic 
indices.  
Other techniques
There is a wide range of cardiac output monitors available, some invasive such 
as the pulmonary artery catheter and transpulmonary thermodilution, some 
“minimally’ invasive such as the esophageal Doppler and some completely 
none invasive such as FAP and echocardiography. Recent studies show that no 
currently available non-invasive cardiac output monitor is interchangeable with 
a thermodilution technique (68-70). The two other uncalibrated pulse contour 
devices, CNAP and T-Line, have a similar percentage error as FAP ranging from 
35 – 45% (69). Thoracic electrical bioimpedance measures cardiac output by 
analyzing the variations in voltage during each beat after application of a high-
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frequency, transthoracic current.  It is found to be inaccurate in the ICU due to 
interference with other electrical devices and increased lung water and showed 
percentage errors ranging from 39 – 82%. Results in the perioperative setting are 
more promising with a percentage error of 42% in a recent meta-analysis. However, 
widespread use in the OR is unlikely due to interference of electrocautery  (68) 
(69, 71, 72). Partial CO2 rebreathing measures CO2 production by multiplying 
the exhaled CO2 content by the respiratory volume. Cardiac output is calculated 
by the difference between normal and rebreathing ratios assuming it is stable in 
both normal and rebreathing conditions. Percentage errors rage from 40-49% 
and clinical applicability is limited due to the fact that it can only be used in 
stable ventilation and pulmonary disease. Common pulmonary conditions in the 
ICU, such as atelectasis and pulmonary edema, interfere with the measurement 
limiting its use in the ICU (68-70, 72).  The esCCO technique  is based on the 
relationship between the timing of the R wave on the EKG and the arrival of the 
pulse wave at the finger. The technique requires measurement of readily available 
parameters; it uses blood pressure, EKG and the input of patient characteristics 
to estimate cardiac output.  Although the technique is very easy and safe, 
applicability is limited due to low reliability with a percentage error of 62% in a 
recent meta-analysis and insufficient trending capabilities (68, 70-72). 
Vincent et al. proposed a list of criteria for an “ideal” cardiac output monitor, 
such as accuracy, operator-independency, being cost-effective and providing 
information that is able to guide therapy (73). However, at this point in time 
no cardiac monitor meets all these criteria and a clinician should base the 
choice for a certain technique on the patient`s specific needs and considering 
the advantages and drawbacks of this technique. The invasive cardiac output 
techniques often provide a more accurate measurement but also provide a higher 
risk of complications, more patient discomfort and/or are more time-consuming 
and cumbersome. FAP, being a completely non-invasive technique, is not and 
perhaps never will be, as accurate as it`s invasive counterparts. In our opinion, it 
doesn’t need to be. Certain clinical situations ask for a highly accurate measuring 
technique, and some scenarios ask for a quick and easy technique. Moreover, 
since there are no “normal” or “target” cardiac output values that will ensure 
an adequate hemodynamic profile, absolute cardiac output values are of less 
importance. In recent years, emphasis is placed on personalized hemodynamic 
management, focusing on cardiac output trending, fluid responsiveness and 
response to interventions (74). Based on its properties and limitations, we would 
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suggest using FAP cardiac output as follows: use FAP in clinical situations where 
a. it aides in the diagnosis of the type of shock, b. a response to hemodynamic 
therapy (fluid optimization, inotropes) needs to be monitored  and/or c. fluid 
responsiveness needs to be assessed. It should not be used when there is a need 
for highly accurate monitoring in complex hemodynamic failure such as right 
ventricular failure, severe septic shock, pulmonary hypertension or ARDS (74, 
75). As such, FAP can be utilized in perioperative medicine, when determining 
fluid responsiveness and in initial resuscitation in the ER, the ward and the ICU, 
serving as a bridge to, postponing or absolving the need for invasive monitoring. 
Fluid responsiveness 
Fluid infusion is an important step in the treatment of low cardiac output. An 
effective fluid bolus leads to an increases the mean systemic filling pressure – 
CVP gradient, which leads to an increase in venous return which in turn leads 
to an increase in cardiac output if the ventricles are still preload dependant. 
However, not only 50% of all fluid boluses are ineffective in increasing stroke 
volume, even when fluid resuscitation does increase stroke volume, this does not 
necessarily lead to improved oxygen consumption or a better outcome (76, 77). 
This may be caused by the fact that the cell simply doesn’t need more oxygen, by 
the fact that tissue hypoxia may persist by mitochondrial dysfunction as seen in 
sepsis or by the fact that resuscitation is simply too late and the damage caused 
by hypoxia has already caused organ dysfunction or failure. Several studies 
have shown that optimizing cardiac output and oxygen delivery without signs 
of tissue hypoperfusion is futile or even harmful (78). This seems plausible, 
trying to improve something that was functioning satisfactorily may not actually 
improve anything and is susceptible to causing adverse effects. Another situation 
on which administering fluids may not lead to satisfactory results is when it is 
given to improve blood pressure. Hypotension is still the most common reason 
for clinicians to administer fluids (79, 80). Administration of fluids to increase 
arterial blood pressure is based on the assumption that an increase in cardiac 
output will lead to an increase in blood pressure using the following formula: 
MAP = (CO x SVR) + CVP
However, SVR represents primarily the vascular smooth muscle tone at the level 
of small arteries and arterioles and is not homogeneously distributed along the 
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arterial vascular tree. It therefore cannot be considered a complete assessment 
of the arterial tone (81). Several previous studies have shown that patients can 
be preload dependant and not respond with an increase in blood pressure after a 
fluid loading (81, 82). Dynamic arterial elastance predicts the pressure response 
in reaction to volume loading and is defined by the ratio of changes in pressure 
to changes in volume (83). Dynamic arterial elastance can be determined 
using pulse pressure variation and stroke volume variation. If dynamic arterial 
elastance is low, in preload dependant patients an increase in cardiac output 
will not lead to an increase in blood pressure. In this scenario, a patient can be 
a volume responder without being a pressure responder. These patients may 
benefit more from vasopressor therapy with or without fluid administration than 
fluid administration alone (65).  Although fluid administration should remain 
an important treatment of septic shock,  dynamic arterial elastance can aide 
in determining if a patient needs vasopressors in addition to fluids to increase 
blood pressure and FAP has been successfully used for this purpose (65).  In 
summary, when considering a fluid bolus, clinicians must first establish there 
is hypoperfusion caused by low cardiac output and/or low blood pressure and 
second, that this will improve by administering fluids. 
Extensive research has been carried out to develop new ways to predict fluid 
responsiveness and several techniques have been introduced in the ICU, each with 
its own indications, limitations and accuracy.  Over the decades, there has been 
a shift away from static markers of fluid responsiveness such as central venous 
pressure, pulmonary artery wedge pressure, global end-diastolic volume, blood 
pressure and urine output. Each measurement has proven to be unreliable in 
the identification of volume responders (83-85). Therefore, current guidelines for 
the haemodynamic management of patients with circulatory shock recommend 
not using these static pressures or volumes to guide fluid therapy and using 
dynamic markers instead (86). The most commonly used dynamic markers of 
fluid responsiveness are listed in table 1. However, research in the field of fluid 
responsiveness is extensive and new techniques are emerging regularly such as 
techniques based on end tidal CO2 or techniques that use recruitment maneuvers. 
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Table 1. 
Most commonly used dynamic markers of fluid responsiveness.
SV = stroke volume, CO = cardiac output, PPV= pulse pressure variation, SPV 
= systolic pressure variation, SVV = stroke volume variation, RV = right ven-
tricle(84, 87-92)
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Technique
Passive leg raising
SV response to
gravitational shift 
of blood to RA by 
raising legs
PPV, SPV, SVV
Variation in pressure or volume 
caused by heart-lung interaction 
during a respiratory cycle.
Mini-fluid challenge
Administration of 100 ml
of fluids over short period
End-expiratory Occlusion test
15 s suspension of mechanical 
ventilation at end expiration to 
increase RV preload
Vena Cava diameter
Variation in vena cava diameter 
caused by heart-lung interaction 
during a respiratory cycle.
Limitations
Intra Abdominal Hypertension
Increased Intracranial Pressure
Impossibility to raise legs
(e.g. surgical procedures)
Spontaneous breathing efforts
Tidal volume ventilation < 8ml/kg
Arrhythmias Heart-rate-to-respi-
ratory-rate ratio below 3.6 Right 
ventricular failure Respiratory 
compliance < 30cmH2O/ml
Only +/- 2% of all ICU patients 
meets criteria
No limitations
Patients unable to 
sustain 15 s. apnea
Spontaneous breathing efforts
Low tidal volume
Low respiratory compliance
Requisites
Continuous CO monitor
Continuous blood pressure
measurement
Arterial pulse contour analysis
Mechanical Ventilation
Fast and precise CO monitor
or CO surrogate (SVV, PPV)
Mechanical ventilation
Continuous CO monitor or
pulse pressure measurement
Ultrasound or esophageal 
Doppler Mechanical
ventilation
Implementation 
Despite the overwhelming amount of research in the field of fluid responsiveness 
and the evidence of the accuracy of predicting fluid responsiveness, there is still 
a major gap between research and clinical outcome. One important reason for 
this gap is the fact that clinicians do not infuse fluids with the aim to improve 
stroke volume > 15%. Clinicians usually base their decision to infuse fluids on 
clinical factors such as hypotension, low urine output, mottled skin, elevated 
lactate, etc. (79, 93) Ideally, the trigger for fluid infusion would also be the 
parameter that defines success or failure of the infusion. However, in clinical 
research regarding fluid responsiveness only the change in stroke volume defines 
responders / non-responders, which decreases the applicability in everyday 
routine (88). As an example, the FACTT trial showed that even in patients 
who were defined as responders based on an increase in stroke volume, the 
physiological parameter that triggered the fluid bolus improved very little (8). 
Another reason for the decreased utility of fluid responsiveness in clinical practice 
is the clinician`s knowledge of the subject. Previous studies have shown a wide 
variation of knowledge of the prerequisites, limitations and practical execution 
of fluid responsiveness markers, promoting misuse and misinterpretation. Also, 
clinicians may use physiological parameters as markers for fluid responsiveness 
that have been proven erroneous, such as central venous pressure, oliguria and 
hypotension (87, 93-95). More research on the accuracy and implementation of 
fluid responsiveness predictors outside the “research environment” and into the 
“everyday practice” environment is needed to establish utility in our daily routine. 
Another problem with the use of fluid responsiveness in clinical practice is 
insufficient implementation. Despite the overwhelming evidence of the importance 
of a rational approach to fluid administration and the deleterious effects of 
fluid overload, the determination of fluid responsiveness before administering 
fluids is far from routine practice for most clinicians and the amount of fluids 
clinician`s infuse is very inconsistent. Recent studies investigating the practice of 
fluid administration during elective, abdominal surgery show that the amount of 
infused crystalloids shows high variability if not “a random chaos” (96-99). Lilot 
et al. found no or a very weak correlation between the amount of infused fluids 
and intra-operative factors such as blood pressure, heart rate and blood loss. 
Individual variation ranged, rather impressively, from 2.3 (SD 3.7) to 14 (SD 10) 
ml/kg/hr. The single most important predictor of the volumes given was by far the 
individual provider of anaesthesia. Minto et al. hypothesized that the variation in 
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fluid administration was caused by either the clinician`s ‘habit’, or inconsistency 
in the way providers interpret and respond to hemodynamic and clinical signals 
(96, 98).  This practice variation is related to postoperative outcomes in terms 
of 30-days mortality, postoperative length of stay and postoperative kidney 
failure (100). Fluid practices in critical care are hardly any more consistent. 
Observational studies amongst critically ill patients find equally large variation 
in fluid administration practices (13, 101-103). This variation may, in part, be 
explained by the lack of use of the well-established fluid responsiveness markers 
in daily practice. Several observational critical care studies show that only 9.6 
- 32% of the administered volume expansions were preceded by determination 
of fluid responsiveness using a dynamic variable, even though they would have 
been applicable in 90% of patients (93, 103, 104). In addition, these dynamic 
indices were often misused or misinterpreted (104).  In an observational study 
performed by Cecconi et.al. the proportion of patients who received further fluids 
after a fluid challenge was similar in patients with a positive, an uncertain or a 
negative response to fluids.  
So why don’t we use fluid responsiveness in our daily routine?
Previous studies have shown that guideline adherence after implementation is 
low in many medical specialties. Even well-established guidelines which have 
proven to be effective and are well-known within the medical community, such as 
The Surviving Sepsis Campaign bundles and hand hygiene protocols, show very 
modest adherence amongst clinicians and nurses (105, 106). Reasons for non-
adherence to guidelines can be divided into three main domains: system, staff 
and intervention, each with four subdomains (107).  To our knowledge, research 
directed towards the barriers clinicians and nurses face implementing the use 
of dynamic indices before administering fluids is lacking. In Table 2 we explore 
each subdomain in the context of inhibitors and barriers to implementation fluid 
responsiveness markers in our daily routine. 
One of the most striking reasons for not using dynamic markers is our belief in our 
clinical assessment of a patient`s fluid status based on physical examination and 
basic clinical signs (blood pressure, heart rate) although these markers cannot be 
used as markers for cardiac output or microcirculatory failure (108). Hiemstra 
et.al. recently described the physician`s accuracy to subjectively estimate CO 
based on clinical examination equal to flipping a coin (109). Moreover, in two 
previous studies about a quarter of all assessments of CO by physical examination 
were the complete opposite of the actual CO (low vs high)(110, 111). However, we 
   8
161
still use these markers as a reason to prescribe fluids despite their disappointing 
applicability (93, 103). Moreover, even if we do perform a passive leg raising to 
assess fluid responsiveness, we may well prescribe fluids anyway regardless of 
the negative result of the PLR (112). The chance of a patient receiving further 
fluid loading after a first fluid challenge  does not seem to be influenced by the 
result of the first fluid challenge, as non-responders are just as likely to receive 
further fluid loading as responders (93). This suggests that the barriers to 
(correctly) implement dynamic indices are very  prominent at staff level. This 
clearly understates not only the need for a strategy to implement the routine use 
of dynamic markers but also the need to improve their interpretation when used. 
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Table 2.
Common barriers to implement fluid responsiveness in our daily clinical routine
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System
Environmental context
Culture
Communication Processes
External Requirements
Staff
Staff commitment and attitudes
Understanding / awareness
Role identity
Skills, ability and confidence
Intervention
Ease of integration
Face validity / evidence base
Safety / legal / ethical concerns
Supportive components
High workload with limited time to spend at the bedside and to return to 
bedside to evaluate effect of intervention. 
Cardiac output monitor and/or ultrasound is not readily available
(Lack of) flexibility and motivation for change
Lack of role models / champions
Lack of belief in fluid responsiveness markers
Overestimation of value of physical examination and static markers to 
determine cardiac output and fluid responsiveness
Overestimation of knowledge of the subject of fluid administration
Readiness of individual to change routine
Limited knowledge on the subject of fluids and hemodynamics
Limited level of education and experience and high personnel turnover
“Doing something is easier than doing nothing” e.g. giving fluid is 
more acceptable than withholding treatment in case of hemodynamic 
compromise
Insufficient ultrasound skills 
Complexity of determining which patient is eligible 
for which fluid responsiveness marker
Absence of requirements of fluid responsiveness marker, eg mechanical 
ventilation, arterial catheter, etc. 
Fear of under-resuscitation and resulting ischemia  
Lack of critical review of fluid management in each patient
So how can we put a more evidence- based approach of fluid administration into 
practice? First, we must systematically evaluate which of the aforementioned (or 
other) barriers play an important role in the specific clinical environment where 
we want to implement. Practical issues, such as the availability of a continuous 
cardiac output monitor, should be addressed first as there is no point in trying 
to change behavior when the intended behavior is very difficult or impossible 
to execute. Hereafter, we need to decide on an effective strategy to encourage 
change. Leng et.al. propose several effective domains to encourage change which 
should be tailored to each individual clinical setting (113).
164
Clinical audit: a clinical audit that evaluates the current use of an evidence 
based approach to fluid responsiveness and compares this to best practice 
could be an effective approach to improve its use. Research shows that 
these audits are most effective when feedback is provided by a colleague 
or supervisor and is provided regularly. Such an audit could be executed 
by reviewing each patient`s fluid management during a fixed period, eg 
total fluid balance, reasons for administering fluids, use of markers of fluid 
responsiveness, and presenting this to the staff. A clinical audit is closely 
related to the Plan-Do-Check-Act cycle, an implementation method widely 
used in healthcare as a continuous improvement tool (114). Rameau et.al. 
recently demonstrated a dramatic improvement in compliance and a 
reduction in total fluid balance after discussing the non-compliance they 
observed during a study period with the medical staff (112). 
Education: although research shows the effect of education is only modest, 
most physician’s current knowledge of fluid responsiveness is limited, 
emphasizing the need for education to ensure a thorough understanding of 
this concept to enhance its use and prevent misinterpretation (93, 94, 113). 
Opinion leaders: a meta-analysis by Flodgren et.al. demonstrated the use 
of likeable, trustworthy and credible opinion leaders can have a significant 
effect on adherence. Opinion leaders increase the overall compliance by 
12% although the way these opinion leaders must be used is unclear. 
1.
2.
3.
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Reminders: implementing computerized reminders has a modest effect on 
adherence. The effect is greatest when they are available at the time and 
location of the decision making and when they provide help in clinical decision 
making (113, 116). A pop-up reminder to determine fluid responsiveness 
when prescribing a fluid bolus could result in higher adherence, especially 
when combined with requesting a reason for non-adherence if the clinician 
decides not to determine fluid responsiveness. This would increase both 
awareness and therefore adherence, but also provide us with insightful 
information as to why the test wasn`t performed, giving us guidance when 
trying to improve hemodynamic management in a clinical environment. 
Also, as previous studies have shown that reminders have the greatest 
effect when aiding in clinical decision making, providing a hemodynamic 
optimization scheme could improve utilization of fluid responsiveness tests. 
A meta-analysis by Bednarczyk et.al.  showed goal-directed therapy guided 
by a dynamic  assessment of fluid responsiveness appeared to be associated 
with reduced mortality, ICU length of stay, and duration of mechanical 
ventilation  although data on protocol adherence were not provided (25).
Nurse-driven protocols: previous studies in other critical care treatments 
have shown high protocol adherence rates and improved study outcomes 
when implementing a nurse-driven guideline, such as strict glucose 
management or feeding protocols (117-119). A nurse-driven fluid 
management protocol for uncomplicated patients, such as post-cardiac 
surgery patients or uncomplicated sepsis, could possibly improve the use of 
fluid responsiveness markers and decrease fluid overload. A previous study 
by vd Kolk et.al. in post-cardiac surgery patients, showed a nurse-driven 
clinical pathway including hemodynamic care was sustainable and clinical 
outcome in the clinical pathway patient group was improved (120). 
4.
5.
Although all the domains mentioned above improve guideline adherence in other 
medical fields, their individual absolute effect was small. Therefore we cannot 
rely on one single intervention to improve adherence when implementing a new 
guideline. According to Grol and Grimshaw, “none of the approaches is superior 
for all changes in all situations; we probably need them all” (121). Therefore, when 
trying to improve the utilization of fluid responsiveness markers, one needs to 
explore the barriers to implementation relevant to a specific clinical environment 
and subsequently employ several of the above-mentioned implementation 
domains.
Future perspectives
So where is FAP headed in the clinical and scientific environment?  A lot of 
research using FAP has been performed, both validation and clinical application 
studies and the use of the finger cuff has been proven feasible and as good as the 
use of the intra-arterial catheter. Therefore, further research should be directed 
at improving the cardiac output algorithm itself, to increase the accuracy and 
therefore applicability. Also, FAP needs to find its place within the clinical arena. 
Due to its limited accuracy, it is unlikely FAP will be used in treatment of critical care 
patients with complicated hemodynamic profiles. Also, these patients generally 
have invasive monitoring, absolving the need for finger measurements. However, 
given its ease of use, simple operation and quick set-up, FAP can prove to be 
highly feasible in the setting of the early resuscitation phase. When encountering 
a patient in shock in the emergency room, the ward or just after admission to the 
ICU, a cardiac output monitor is not the first priority. We typically start working 
our way through the ABC`s and administer fluids liberally in this phase. And 
then, after the patient stabilizes, we contemplate starting up a cardiac output 
measurement,  weighing the benefits of better hemodynamic understanding 
against the risks of invasive monitoring. However, even in the resuscitation phase, 
a better understanding of the specific hemodynamic profile, provided by a simple 
and fast technique such as FAP, could save the patient from excessive fluid loading, 
delayed start of vasopressors or inotropic medication or under-resuscitation. 
But also during the second and third phase of fluid therapy, optimization and 
stabilization, FAP could be feasible in the decision to administer (further) fluids, 
especially in the “simple” patients without mechanical ventilation and invasive 
hemodynamic monitoring. In this group FAP may be used during a mini fluid 
challenge or when evaluating the effect of a first fluid challenge.  Also, FAP can 
have a place in anesthesia. During general anesthesia many patients, contrary to 
ICU patients, do meet the criteria for pulse pressure and stroke volume variation 
making the FAP suitable for determining fluid responsiveness. In these patients, 
FAP can also be incorporated in fluid management protocols, thereby decreasing 
the wide variability in fluid regimes and guiding hemodynamic optimization 
during high risk surgery. Lastly, as previously mentioned, even short periods of 
hypotension during anesthesia have an adverse effect on outcome and these can 
be prevented using a continuous blood pressure monitor. Further research should 
be directed at answering the question whether FAP blood pressure measurement 
leads to a decrease in postoperative complications due to hypotension, such as 
stroke, acute kidney injury and mortality. 
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Conclusion
FAP provides a simple, fast, safe and continuous blood pressure and cardiac 
output measurement using only a finger cuff. Although FAP adequately 
measures diastolic and mean arterial blood pressure, it underestimates 
systolic blood pressure in children and adult patients. The technique is 
not interchangeable with invasive thermodilution techniques in measuring 
cardiac output but it can adequately follow cardiac output changes. Fluid 
responsiveness cannot be predicted with FAP using a passive leg raising 
test but it can be determined measuring pulse pressure and stroke volume 
variation with FAP. Considering the above, FAP can be of use in the 
monitoring,  resuscitation and optimization of hemodynamically unstable 
patients in the operating theatre, the emergency room, the ward and the 
critical care environment. 
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CHAPTER 9
Samenvatting, toekomstperspectieven
en conclusie
Samenvatting
Het transport van zuurstof naar de cellen is het belangrijkste doel van de 
bloedsomloop, zonder zuurstof kan het menselijk lichaam niet bestaan. De 
belangrijkste determinant van het zuurstoftransport is de cardiac output; het 
aantal liters bloed wat het hart per minuut rondpompt. De bloeddruk zorgt er 
vervolgens voor de het zuurstofrijke bloed door de weefels geduwd wordt. De 
relatie tussen bloeddruk en cardiac output laat zich in de volgende formule 
omschrijven: 
MAP = (CO x SVR) + CVP
Waar MAP = de gemiddelde bloeddruk, CO = de cardiac output, SVR = de 
gemiddelde perifere weerstand en CVP = centraal veneuze druk. Indien het 
zuurstofaanbod aan de weefsels onvoldoende is of mogelijk onvoldoende gaat 
zijn, kan men proberen dit te optimaliseren. Patiënten waar dit speelt liggen 
veelal opgenomen op de intensive care maar kunnen zich ook op de eerste 
hulp, de verpleegafdeling of de operatiekamer bevinden. Het optimaliseren van 
de bloedsomloop geschiedt veelvuldig door het geven van extra vloeistof via 
een zogenaamde vloeistofbolus, maar een falende circulatie kan ook worden 
behandeld door juist het vocht aan de bloedsomloop onttrekken of met het 
geven van medicatie die direct effect heeft op de cardiac output of de bloeddruk. 
Bepalen welke patiënt met een falende circulatie welke van de bovenstaande 
behandelingen nodig is een essentieel onderdeel van de resuscitatie, er kan hierin 
geen sprake zijn van een “one size fits all” behandeling. Echter, om de circulatie 
adequaat te kunnen behandelen moet men hem eerst kunnen meten. 
Bloeddruk en cardiac output zijn twee van de meest gemeten variabelen van 
de bloedomloop en hun bepaling is essentieel in de behandeling van patiënten 
met een falende circulatie, met andere woorden: shock. Dit kan door middel 
van verschillende technieken en iedere techniek brengt zijn eigen indicaties, 
contra-indicaties, voor- en nadelen met zich mee. De bloeddruk van patiënten 
op de IC of tijdens een operatie wordt doorgaans op een van de twee volgende 
manieren gemeten: de oscillometrische techniek die gebruik maakt van een 
bloeddrukband rondom de bovenarm of door middel van een catheter die in de 
slagader wordt ingebracht. De cardiac output kan op vele verschillende manieren 
gemeten worden waarbij ook hier iedere techniek anders presteert op het gebied 
van nauwkeurigheid, snelheid, risico`s en herhaalbaarheid. Echter, geen enkele 
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techniek is perfect en de keuze voor een bepaalde techniek moet per specifiek 
klinisch scenario worden gemaakt.
Wat is er nodig? Een hoog nauwkeurige techniek of juist een snelle en simpele 
techniek? Nexfin (Edwards Lifesciences/BMEYE B.V., Amsterdam, The 
Netherlands) meet zowel bloeddruk als cardiac output op geheel niet-invasieve 
en continue wijze door gebruik te maken van een vingercuff. Door middel van 
deze opblaasbare cuff rondom het middelste vingerkootje met hierin een LED 
lamp kan de bloeddruk worden gemeten en de cardiac output worden berekend. 
De meting brengt geen risico`s of discomfort voor de patiënt met zich mee en kan 
derhalve ook bij wakkere patiënten worden gebruikt. 
Dit proefschrift onderzoekt de toepasbaarheid en de nauwkeurigheid van 
vingerbloeddruk (FAP) in het meten van bloeddruk bij kinderen op de intensive 
care. Daarnaast kijken we naar de nauwkeurigheid van FAP in het meten van 
cardiac output bij volwassenen en het volgen van cardiac output veranderingen. 
Ook onderzoeken we of FAP kan voorspellen of het geven van vloeistof aan een 
individuele patiënt zal leiden tot een verhoging van de cardiac output, het bepalen 
van de zogenaamde volumeresponsiviteit. In het laatste klinische hoofdstuk wordt 
het effect van anesthesie middels een ruggenprik op de bloedsomloop onderzocht 
door middel van FAP. 
In hoofdstuk 2 onderzoeken we de betrouwbaarheid van vingerbloeddruk (FAP) 
bij ernstig zieke kinderen. We hebben simultaan de bloeddruk gemeten door 
middel van FAP en door middel van een intra-arteriële bloeddrukmeting (IAP) 
met een catheter in de arteria radialis, brachialis of femoralis en deze drukken 
hebben we met elkaar vergeleken. Hiernaast hebben we bij een subgroep ook de 
oscillometrische techniek, welke gebruik maakt van een bloeddrukband rondom 
de bovenarm (NIBP), meegenomen in de analyse. De NIBP hebben we enkel 
gedaan bij 13 kinderen die diep gesedeerd waren daar de meting zelf onrust en 
dientengevolge bloeddrukschommelingen kan veroorzaken. Alle metingen zijn 
gedaan in een periode van relatieve hemodynamische stabiliteit. De bloeddruk in 
de vinger is fysiologisch lager dan de bloeddruk in de bovenarm. Daarom hebben 
we een software filter gebruikt wat brachialis-bloeddruk reconstrueert uit het 
vingerbloeddruk signaal, reBAP, en hebben dit eveneens vergeleken met IAP en 
NIBP. Er zijn 35 kinderen geïncludeerd, zij waren allen gesedeerd en lagen aan 
de mechanische ventilatie. Bij 103 metingen kregen de kinderen behandeling 
middels vasoactieve en/of inotrope medicatie. 
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Van de 152 pogingen om FAP te verkrijgen was 4.2% niet succesvol, dit kwam 
vaker voor bij kleine kinderen. Het aantal pogingen wat nodig was om FAP te 
verkrijgen steeg naarmate het lichaamsgewicht daalde. Het gemiddelde verschil 
tussen FAP en IAP was 16.2, -7.7, en -10.2 mmHg voor respectievelijk de systolische 
(SAP), de diastolische (DAP) en de gemiddelde bloeddruk (MAP). De “limits of 
agreement” (LOA) waren respectievelijk 26.1%, 30.1%, and 22.6%.  Het reBAP 
signaal gaf een verbetering van de nauwkeurigheid en precisie met een gemiddeld 
verschil van -11.8, 0.6, en -0.9 mm Hg en LOA van 21.7%, 8.9%, and 8.9%. Het 
gemiddelde verschil tussen NIBP en IAP was -6.8, -0.9, en -3.8 mmHg met LOA 
van 18.2%, 38.6%, en 22.1%. Wij concluderen dat FAP met gebruikmaking van 
reBAP betrouwbaar en uitvoerbaar is in het continue en niet-invasief meten van 
bloeddruk bij ernstig zieke kinderen. Daarnaast is FAP minstens zo betrouwbaar 
in het meten van diastolische en gemiddelde bloeddruk als de NIBP. 
Na de betrouwbaarheid van FAP te hebben bepaald in het meten van absolute 
bloeddruk bij kinderen onderzoekt  Hoofdstuk 3  de betrouwbaarheid van FAP 
in het volgen van bloeddrukveranderingen. We includeerden 13 kinderen met een 
leeftijd van tussen 2 en 90 maanden (gewicht 4 – 31 kilo) die een cardiochirurgische 
ingreep ondergingen waarbij significante bloeddrukveranderingen voorkomen. 
FAP en IAP werden continue gemeten en de 4 grootste bloeddrukveranderingen 
gedurende de ingreep werden gebruikt voor verdere analyse waarbij reBAP en 
IAP met elkaar werden vergeleken. Bij drie kinderen (leeftijd 3 en 4 maanden) 
slaagden we er niet in om FAP te meten wat leidt tot een slagingspercentage 
van FAP van 76%. Deze 3 kinderen verschilden niet van de overige 10 kinderen 
waar wel een FAP meting te verkrijgen was wat betreft type chirurgie, baseline 
hemodynamische parameters of temperatuur van de hand. Het opstarten van FAP 
was tijdrovend waarbij er gemiddeld 5 pogingen (range 1 – 22) nodig waren om een 
goed FAP signaal te verkrijgen. ReBAP volgde bloeddrukveranderingen gemeten 
met IAP nauwkeurig met een R2 van 0.96, 0.97 en 0.98 voor respectievelijk 
SAP, DAP en MAP. Daarnaast volgde reBAP bloeddrukveranderingen met een 
gemiddeld verschil met IAP van 0.0 (SD 5.8), 0.1 (SD 2.8), and 0.2 mm Hg (SD 
2.7), respectievelijk. Wij concludeerden dat FAP bloeddrukveranderingen zeer 
nauwkeurig volgt bij kinderen gedurende cardiochirurgie. Echter, het verkrijgen 
van een FAP signaal van voldoende kwaliteit was tijdrovend of zelfs onmogelijk 
in een significant deel van de studiepopulatie.   
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In hoofdstuk 4 onderzoeken we de betrouwbaarheid van FAP in het meten van 
absolute cardiac output alsook in het volgen van cardiac output veranderingen. 
We includeerden 20 gesedeerde en mechanisch geventileerde volwassen 
patiënten (gemiddelde leeftijd 67 jaar) post-cardiochirurgie opgenomen op de 
intensive care. Zij hadden allen een transpulmonale thermodilutie catheter in situ 
en waren volumebehoeftig. Als een patiënt per order van de behandelend arts een 
volume bolus kreeg (6 ml/kg) werden FAP bloeddruk (ABPNI) en cardiac output 
(CONI), intra-arteriële bloeddruk (ABPIA) en transpulmonale thermodilutie 
(COTD) simultaan gemeten voor en na de volumebolus. Onnauwkeurigheid van 
het meten van cardiac output door middel van FAP kan veroorzaakt worden door 
het algoritme CO-TREK of door het feit dat er aan de vinger gemeten wordt.  Om 
dit te onderzoeken is het IAP signaal offline geanalyseerd dmv CO-TREK en is 
hieruit cardiac output bepaald (COIA) welke eveneens is vergeleken met COTD. 
FAP kon in alle patiënten worden verkregen en er zijn 28 volume bolussen gegeven 
verdeeld over 19 patiënten. Het gemiddelde verschil tussen ABPIA en ABPNI was 
2.7mm Hg (LOA, ±22.2), 4.9 mm Hg (LOA, ±13.6), and 4.2 mm Hg (LOA, ±13.7) 
voor respectievelijk SAP, DAP en MAP. ABPNI volgde bloeddrukveranderingen 
gemeten met ABPIA nauwkeurig met een gemiddeld verschil van 0 (LOA, ±13.7), 
−1 (LOA, ± 10.0), en −1 (LOA, ±9.6) mm Hg voor respectievelijk SAP, DAP and 
MAP en een concordantie van 100%. Het gemiddelde verschil tussen CONI en 
COTD en tussen  COIA en COTD was respectievelijk −0.26 (LOA, ±2.2) L/min 
en −0.78 (LOA, ±1.9) L/min. De “percentage error” tussen CONI and COTD was 
38.9%; de percentage error tussen COIA en COTD was 35.1%. Het gemiddelde 
verschil tussen de technieken werd niet beïnvloed door temperatuur van de 
hand of het gebruik van vasoactieve middelen. FAP volgde cardiac output 
veranderingen nauwkeurig met een concordantie tussen CONI en COTD en tussen 
COIA en  COTD van respectievelijk 100% and 91.7% waarbij we een exclusie zone 
van 5% hanteren. 
Wij concluderen dat FAP bloeddruk en bloeddrukveranderingen bij volwassenen 
nauwkeurig meet. FAP  cardiac output is niet inwisselbaar met transpulmonale 
thermodilutie cardiac output met een percentage error van 38.9% hoewel FAP 
cardiac output veranderingen nauwkeurig volgt.
De nauwkeurigheid van de meting verbeterde niet als het intra-arteriële bloeddruk 
signaal wordt gebruikt in plaats van het vingerbloeddruk signaal.  
Een van de belangrijkste doelen van het meten van cardiac output is de bepaling 
van volume responsiviteit. Dit, om zowel overvulling als ondervulling van een 
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hypovolemische patiënt te voorkomen. Een makkelijke en continue techniek 
om cardiac output mee te meten is essentieel om volumeresponsiviteit goed te 
kunnen bepalen, omdat snelle cardiac output veranderingen moeten kunnen 
worden waargenomen. Twee veelvoorkomende methoden voor het bepalen van 
volumeresponsiviteit zijn de passive leg raising test (PLR-test) en het bepalen 
van dynamische indices uit het een continue bloeddruksignaal. In hoofdstuk 5 
onderzoeken we of volumeresponsiviteit kan worden bepaald door middel van de 
PLR-test en dynamische indices met gebruikmaking van FAP. We includeerden 
gesedeerde en mechanisch beademde patiënten postcardiochirurgie opgenomen 
op de intensive care die volumebehoeftig waren. Allereerst werd cardiac output 
bepaald door middel van FAP (CONI) en transpulmonale thermodilutie (COTD) 
waarna er een PLR-test werd gedaan met behulp van CONI. Hierna werd de 
volumebolus gegeven (6 ml/kg) en werd cardiac output nogmaals bepaald door 
middel van CONI en COTD. De respons van het slagvolume gemeten met FAP 
(SVINI) op de PLR-test werd vergeleken met de slagvolume respons op vulling 
gemeten met transpulmonale thermodilutie (SVITD). De dynamische indices 
werden continue gemeten door middel van FAP en de intra-arteriële catheter en 
hun voorspellende waarde werd eveneens bepaald aan de hand van de slagvolume-
respons op vulling gemeten met transpulmonale thermodilutie. In deze studie 
is eveneens gekeken of eventuele onnauwkeurigheid in het voorspellen van 
volume responsiviteit werd veroorzaakt door het CO-TREK algoritme of door 
de vingerbloeddrukmeting zelf. Hiervoor hebben we ook offline het slagvolume 
bepaald uit het intra-arteriële bloeddruksignaal (SVIIA) en dit vergeleken met 
SVITD na een volumebolus. Uiteindelijk resulteerde dit in de analyse van 27 
vochtbolussen verdeeld over 19 patiënten. 14 patiënten werden geclassificeerd 
als responder met een slagvolume verhoging van meer dan 12%. De concordantie 
tussen de verandering in SVINI tijdens een PLR-test en SVITD na een vochtbolus 
was 89%. De oppervlakte onder de AUC curve van de PLR-test met behulp van 
FAP was 0.64 (95% betrouwbaarheidsinterval 0.42-0.82) . De oppervlaktes onder 
de curve van de AUC van de dynamische indices waren respectievelijk 0.78, 0.55 
en 0.83 voor PPV, SPV en SVV gemeten met FAP.
Er was geen significant verschil tussen de voorspellende waarde van de PLR-test 
en de dynamische indices gemeten met FAP of met de intra-arteriële catheter. 
Hieruit kunnen we concluderen dat FAP niet geschikt is om volumeresponsiviteit 
te bepalen met behulp van de PLR-test. Wel kunnen volumeresponders worden 
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herkend met behulp van de PPV en SVV gemeten met FAP. Er is geen verschil 
tussen de voorspellende waarde van de PLR-test en de dynamische indices 
gemeten met FAP of intra-arterieel gemeten. 
In hoofdstuk 6 hebben we een fenomeen bestudeerd wat veelvuldig voorkomt 
bij spinaal anesthesie: hypotensie. Een veelgebruikte hypothese is dat de 
hypotensie die ontstaat tijdens spinaal anesthesie wordt veroorzaakt door het 
verlies van vaattonus en niet door een daling in cardiac output welke ontstaat 
door een afname in veneuze return. FAP meet cardiac output op een continue 
en niet-invasieve wijze waardoor de techniek geschikt is voor het meten bij 
wakkere patiënten gedurende regionale anesthesie. De patiënten kregen een van 
de twee anesthesieregimes intrathecaal: 15 mg bupivacaïne (medium dose, MD) 
of 10 mg bupivacaïne + 5 mcg sufenta (low dose, LD) we bloeddruk en cardiac 
output werden continue gemeten middels FAP. Hypotensie werd opgevangen 
met vasopressoren, bradycardie werd behandeld middels atropine, de patiënten 
kregen geen intraveneus vocht toegediend. Er werden 33 patiënten geïncludeerd 
in de MD groep en er zaten 31 patiënten in de LD groep, alle patiënten waren ouder 
dan 65 jaar. Er was geen verschil in baseline hemodynamische parameters tussen 
de twee groepen. Bij drie patiënten kon er geen FAP signaal worden verkregen. 
Het slagvolume (SV) daalde gemiddeld 11% in de MD groep en 8% in de LD groep. 
De incidentie van een klinisch significante daling in het SV was hoger in de MD 
groep. Er was geen significante verandering in systemische vasculaire weerstand. 
De gemiddelde dosis van efedrine die werd gegeven was 7.8 mg in de MD groep 
en 4.7 mg in de LD groep, in de MD groep kregen drie patiënten rescue medicatie 
(phenylefrine) vanwege aanhoudende hypotensie. 
Spinaalanesthesie veroorzaakt hypotensie bij oudere patiënten zonder het geven 
intraveneus volume. Deze hypotensie wordt veroorzaakt door een daling in het 
slagvolume en niet door een daling in systemische vasculaire weerstand. Er was 
geen verschil in cardiac output en bloeddruk veranderingen tussen de beide dosis 
groepen. 
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Conclusies
FAP is uitvoerbaar en betrouwbaar in het meten van absolute bloeddruk
en   het volgen van bloeddrukveranderingen bij ernstig zieke kinderen.
Echter, het   verkrijgen van een FAP signaal van voldoende kwaliteit is 
tijdrovend of onmogelijk in een significant deel van de populatie. 
FAP is betrouwbaar in het meten van bloeddruk en het volgen van bloed-
druk veranderingen bij volwassen patiënten opgenomen op de intensive 
care.
FAP cardiac output is niet inwisselbaar voor cardiac output gemeten mid-
dels transpulmonale thermodilutie met een percentage error van 38.9%. 
FAP volgt cardiac output veranderingen met een hoge concordantie. 
Volume responsiviteit kan niet worden bepaald met FAP door middel van 
een PLR-test.
Volume responders kunnen worden herkend door middel van PPV en SVV 
gemeten met FAP. 
Er is geen verschil tussen de voorspellende waarde van de PLR-test
en PPV en SVV gemeten met FAP of met behulp van de intra-arteriële
catheter. 
Hypotensie die ontstaat tijdens spinaal anesthesie wordt veroorzaakt
door een daling in het slagvolume en niet door een daling in de
systemische vasculaire weerstand.
190
1.
2.
3.
4.
5.
6.
7.
Toekomstperpectieven
Wat is nu de plaats van FAP  binnen de klinische en wetenschappelijke omgeving? 
Er is al veel onderzoek gedaan met FAP, zowel validatie studies als klinische 
toepassingsstudies en het gebruik van de vingercuff is zowel uitvoerbaar als 
betrouwbaar gebleken in vergelijking met de intra-arteriële catheter. Om deze 
reden moet toekomstig onderzoek zich richten op verbetering van het CO-TREK 
algoritme zelf, om de betrouwbaarheid en daarmee toepasbaarheid van cardiac 
output meting door middel van FAP te vergroten.   
Ook moet FAP zijn plaats vinden binnen het klinische veld. Door de beperkte 
betrouwbaarheid van FAP in het meten van cardiac output is het onwaarschijnlijk 
dat er een plaats is voor FAP in de behandeling van patiënten met gecompliceerde 
hemodynamische profielen op een intensive care. Daarnaast worden deze 
patiënten veelal behandeld met een intra-arteriële catheter voor een andere reden, 
zoals arteriële bloedafnames, waardoor de indicatie voor een vingermeting komt 
te vervallen. Echter, vanwege het feit dat FAP makkelijk en snel in het gebruik 
is, kan FAP zeer toepasbaar zijn in de vroege resuscitatie fase. Bij de opvang en 
eerste behandeling van een patiënt in shock op de eerste hulp, de verpleegafdeling 
of na opname op de intensive care is cardiac output meting geen prioriteit. We 
beginnen de behandeling volgens het ABC schema en dienen doorgaans ruim 
intraveneus vocht toe in deze fase. En dan, nadat de patiënt gestabiliseerd is, 
overwegen we of aanvullende hemodynamische monitoring geïndiceerd is 
waarbij we de voordelen van een beter inzicht in de hemodynamiek moeten 
afwegen tegen de risico`s van invasieve monitoring. Echter, ook of zelfs juist in 
de resuscitatiefase, kan een beter begrip van de hemodynamiek door middel van 
een simpele en snelle techniek zoals FAP excessieve volumetoediening, het (te) 
laat starten van vasoactieve medicatie of onderresuscitatie voorkomen.  Maar ook 
tijdens de tweede en derde fase van volume-therapie, optimalisatie en stabilisatie, 
kan FAP helpen in de afweging om wel of niet meer volume toe te dienen, juist 
bij de “simpele” patiënten zonder invasieve monitoring en/of mechanische 
ventilatie. In deze groep kan FAP gebruikt worden voor de evaluatie van een 
mini-fluid challenge of om het effect van een gegeven volumebolus te bepalen. 
Daarnaast kan FAP een plek hebben binnen de anesthesie. Tijdens narcose 
voldoen de meeste patiënten, in tegenstelling tot op de intensive care, wel aan 
de criteria die nodig zijn voor het bepalen van de volumeresponsiviteit middels 
pulse pressure variation of stroke volume variation. Op de operatiekamers kan 
FAP worden geïncorporeerd in vloeistof protocollen waardoor de (te) grote 
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variatie in volumeregimes binnen afdelingen kan worden verkleind en kan FAP 
worden gebruikt bij hemodynamische optimalisatie tijdens hoogrisico chirurgie. 
Hiernaast is aangetoond dat zelfs kortdurende episodes van hypotensie een 
negatief effect hebben op outcome en dat deze kunnen worden voorkomen met 
behulp van een continue  bloeddrukmonitor. Verder onderzoek moet uitwijzen of 
FAP bloeddrukmeting tijdens anesthesie de kans op postoperatieve complicaties 
ten gevolge van hypotensie, zoals acuut nierfalen, beroerte en overlijden, verkleint. 
Conclusies
FAP meet bloeddruk en cardiac output op een continue, snelle, simpele en 
veilige manier met gebruikmaking van een vingercuff. Hoewel FAP diastolische 
en gemiddelde bloeddruk adequaat weergeeft, onderschat het de systolische 
bloeddruk bij kinderen en volwassenen. De techniek is niet uitwisselbaar met 
transpulmonale thermodilutie techniek in het meten van absolute cardiac 
output waardes maar geeft cardiac output veranderingen wel adequaat weer. 
Volumeresponsiviteit kan niet worden bepaald door middel van een PLR-test met 
gebruikmaking van FAP maar kan wel worden voorspeld door het bepalen van PPV 
en SVV met behulp van FAP. Gezien het bovenstaande kan FAP een plaats hebben 
bij het monitoren, resusciteren en optimaliseren van hemodynamisch (dreigend) 
instabiele patiënten op de operatiekamer, de eerste hulp, de verpleegafdeling en 
de intensive care. 
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CHAPTER 10
Dankwoord, Curriculum Vitae 
en Publicatielijst
Dankwoord
“No (wo)man is an island” zei John Donne (1572-1631) ongeveer en dat geldt 
zeker ook voor onderzoek doen. Vele mensen hebben mij in de afgelopen jaren 
bijgestaan in de totstandkoming van dit proefschrift en een woord van dank is 
dan ook ruimschoots op zijn plaats. 
Allereerst Joris, jouw bijdrage aan dit proefschrift is enorm geweest. We 
leerden elkaar kennen op het moment dat ik eigenlijk wilde stoppen met de 
geneeskundeopleiding om bedrijfskunde te gaan studeren, ik had alleen nog even 
een wetenschappelijke stage nodig. Dat is wat anders gelopen. Waar we eerst 
samen zijn begonnen met onderzoek doen bij de kinderen op H30, ik in het kader 
van mijn wetenschappelijke stage en jij als begeleider en promovendus, zijn de 
rollen langzaam doorgeschoven naar die van promovendus en co-promotor. Er 
waren vele hoogtepunten zoals jouw promotie, de Edwards award, congressen, 
etc. en ook enkele dieptepunten, zoals een obductie op een lauwwarm aapje om 
elf uur s`avonds en die verfoeide zes. Maar veel belangrijker nog dan je rol als 
copromotor, was de rol die je hebt gespeeld bij de rest van mijn carrière. Je was 
altijd bereid om mee te denken over de grote beslissingen, hobbels te overwinnen 
en successen te vieren. Ik zou iedereen zo`n mentor gunnen die langs de zijlijn 
meebeweegt. Wat de toekomst ook moge brengen, ik reken erop dat we er samen 
over kunnen filosoferen onder het genot van een Nespresso of twee. 
Prof. dr. J.G. van der Hoeven, beste Hans, je bent een bijzonder mens en ik prijs 
me uitzonderlijk gelukkig met jou als baas en promotor. Wat ben je belangrijk 
geweest voor mijn carrière en afronding van dit proefschrift. Jouw vertrouwen 
in mij is een geweldige motivator geweest en heeft me over de streep getrokken 
om op de IC te gaan werken, een beslissing waar ik geen dag spijt van heb gehad. 
Jouw manier van patiëntenzorg geven en je blik op de mens achter de ziekte zijn 
voor mij altijd een grote inspiratie geweest. 
Prof. dr. G. J. Scheffer, beste Gert-Jan,  dank voor alle ruimte die je altijd hebt 
gegeven om me te ontwikkelen en mijn ambities waar te maken. Je deur staat 
altijd open voor advies, om even mee te denken of om iets te regelen.  Je bent van 
grote invloed geweest op mijn carrière, veel dank hiervoor. 
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Beste Benno, ik zie ons nog staan, op kerstavond op AOV met een van onze 
eerste patiënten met drukcatheters rond het hart. Die studie heeft een “beetje” 
meer moeite en tijd gekost dan we van tevoren hadden gedacht maar hij heeft 
uiteindelijk wel drie mooie artikelen opgeleverd. Dank voor de samenwerking en 
de gezelligheid! Hier wil ik ook de thoraxchirurgen,  cardioanesthesiologen 
en in het bijzonder Peter Kievit bedanken, die ruim medewerking hebben 
verleend aan deze bewerkelijke studie. 
Beste Marc, wij kennen elkaar van de perifere stage alwaar de we studie bij spinaal 
anesthesie hebben opgezet en uitgevoerd. Uiteraard duurde het aanvragen en 
opzetten van de studie zo lang dat mijn perifere stage al ruimschoots voorbij was 
voordat we de studie hadden afgerond. Dit heb jij op je genomen, met hulp van de 
andere anesthesiologen uit het CWZ waarvoor heel veel dank. Daarnaast was 
je een geweldige opleider, zowel medisch inhoudelijk als wat betreft planning, 
ziekenhuis-politiek, samenwerking, etc. en ik kijk er met veel plezier op terug!
Beste Prof. dr. Pickkers, Peter,  veel dank voor je advies, kritische en opbouwende 
houding ten aanzien van het schrijfwerk en hulp met de statistiek. Uiteraard ook 
mijn dank voor je “satelliethulp” in de vorm van het even beantwoorden van 
een veelheid aan vraagjes die bij jou terechtkwamen omdat jouw werkkamer nu 
eenmaal naast de mijne is. En natuurlijk ook doordat je deur altijd open staat 
voor wetenschappelijk advies, het ventileren van frustraties, levenswijsheid en 
allerhande onzin. Met een beetje humor, relativering en spierballen wordt het 
(werk)leven een stuk aangenamer. 
Carine en Renske, heel veel dank voor jullie grote bijdrage aan onze studie. 
Zonder jullie was het zeker niet gelukt en het wordt een mooie publicatie. Ook 
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eerste uur in Nijmegen. Ondertussen niet meer zo heel erg jong en vele life-events 
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